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 The membrane of the endoplasmic reticulum (ER) is the site of numerous 
complex activities essential to the survival of eukaryotic cells. In the membrane sheets 
of the rough ER (rER), integral membrane proteins are synthesized, folded, modified, 
and transported throughout the cell. In the smooth ER (sER) tubules, lipids are 
synthesized and processed with a variety of functionalities, and trafficked to specific 
membrane compartments. The sER is also the site of calcium storage and controlled 
release, an important function for several cell types including neurons and muscle.  
 The sER requires energy and the action of numerous proteins to maintain its 
highly curved, tubular shape and its reticular, interconnected structure. The recent 
discovery of a family of proteins called atlastins has helped answer some of the 
questions surrounding the tubular, reticular nature of the sER. Atlastins comprise a 
group of ER resident proteins that have been shown to facilitate the fusion of 
membrane tubules within this organelle. They are part of the dynamin superfamily of 
proteins, which use the energy stored in GTP to sculpt membranes throughout the cell. 
However, the exact molecular mechanism for how atlastin mediates membrane fusion 
remained mysterious. In this study, we have taken apart and analyzed atlastin-1, one of 
three isoforms of atlastin in humans. This isoform is found primarily in the central 
nervous system and is mutated in the neurodegenerative disorders Hereditary Spastic 
Paraplegia and Hereditary Sensory Neuropathy.  
  This study has resulted in a collection of three-dimensional, high-resolution 
structures of atlastin-1’s catalytic core fragment, comprising its GTPase and middle 
domains bound to various forms of the guanine nucleotide. These structures revealed 
key information about the catalytic mechanism of atlastin-1, as well as interesting and 
important conformational changes that occur within the structure. Using these 
structures, as well as information from small-angle X-ray scattering (SAXS), size-
exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), 
Förster resonance energy transfer (FRET), and enzymatic activity assays, we have put 
together a general working model for atlastin membrane fusion and have gathered 
important information about its mechanism that may be used to target the protein for 
the treatment of disease.  
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CHAPTER 1 
INTRODUCTION 
 
MEMBRANE FUNCTION AND DYNAMICS 
 In the world of the cell, the membrane is the supreme mediator of organization. 
It provides structure, a means of separation, and a platform for reactions that would 
otherwise be impossible in the environment of the cytoplasm. In some ways even 
more so than DNA, a lipid membrane is a universal component in all forms of life, 
including viruses.  
 In eukaryotes the membrane is an essential tool in a variety of tasks that allow 
for the cell’s intense complexity. Billions of years ago the simple prokaryotic cell 
evolved from a single plasma membrane enclosing the entire cell to an organism with 
several membrane-bound organelles within it (1). Importantly, the nucleus was 
cordoned off from the cytoplasm and an organelle called the mitochondria appeared 
that revolutionized the way cells produce energy. With the mitochondria, cells could 
use aerobic respiration to metabolize the same amount of their carbon-based energy 
sources (sugar) to make almost twenty-times as much energy for cellular activities as 
they could before using anaerobic respiration (1). This newfound energy would allow 
eukaryotes to develop more complex ways to take advantage of their environment and 
compete with other organisms. Eventually this would lead to the emergence of multi-
cellular life, including the metazoans to which human beings belong. 
 Modern eukaryotes not only contain a nuclear membrane and mitochondria, 
but have also developed a highly coordinated and intricate system for transportation, 
modification, and metabolism of nutrients, proteins, lipids, ions, and other signals the 
cell uses to survive and interact with the environment. This system includes a 
collection of membranous compartments that have specific jobs, but are all 
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interrelated in their activities. These include the endoplasmic reticulum (ER), the 
Golgi complex, and the endosomal membrane system. These organelles are involved 
in the synthesis, modification, targeting, and recycling of membrane proteins 
throughout the cell. Additionally, they orchestrate the production and organized 
shuffling of lipids.  
 Clearly, cellular membranes cannot be static, unchanging structures. Many 
years of research has revealed that membranes are anything but simple. The lipids that 
make up membranes are structurally and functionally diverse, with phosopholipids 
constituting the main components of biological membranes (Figure 1.1.). These types  
 
 
Figure 1.1. Chemical structure of phospholipids. Structures of three common phospholipids 
found in mammalian cell membranes: POPC (top), POPE (middle), and POPS (bottom). All 
phospholipids are made up of a hydrophobic, fatty acid tail that often contains unsaturated 
carbon-carbon double bonds. A glycerol moiety (in most cases) links these fatty acid tails to a 
phosphate group, which is followed by a simple organic molecule (called the headgroup). 
Variations in the identity of the headgroup and degree of saturation in the fatty acid tails 
determine the specific properties of phospholipids in the membrane.  
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of lipid are comprised primarily of three parts: a glycerol core, hydrophobic fatty-acid 
tails, and a phosphoester linked hydrophilic head group that can take on a variety of 
shapes, sizes, and charge states. Each membrane subcompartment can be comprised of 
numerous lipid types, differing both in their hydrophobic tails and their head groups. 
Some of these lipids are present for signaling purposes (i.e. Phosphatidylinositol 
phosphates [PIPs]), some serve to impart a certain structure to a membrane 
(curvature), while others are present to form platforms on which biological reactions 
and interactions can occur (rafts). Each organelle compartment is comprised of a 
specific mixture of lipids that both defines it and aids it in its function.  
Of particular relevance to the topic of this dissertation is the smooth ER (sER). 
The sER is the site of lipid synthesis, where they are assembled from cytosolic 
precursors, packaged into vesicles, and finally trafficked to their target organelle via 
endosomal transport or direct contact sites (2, 3). The tubular, reticular shape of the 
sER serves to maintain its luminal continuity and increase the surface area of this 
organelle in order for it to do the job of lipid synthesis, calcium buffering, and 
metabolism of various molecules in locations throughout the cell. This tubular 
structure requires energy to stabilize its highly curved structure. This can often be 
accomplished simply by distributing specific proteins and lipids unevenly across the 
two leaflets of the membrane. In particular, ER resident proteins called Receptor 
Accessory Proteins (REEPs) and reticulons (4) can insert into the outer leaflet of the 
bilayer, effectively increasing the surface area of that leaflet and causing the 
membrane to take on an inherently curved structure to accommodate the mismatched 
surface area of the two leaflets, a phenomenon called hydrophobic insertion (5, 6) 
(Figure 1.2.). Lipids can also accomplish this task if the headgroups of the lipids in 
one leaflet of the bilayer take up more volume than those on the opposite leaflet. In the 
sER, both of these strategies are used in order to create long tubules. The branched (or  
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Figure 1.2. Hydrophobic insertion. (A) Within the lipid membrane, the hydrophobic tails 
(black, curvy lines) of lipids are buried within the bilayer and protected from water exposure 
by hydrophilic headgroups (brown circles). (B) When a protein inserts a hydrophobic region 
into one leaflet of the membrane, the surface area of that leaflet is effectively increased. (C) 
This disparity in surface area can be accommodated on the opposite leaflet by curving the 
membrane.   
  
reticular) nature of the sER is achieved through the fusion of these tubules (3, 7-10). 
However, membrane fusion is a non-trivial process that also requires energy and 
importantly, specificity in order to control the shape of the resulting structure. In most 
fusion events throughout the secretory pathway, proteins called SNAREs (Soluble 
Attachment N-ethyl-maleimide-sensitive fusion Protein REceptor) mediate this 
process through the use of metastable protein-folding intermediates that store the 
potential energy used to power fusion (11-14). Within this family of proteins, there are 
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both target (t) and vesicle (v) SNAREs that are paired specifically to one another in 
order to fuse only vesicles containing the correct v-SNARE with a target membrane 
containing the corresponding t-SNARE. Although the sER contains SNAREs for 
exporting lipids and proteins, it was recently discovered that homotypic fusion of sER 
tubules into a reticular network is accomplished through a new family of fusogenic 
proteins called atlastins (8, 10, 15-17). Atlastins are integral membrane proteins 
belonging to the dynamin superfamily of proteins that use chemical energy to sculpt 
membranes. In the case of atlastins, the chemical energy stored in GTP is used to bring 
together and ultimately fuse opposing membranes in the sER. Atlastin’s fusion activity 
is necessary for both ER establishment and maintenance, with knockdowns of atlastin 
in Drosophila melanogaster exhibiting fragmentation of the ER (10).  
The ability of a membrane to be dynamic, to achieve fusion and fission, and to 
take on specific morphologies is not a unique requirement of the sER. These activities 
go on throughout the cell in every membrane, involving a vast number of proteins to 
control these processes. The dynamin-superfamily of large guanosine triphosphatases 
(GTPases, to which atlastin belongs), is a major player in these processes, especially 
membrane fusion and fission, and will be discussed further below.  
 
DYNAMIN RELATED PROTEINS 
 Proteins of the dynamin superfamily have ancestors dating all the way back to 
prokaryotes (18), highlighting their importance in mediating membrane dynamics in 
all types of cells. A major subset of this diverse group of proteins is primarily involved 
in facilitating membrane fission and fusion. These proteins take part in numerous 
essential cellular processes, including pathogen resistance, endocytosis, organelle 
fission and fusion, and cytokinesis (19, 20). The genetic locus of the family’s 
namesake, dynamin, was first discovered as a temperature-sensitive mutation in 
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Drosophila melanogaster that caused paralysis (21). Even before this, the protein 
dynamin was found in extracts of cow brain, associated with microtubules and 
reported as a mechanochemical enzyme (22). Presently, dynamin is the most 
intensively studied member of the superfamily, with numerous high-resolution 
structures that have helped shape our understanding of this important protein (23-27).  
 Dynamin and it’s related proteins are composed of a large GTPase domain as 
well as one or several domains that aid in their mechanochemical functions. The 
GTPase domains of proteins in the dynamin family are related to the well-known Ras-
like GTPases, but with several distinct differences. First, the GTPase domain of 
dynamin-like proteins is larger in size compared to Ras-like GTPases (~300 amino 
acids compared to ~180). Second, instead of relying on GTPase activating proteins 
(GAPs) many dynamin-like proteins have been shown to use homo-oligomerization to 
activate and accelerate their GTPase activity (28). In this regard, dimerization is 
believed to stabilize the conformation of the otherwise flexible switch regions and 
hence the catalytically active state. In addition, they do not need Guanine-nucleotide 
Exchange Factors (GEFs) in order to initially bind GTP in exchange for GDP, because 
they have a much lower affinity for nucleotide in general compared to Ras-like 
GTPases. Dynamin-like GTPases are also fundamentally different from their Ras-like 
cousins in that their main function is not for signaling using GTP and GDP as an on-
off switch, but instead they use it to do mechanical work in the cell. Because of this, 
all dynamin-like proteins contain other functionally relevant domains in addition to 
their GTPase domain. In particular, they all include a middle or helical domain that is 
involved in oligomerization and usually assists in the mechanics of the protein’s 
function. They are also all targeted to one or more membranes by an integrated 
membrane interaction domain or via post-translational modification with the addition 
of a lipid group such as an isoprenoid moiety (29). Some members also contain other 
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types of targeting domains, such as PRD (Proline-rich domain) to mediate protein-
protein interactions (Figure 1.3.).  
 
 
 
Figure 1.3. Dynamin superfamily proteins. Domain architecture of the human dynamin 
superfamily members, broken down into subfamilies according to Praefcke and McMahon 
(19). The Classical Dynamins include the three human isoforms, each containing the five 
domains shown above. The Dynamin-related Protein subfamily includes Dlp-1, MxA/B, OPA-
1, and Mitofusin-1 and 2. The last subfamily, and furthest related by sequence, are the GBP-
related Proteins, which include the five GBP isoforms and three atlastin isoforms. All domains 
and interdomain regions are drawn to scale and are color coded as follows: GTPase domains 
(off white), Middle domain (Blue), GED [GTPase effector domain] (Orange), PH [Pleckstrin 
homology] (Green), PRD [Proline-rich domain] (Purple), Transmembrane domains (Grey), 
HR [Heptad repeat] domains (Red), and MIS [Mitochondrial import sequence] (Teal).  
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Figure 1.4. Dynamin superfamily nucleotide binding and switch region homology. Switch 
regions G1-4, regions of homology. Sequence alignment of several dynamin superfamily 
members shows conserved regions involved in nucleotide binding and hydrolysis, with strictly 
conserved residues highlighted in green. Arginine-77, specifically conserved in atlastins and 
GBPs, is highlighted in black.  
 
Within the dynamin superfamily the sequence homology between members 
can vary widely; but in the GTPase domain the homology is closer, especially within 
the GTP binding motifs (switch regions G1-G4) that are essential for nucleotide 
binding and GTPase activity (Figure 1.4.). Using sequence homology, domain 
organization, and functional homology the dynamin superfamily can also be broken up 
into three subgroups, namely the classical dynamins, the dynamin-related proteins, and 
the GBP-related proteins. The classical dynamins all contain the following five 
domains: GTPase, middle, PH, GED, and PRD. By contrast, the dynamin-related 
proteins do not contain a PRD. This subfamily includes the proteins Dlp (Dynamin-
like protein), MxA and B, OPA1 (Optic-atrophy 1), and mitofusin1 and 2. The last 
subfamily, the GBP-related proteins, is made up of GBP1-5 (Guanylate binding 
proteins: isoforms 1 through 5) and the atlastin1-3 (Figure 1.3.).  
 Dynamin, the founding member of this superfamily, is the best characterized in 
the group. There are three isoforms of dynamin in mammals. Dynamin-1 is found 
mostly in the brain, where it is involved in vesicle recycling in the presynapse. 
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Dynamin-2 is found all throughout the body, and is involved in endocytosis generally. 
Dynamin-3 is found in the testis, as well as the brain but mostly postsynaptically in 
neurons. These classical dynamins have been shown to take part in not only clathrin-
mediated endocytosis (for which they are best known), but also budding of caveoli, 
podosome formation, phagocytosis, and cytokinesis. Much of the molecular 
mechanism for dynamin-mediated membrane fusion has been studied and is now well 
understood. Cyro-EM reconstructions of near full-length dynamin coated membrane 
tubes revealed that the middle domain and GED form a stalk-like structure involved in 
self-assembly. In addition, a three-helix bundle formed by the C terminus of the 
GTPase domain and the GED of dynamin, termed the bundle signaling element (BSE) 
was found to modulate dynamin function (26, 30), along with the PH domain, which 
regulates membrane binding and GTPase activity (31). Furthermore, membrane-
mediated higher-order oligomerization stimulates dynamin GTPase activity, properties 
that have also been shown to be important for the function of other dynamin family 
members including MxA and GBP (32, 33). In a recent report, it was shown that 
following dynamin assembly on nanotubes, GTP addition caused disassembly of 
dynamin coats, but allowed shorter segments (2-3 rungs) of dynamin rings to catalyze 
membrane fission by application of elastic stress and coordination of membrane 
rearrangements through its PH domain (34).  
 The members of the subfamily of dynamin-related proteins have a similar 
domain structure to the classical dynamins, containing the large GTPase domain, 
middle domain, and GED. Dlp1, the member most closely related to the classical 
dynamins, also contains a PH domain, but the other members (MxA/B, OPA-1, and 
the mitofusins) do not. Instead, the mitofusins and OPA-1 contain a transmembrane 
domain. In the case of MxA/B it is thought that a cluster of positively charged residues 
on an unstructured loop (Loop 4 in the recently solved structure; located between the 
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middle domain and GED) mediates its interaction with lipids, since charge-reversal 
mutations in this loop abolish lipid binding (35). Excluding MxA and B, the remaining 
members of this subfamily are all localized to the mitochondria and are indispensible 
parts of mitochondrial fission and fusion events. Specifically, Dlp-1 (called Dnm1 in 
yeast) is necessary for the fission of this organelle, and similar to dynamin, forms ring-
like structures around mitochondrial fission sites (36-38). Both mitofusin and OPA1 
are required for mitochondrial fusion, with the mitofusins involved in fusion of the 
outer mitochondrial membrane and OPA1 (called Mgm1 in yeast) the inner 
mitochondrial membrane (39, 40).  
The GBP-related subfamily of dynamin proteins contains only two subtypes, 
the GBPs and the atlastins (discussed in more detail in the next section); but these two 
protein types have very different functions and molecular details. Atlastins function as 
membrane fusogens, whereas GBPs function in pathogen resistance. The GBP’s are a 
large group of proteins (with at least 5 isoforms in humans) that have been studied 
extensively, with many aspects of its biochemical and structural characteristics 
revealed in the last ten years (41-46). In addition to its anti-microbial activities, GBPs 
have been linked to new functions including cell proliferation (47), inhibition of 
matrix metalloprotease expression (48), inhibition of cell spreading (49), and intestinal 
epithelial cell development and barrier functions (50, 51). Yet, it is still not well 
understood how these proteins perform these functions in vivo. What is known about 
GBP is that it can be targeted to membranes via lipid modification on its CaaX motif 
(29, 52), and that some isoforms have the unique ability among dynamin superfamily 
members not only to hydrolyze GTP to GDP, but also to subsequently hydrolyze GDP 
to GMP. In vitro experiments have shown that GBP does rely on homodimerization to 
accelerate these reactions (42-46). Two crystal structures of GBP-1 have been solved 
including one full-length, nucleotide-free form and one of the GTPase domain alone 
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bound to the non-hydrolyzable GTP analog GppNHp. The full-length structure 
illustrates how the GTPase and middle domains can interact with its C-terminal GED, 
while the GTPase domain structure shows how two of these proteins can 
homodimerize when bound to nucleotide, consistent with in vitro studies.  
 Although the dynamin-superfamily members are somewhat diverse in 
sequence and functionality, comparisons between them can also be enlightening. 
Numerous structures of dynamin family proteins have been solved to date (Table 1.1.), 
and while they have indeed helped shed light on their own molecular mechanisms they 
also all show striking structural similarity, suggesting that these proteins may have 
more in common than their sequences suggest. 
 
Table 1.1. Functions of mammalian Dynamin-like proteins at the membranea 
Name Location in the cell Functionality Structuresb Refs 
Classical 
Dynamin 
Endocytic sites at the PM, 
ARP2/3 containing actin 
meshworks 
Endocytic membrane 
fission, ARP2/3-
dependent actin 
dynamics regulation 
11 (23-27, 
53-56) 
Dynamin-
related protein 1 
(Dynamin 1-like 
protein) 
Mitochondrial outer membrane, 
peroxisomes 
Mitochondrial and 
peroxisomal 
fission/division 
1 (36, 
57-60) 
Mitofusins Mitochondrial outer membrane Mitochondrial fusion 1 (57-61) 
OPA1 Mitochondrial inner membrane Mitochondrial fusion 0 (57-60, 
62) 
Myxovirus 
resistant 
proteins 
ER Antiviral  2 (32, 63, 
64) 
Guanylate-
binding proteins 
Intracellular vesicles Viral and bacterial 
pathogen resistance 
6 (43, 45, 
65, 66) 
Atlastins ER, cis-Golgi ER membrane fusion 10 (3 
unique) 
(10, 17, 
67-70) 
amodified from Ferguson et al 2012 (20) 
bnumber of high-resolution structures solved to date; does not include EM reconstructions 
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ATLASTIN 
 As the most distantly related members of the dynamin superfamily, atlastin 
proteins have several unique features. Unlike dynamin they have been shown to 
catalyze membrane fusion as opposed to fission. They are the smallest members of the 
superfamily at around 60kDa in size, but still contain a large (280AA) GTPase 
domain, a helical middle domain, a membrane interaction domain in the form of two 
transmembrane alpha helices, and an amphipathic C-terminal tail. The N- and C-
termini of atlastin lie on the cytosolic side of the membrane, with the two 
transmembrane helices each spanning the membrane (16). Atlastin proteins have been 
found in all types of metazoans, and although there is no sequence homology, there 
are functional homologs of atlastin in yeast and plants, called Sey1p and RHD3 
respectively (71, 72). Presently, the most well studied forms of atlastin are the human 
isoforms (mainly isoform 1), atlastin from Drosophila melanogaster (DmAtl), and 
atlastin from the plant Arabidopsis thaliana (called Root Hair Defective-3, RHD3).   
In humans there exist three isoforms, named atlastin-1 through atlastin-3, with 
several alternative splice-forms listed in the Genbank. All three isoforms share a high 
degree of homology (66-72% identical) in their overall amino acid sequences, with 
most variability confined in the extreme N- and C-termini. The isoforms differ in their 
tissue expression patterns, with isoforms 2 and 3 expressed ubiquitously throughout 
the body and isoform 1 more restricted, found mostly in the central nervous system. 
Within the cell, all three isoforms contain ER retention signals on their C-termini and 
are found in the ER, with atlastin-1 also located in the cis-Golgi and growth cones of 
neurons (9). Within the ER atlastins are associated with three-way junctions. This 
reticular morphology is reduced and partially replaced by long, unbranched tubules 
when atlastin-2 and -3 are knocked down in HeLa cells (17, 73). A similar but more 
drastic phenotype is observed when DmAtl is knocked down in Drosophila, where the 
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authors observe extreme ER fragmentation in muscle and neurons (10). Since 
Drosophila only have a single isoform, the more pronounced effect of knocking down 
atlastin is unsurprising. It will take more study to figure out the functional disparities 
or overlaps between the three human isoforms and to determine whether they retain 
similar fusion capabilities as the Drosophila homolog.  
Atlastin-1 has several interacting protein partners, including spastin/SPG4 (74, 
75), reticulons/DP1 (17), REEP1/SPG31 (73), and NIPA1/SPG6 (76). Interestingly, 
atlastin-1 and most of its interaction partners have been identified as some of the most 
frequently mutated loci in Hereditary Spastic Paraplegia (HSP; also called Familial 
Spastic Paraplegia and Strumpell-Lorrain disease), a neurodegenerative disorder 
caused primarily by axonal degeneration of upper motor neurons (77). Atlastin-1 
mutations have also been found in patients of another neurodegenerative disease called 
Hereditary Sensory Neuropathy Type I (HSN I). Both of these disorders involve 
progressive axonal degeneration of neurons that control muscles, and will be discussed 
in more detail in the next section. Atlastin’s interaction with another HSP locus 
spastin, a microtubule severing enzyme, has been observed by a number of groups, but 
the exact mode of interaction remains unclear from these studies. In the case of 
atlastin’s interactions with the reticulon and REEP1 (receptor accessory protein-1) 
proteins (integral membrane proteins that stabilize the highly-curved tubules found in 
the sER) the most likely domain of interaction with atlastin-1 is in their membrane-
spanning domains (73). Although an interaction between HSP proteins NIPA-1 and 
atlastin-1 has been shown via immunoprecipitation studies (76), other groups have not 
confirmed this interaction, nor has the domain of interaction been identified.  
It has been assumed that all isoforms of atlastin are involved in membrane 
fusion of ER tubules, but no conclusive in vitro evidence for this exists for any atlastin 
isoforms in human. The only convincing case for atlastin-mediated membrane fusion 
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is for the Drosophila atlastin homolog. First, as stated previously, an RNAi 
knockdown of atlastin in Drosophila causes fragmented ER (10). Perhaps more 
convincingly, DmAtl has been shown to fuse membranes in vitro. Using a simple 
lipid-mixing assay, reconstituted full-length DmAtl is able to fuse synthetic liposomes 
when GTP and a divalent cation (magnesium) are added, an activity that is blocked 
when a GTPase defective mutant is used (10). Interestingly, both of atlastin’s 
transmembrane domains (the specific sequences of which was also important) and the 
C-terminal amphipathic helix are necessary for catalyzing membrane fusion (78). In 
addition to Drosophila, atlastins from Xenopus laevis gained some additional evidence 
for their role as fusogens when it was observed that antibodies against Xenopus 
atlastins (as well as GTP analogs) inhibited reformation of ER tubules from ER 
derived vesicles in Xenopus egg extracts (17).  
Although atlastin-1 is implicated in ER fusion, it has also been associated in 
other cellular processes such as vesicle transport and BMP (bone morphogenetic 
protein) signaling (79, 80). In addition, evidence suggests that atlastin is indirectly 
and/or directly involved in the transport of sER tubules down the axon via 
microtubules where they serve as calcium stores (81-83), a necessary function in 
axons of any length (84, 85). One possible mode of regulation of this process is 
through the protein spastin-1 (specifically the M1, or long form), a microtubule 
binding and severing AAA ATPase (85), whose activity atlastin-1 has been shown to 
modulate. For these reasons, it will be important for future research to not only 
address the role of atlastins in membrane fusion but also assess other possible cellular 
functions that may have evolved in higher eukaryotes and that could contribute to 
disease.  
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HEREDITARY SPASTIC PARAPLEGIA AND HEREDITARY SENSORY 
NEUROPATHY 
 Perhaps the most interesting aspect of neurons is their complexity. Neurons 
have amazing capabilities that we are just beginning to understand, and without them 
our ability to think, move, and sense our environment would be impossible. However, 
the complexity of neuronal cells can ultimately become their downfall. Many types of 
neurodegenerative diseases have been found that affect each of the different types of 
neurons in the human body, but unlike other diseases that can be treated, cured, or 
otherwise overcome with modern medicine, neurodegenerative diseases currently have 
few proven treatments, are generally devastating in their effects (physically and/or 
mentally), and are usually progressive in nature.  
 One of the reasons neurons tend to be more prone to disease is because of their 
unusual architecture. Neurons are made up of a cell body, dendrites, and an axon. The 
cell body contains the nucleus and all of the organelles found in other cells (i.e. ER, 
Golgi complex, mitochondria, etc.). In order to communicate between neurons, they 
also contain dendrites, which are long, branched projections containing many types of 
receptors to sense incoming chemical and electric signals from neighboring neurons. 
Dendrites receive these signals by forming a connection (called a synapse) with the 
axon of a neighboring neuron. The axon is usually a single, long projection from the 
cell body that transmits a chemical or electric signal (first sensed in the dendrite) to the 
next neuron. Axons in the human nervous system can span vast distances, especially 
those of upper and lower motor neurons (Figure 1.5.). The main problem neurons face 
is how to get nutrients and signals from the cell soma to the ends of the neurites. 
Neurons solve this problem in different ways for axons and dendrites. Dendrites have 
areas of ER extensions and “Golgi outposts” to provide them with the proteins 
necessary for their function (86, 87). In axons, smooth ER tubules and mitochondria  
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Figure 1.5. The human cortical spinal tract. Adapted from Goyal et al (7). Upper motor 
neurons that control voluntary muscle movement originate with their cell bodies in the motor 
cortex with axons that traverse down to the spinal cord (often crossing the midline) to connect 
to the cell body of lower motor neurons. Lower motor neuron cell bodies start in the spinal 
cord, where they receive signals from upper motor neurons, and extend their axons away 
eventually connecting directly to muscle cells. Green and blue boxes indicate areas affected by 
HSP and HSN, respectively.  
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are transported down the axon and are positioned strategically along the axon as well 
as in the synapse itself. These two organelles are necessary for axonal function and 
maintenance because of the axon’s high-energy needs and reliance on calcium 
signaling (81, 88). Mitochondria, for example, are found concentrated in areas with 
extreme energy needs such as nodes of Ranvier and at the synapse (89-91). Organelles 
as well as vesicles containing necessary proteins from the soma are transported down 
the axon via anterograde microtubule transport. When transport in either direction is 
compromised, axonal degeneration followed by apoptosis can occur (92). 
 Hereditary Spastic Paraplegia (HSP) comprises a group of related inherited 
disorders, which cause progressive weakness and spasticity beginning in the lower 
extremities (77). The disease is characterized by axonal degeneration at the distal tips 
of long, cortical motor neurons. While over 40 genetic loci have been identified to 
cause this disease, just three of these loci, spastin-1 (SPG4), atlastin-1 (SPG3A), and 
REEP1 (SPG31), account for over 60% of cases (77). First discovered in 2001 (15), 
over 40 mutations in atlastin-1 have been identified to date, with the majority being 
missense mutations (Figure 1.6.). Although atlastin-1 mutations cause only about 10% 
of autosomal dominant HSP cases, they are the most common when the disease occurs 
in infancy and early childhood. In these cases, the disease progresses slowly or has no 
apparent progression, leading to the presumption that atlastin-1 may be involved in 
development as opposed to maintenance of affected neurons (9). Recently, this 
conjecture has gained some support in a study using zebrafish, where researchers 
observed an apparent inhibition of BMP signaling by atlastin-1 during neuronal 
development via regulation of BMP receptor trafficking, which affected motor axon 
architecture and larval mobility (79).  
Hereditary Sensory Neuropathies (or Hereditary Sensory and Autonomic 
Neuropathies) are a group of five types of sensory/autonomic neuropathies (HSNI-V). 
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Juvenile and adult onset cases of HSN that are caused by autosomal dominant 
mutations are classified as HSN Type I, whereas the other four subtypes are autosomal 
recessive and are either congenital or early-onset diseases. It is a rare disease, though 
the exact prevalence is unknown. HSN I, for which atlastin-1 is one of four genetic 
loci identified to cause the disease, is characterized by progressive loss in sensation of 
the lower limbs with some motor involvement. Symptoms include general sensory 
loss, along with slow wound healing and chronic skin ulcers. Atlastin-1 was first 
discovered in HSN I patients in 2011, with two missense mutations and one truncation 
mutation so far identified (93) (Figure 1.6.). The other three genetic loci identified for 
HSN I include serine palmitoyltransferase long chain subunit 1 and 2 (SPTLC1 and 2) 
and Ras-related GTPase Rab7 (94-96).  
 
 
 
Figure 1.6. Atlastin-1 mutations. HSP and HSN mutations identified to date. Mutations are 
positioned at the location in the primary sequence in which they occur. An asterisk indicates 
mutations that are specific to HSN, while the remaining mutations are associated with only 
HSP.  
 
Currently, no drug-based therapies exist for treating either of these 
neurological disorders. By studying the molecular mechanisms of proteins associated 
with these diseases, we can gain a better understanding of disease pathogenesis as well 
as axonal maintenance and development. Not only will this result in the possibility of 
new and improved therapies for patients, but it can also lead to breakthroughs in our 
understanding of how the nervous system works in general. Since atlastin-1 and other 
dynamin superfamily members are involved in a number of different 
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neurodegenerative diseases (including Charcot-Marie Tooth 2A, HSP, HSN I, and 
Optic Atrophy Type 1), a better understanding of their molecular mechanisms and 
functions within the cell will push the field of neurobiology closer to finding better 
ways to combat these and perhaps other debilitating neurological disorders.  
 
OVERVIEW 
 
 Until now, most research pertaining to atlastin remained in vivo, which can 
yield significant and relevant results for figuring out the function of the protein in the 
cell. However, in vivo experiments are often complicated by many different factors 
such as the numerous unseen protein partners and chemical processes that occur in the 
cell, but not in a purified in vitro system. Furthermore, structural analysis of similar 
proteins, including dynamin and GBP, has contributed immensely to our 
understanding of how these proteins work and has guided new research efforts. The 
saying “form follows function” truly does apply to these and most biological 
molecules, and explains why structural biology has grown so rapidly in recent years. 
This thesis aims to use both biophysical and biochemical in vitro techniques to answer 
fundamental mechanistic questions pertaining to the protein atlastin-1. In particular, 
high-resolution structures solved via x-ray crystallography are used as a basis for 
designing more targeted biochemical and biophysical experiments in order to gain 
insight into the molecular mechanism of atlastin-1 membrane fusion.  
 In the second chapter, the first structures of atlastin are reported. In this study 
we utilized a construct of human atlastin-1 that contained the N-terminal soluble 
region of the protein, stopping just before the transmembrane domains but including 
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the large GTPase domain and middle domain (the catalytic core fragment). We were 
able to solve the structure of two completely different crystal forms from the same 
protein construct bound to the same nucleotide. Interestingly, these two crystal forms 
displayed distinct conformations, where the GTPase and middle domains were rotated 
with respect to one another, although it was unclear how the observed conformational 
change could occur with the same nucleotide. The protein also showed a weak dimeric 
assembly in the crystal structures. We were able to show that in solution the protein 
does indeed dimerize but not with the nucleotide contained in the crystal structures. In 
addition, we were able to map mutations in atlastin-1 that occur in patients suffering 
from HSP onto our structures, and analyze many of them for defects in activity and 
oligomerization.  
In the third chapter, we have solved new structures of atlastin-1 bound to two 
new nucleotides. The four resulting crystal structures are virtually identical, excluding 
the bound nucleotide. These new nucleotide bound states reveal a much tighter, 
physiologically relevant dimeric state. Additionally, the structures uncover important 
changes in the nucleotide binding and hydrolysis motifs that are of fundamental 
importance to the molecular mechanism. Using knowledge gained from the structures 
in both this chapter and the previous chapter, we designed and implemented an assay 
to track changes in the conformation of atlastin-1 during nucleotide binding and 
hydrolysis. This analysis allowed us to better understand and follow the order of 
events during the hydrolysis cycle. Lastly, using information from one of our first 
structures as well as studies from other groups, we discovered a unique mode of 
internal regulation within atlastin-1’s catalytic core. This mechanism allows atlastin-1 
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to regulate the process of nucleotide binding and possibly protein oligomerization. All 
of the data from chapters two and three have been condensed into a working model at 
the end of chapter three.  
Chapter four delves deeper into the mechanism of atlastin-1 nucleotide binding 
and hydrolysis with two new structures including the isolated GTPase domain and an 
arginine finger mutant. Using these and our previous structures as guides, we also 
made two mutations in the catalytic core of atlastin-1. The first mutation probes the 
importance of a bulky aromatic side chain in a conserved nucleotide-binding motif. 
The second deletes an interaction observed in all of the dimeric structures, revealing 
the importance of this interaction on atlastin’s GTPase activity.  
The last chapter provides a summary of the results found in this thesis and 
extends them to future directions in the study of atlastin. Some preliminary results are 
presented and used as a platform to discuss new opportunities for exploration. In 
addition, the remaining issues and questions about atlastin membrane fusion and 
disease will be reviewed. 
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CHAPTER 2 
STRUCTURAL BASIS FOR THE NUCLEOTIDE-DEPENDENT 
DIMERIZATION OF THE LARGE G PROTEIN ATLASTIN-1/SPG3A‡ 
 
ABSTRACT 
The large GTPase atlastin belongs to the dynamin superfamily that has been 
widely implicated in facilitating membrane tubulation, fission, and in select cases, 
fusion. Mutations spread across atlastin isoform 1 (atlastin-1) have been identified in 
patients suffering from hereditary spastic paraplegia (HSP), a neurodegenerative 
disorder affecting motor neuron function in the lower extremities. On a molecular 
level, atlastin-1 associates with high membrane curvature and fusion events at the 
endoplasmic reticulum and cis-Golgi. Here we report crystal structures of atlastin-1 
comprising the G and middle domains in two different conformations. Although the 
orientation of the middle domain relative to the G domain is different in the two 
structures, both reveal dimeric assemblies with a common, GDP-bound G domain 
dimer. In contrast, dimer formation in solution is observed only in the presence of 
GTP and transition state analogs, similar to other G proteins that are activated by 
nucleotide-dependent dimerization. Analyses of solution scattering data suggest that 
upon nucleotide binding, the protein adopts a somewhat extended, dimeric 
conformation that is reminiscent of one of the two crystal structures. These structural 
studies suggest a model for nucleotide-dependent regulation of atlastin with 
implications for membrane fusion. This mechanism is affected in several mutants 
associated with HSP, providing insights into disease pathogenesis. 
_______________________ 
‡ The following sections are reproduced from: Byrnes, L.J. and Sondermann, H. 2011. Structural basis 
for the conformational switching and GTP loading of the large G protein atlastin. PNAS. 108(6) 
pp2216-2221, doi: 10.1073/pnas.1012792108, with modifications to conform to the required format. 
LJB and HS conceived the project, designed and performed the experiments, analyzed the data, and 
wrote the paper. 
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INTRODUCTION 
 The superfamily of dynamin GTPases comprises a group of proteins that are 
involved in diverse cellular functions and are often closely associated with biological 
membranes (1). They function in a wide range of cellular scenarios including vesicle 
scission, fusion and fission of organelles, cytokinesis, and antiviral activity (1). 
Although they contain G domains that are structurally related to the small G proteins 
of the Ras superfamily, the corresponding domains in the dynamin superfamily are 
significantly larger (300 vs. 180 residues) and have a low intrinsic affinity for 
nucleotide. In addition, GTPases of this family often depend on nucleotide-dependent 
homodimerization to facilitate GTP hydrolysis rather than heterodimerization with a 
GTPase activating protein (2). Such a regulatory mechanism has been established for 
guanylate-binding protein (GBP) and dynamin (3, 4). 
Dynamin and most dynamin-related proteins have a common domain 
architecture comprising a middle domain and a GTPase effector domain (GED) in 
addition to the N-terminal G domain (1). To date, the molecular mechanism 
responsible for nucleotide-dependent functional and structural transitions is best 
understood for the prototypical member dynamin, a protein that catalyzes membrane 
fission (5). In low-resolution models of dynamin, the middle domain and GED form a 
stalk-like structure that is involved in self-assembly (6, 7). Furthermore, the GED and 
the C terminus of the G domain form a three-helix bundle, called the bundle signaling 
element (BSE), which modulates dynamin function (4, 8). A recent crystal structure of 
a minimal G domain-GED fusion protein revealed dimeric G domains in a 
catalytically competent transition state that was proposed to play a role in the 
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disassembly of dynamin coats from membrane tubes proceeding the fission event (4, 
9). Membrane binding and the GTPase of dynamin are further regulated by the 
pleckstrin homology (PH) domain, which is located at the tip of the stalk distal to the 
G domain and serves an autoregulatory function (7). Membrane-mediated, higher-
order oligomerization of dynamin stimulates its basal GTPase activity further (10, 11). 
A similar model has been proposed for MxA, a dynamin-like protein involved in 
innate immunity (12). 
Atlastin, a large G protein most closely related to the GBP subfamily, has been 
identified as a crucial protein in maintaining endoplasmic reticulum (ER) morphology 
and vesicle trafficking (13-17). Atlastin lacks a GED but instead contains two trans-
membrane helices and a C-terminal domain in addition to its large G and middle 
domains, both of which face the cytoplasm (1, 18). Three isoforms of atlastin are 
found in humans, differing in their N and C termini as well as their expression 
patterns. Atlastin-2 and -3 are found ubiquitously and localize to the ER. In contrast, 
atlastin-1 is mainly found in the central nervous system, especially in neurons of the 
corticospinal tract as well as the cerebral cortex and hippocampus and is localized to 
the cis-Golgi and to a lesser extent in the ER (1, 18, 19). On a microscopic level, they 
are found to associate with three-way junctions in the ER, and their absence results in 
a loss of this morphology in exchange for long, unbranched tubules (2, 14, 20). At the 
ER, atlastin interacts with proteins from the reticulon and DP1 families (3, 4, 14), 
spastin/SPG4 (1, 21, 22), and REEP1/SPG31 (5, 20). Notably, members of these 
families have been found to be among the most frequently mutated loci in the 
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neurodegenerative disorder hereditary spastic paraplegia (HSP; also known as familial 
spastic paraplegia or Strumpell–Lorrain disease) (6, 7, 23). 
HSP is a group of inherited disorders that cause progressive spasticity and 
weakness in the lower extremities. Mutations in the atlastin gene account for ∼10% of 
autosomal dominant HSP cases (4, 8, 20). Nearly 40 atlastin-1 mutations have been 
identified in HSP patients, which affect upper motor neurons of the cortical spinal 
tract (4, 9, 23). The vast majority of disease-associated alleles encode missense 
mutations, with one deletion and several nonsense mutations also identified (7, 24, 
25). Although atlastin accounts for only a tenth of the total HSP cases, it is the most 
common form in instances where the disorder occurs in infancy or childhood. In 
addition, many forms of atlastin show very slow progression or no apparent 
progression when the disease occurs in childhood, which led to the presumption that 
atlastin may have its effect in development rather than maintenance of affected 
neurons (10, 11, 26). 
Understanding the molecular basis of atlastin function and of HSP-associated 
alleles will be important for diagnostic and prognostic applications as well as for a 
basic understanding of HSP pathogenesis. Furthermore, a structural analysis may 
reveal basic mechanisms controlling the cellular function of atlastin and related 
proteins. In this study, we determined the crystal structure of the cytoplasmic domain 
of human atlastin-1 in two different crystal forms, both bound to GDP. This portion of 
the protein comprises the G domain followed by the middle domain, a common 
modular architecture found in other members of the large G-protein family. 
Additionally, we determined the apo- and nucleotide-bound oligomerization states and 
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low-resolution structures of the cytoplasmic domain in solution by using static light 
scattering and small-angle X-ray scattering (SAXS). Several mutations associated with 
HSP affect GTPase activity and/or nucleotide-dependent dimerization suggesting a 
basis of disease pathogenesis. 
 
MATERIALS AND METHODS 
Protein expression and purification 
The cytoplasmic domain of human atlastin-1 (residues 1–446) was amplified 
by standard PCR and cloned into a modified pET28a expression plasmid (Novagen) 
yielding N-terminally hexahistidine-tagged small ubiquitin-like modifier (SUMO) 
fusion proteins. The hexahistidine-tagged SUMO moiety was cleavable using the 
protease Ulp-1 from Saccharomyces cerevisiae. 
Native and selenomethionine-derivatized proteins were overexpressed in 
Escherichia coli BL21 (DE3) (Novagen) or T7 Crystal Express (NEB) cells, 
respectively. For the expression of native proteins, cells were grown in Terrific Broth 
media supplemented with 50 µg/mL kanamycin at 37 °C. At a cell optical density 
corresponding to an absorbance of 0.8–1.0 at 600 nm (OD600), the temperature was 
reduced to 18 °C, and protein production was induced with 1 mM IPTG. 
Selenomethionine-derivatized proteins were produced using a modified protocol (1, 
27). Cells were grown in 4 L of LB to an OD600 of 0.7. The cells were centrifuged at 
4,000 rpm for 20 min. Cell pellets were resuspended in 1 L of 1×M9 salt solution and 
centrifuged a second time. This step was repeated once more, and the final cell pellet 
was resuspended in 1 L of M9 minimal media supplemented with 50 µg/mL 
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kanamycin, 1× vitamin mix, 0.4% glucose, 2 mM MgSO4, 25 µg/mL FeSO4, and 40 
µg/ml of each of the 20 amino acids with selenomethionine substituting for 
methionine. Cells were grown at 37 °C for an additional hour before reducing the 
temperature to 18 °C and inducing with 0.5 mM IPTG. After 16 h, cells were 
harvested by centrifugation, resuspended in NiNTA buffer A (25 mM Tris-Cl, pH 8.5, 
500 mM NaCl, and 20 mM imidazole), and flash-frozen in liquid nitrogen. 
After cell lysis by sonication and removal of cell debris by centrifugation, clear 
lysates were loaded onto NiNTA Superflow (Qiagen) equilibrated in NiNTA buffer A. 
The resin was washed with 20 column volumes of NiNTA buffer A, and proteins were 
eluted three times with 2 column volumes of NiNTA buffer A supplemented with 500 
mM imidazole. Proteins were buffer exchanged into desalting buffer (25 mM Tris-
HCl, pH 7.5, 400 mM NaCl, 5 mM β-mercaptoethanol), and affinity tags were 
removed by incubation with the yeast protease Ulp-1 at 4 °C overnight. Cleaved 
proteins were collected in the flow-through during NiNTA affinity chromatography 
and were subjected to size exclusion chromatography on a Superdex 200 column (GE 
Healthcare) equilibrated in gel filtration buffer (25 mM Tris-HCl, pH 7.5, 100 mM 
NaCl, 2 mM DTT). Proteins were concentrated on a Centricon ultrafiltration device 
(10 kDa cutoff; Millipore) to a final concentration of approximately 0.5–1 mM. 
Protein aliquots were flash-frozen in liquid nitrogen and stored at -80 °C. 
Site-directed mutagenesis was carried out using Quikchange (Agilent) 
following the manufacturer’s instructions, followed by validation through DNA 
sequencing. 
 
 36 
Crystallization of atlastin-1 
Crystals were obtained by hanging drop vapor diffusion mixing equal volumes 
of protein (30 mg/mL) and reservoir solution followed by incubation at 20 °C. Initial 
crystals were obtained in the presence of 2 mM GTPγS (Sigma) and 5 mM MgCl2. For 
the P6522 crystals (form 1), the reservoir solution contained 0.1 M Bicine, pH 8.5, 
30% PEG-MME550, and 0.1 M succinic acid, pH 7.0. Diamond-shaped crystals 
appeared within 3 d with typical dimensions of 0.30 mm × 0.15 mm × 0.2 mm. For 
cryoprotection, crystals were soaked in reservoir solution supplemented with 25% 
glycerol. For the P212121 crystals (form 2), the reservoir solution contained 20% PEG 
3350 and 0.15 M ammonium phosphate dibasic. Crystals appeared as thin rods 
overnight with typical dimensions of 0.4 mm × 0.1 mm × 0.05 mm. Crystals were 
cryoprotected by soaking in the crystallization solutions supplemented with 15% 
xylitol. Cryopreserved crystals were flash-frozen and stored in liquid nitrogen. Data 
were collected on frozen crystals at 100 K. 
Data reduction was carried out with the software package HKL2000 (1, 28). 
Experimental phases for P6522 crystals were obtained from single anomalous 
diffraction (SAD) experiments on crystals grown from selenomethionine-derivatived 
proteins. By using the software package Phenix (2, 29), 10 (out of 10) heavy atom 
positions could be determined. The structure of the P212121 crystal was determined by 
Molecular Replacement by using the software package PHENIX (3, 4, 29) with the 
GTPase domain and the middle domain of atlastin-1 as separate search models. 
Refinement in PHENIX (1, 29) and COOT (5, 30) yielded the final models. Data 
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collection and refinement statistics are summarized in Table 2.1. Illustrations were 
made in Pymol (DeLano Scientific). 
 
Small-angle X-ray scattering (SAXS) data collection and processing 
SAXS experiments were carried out at the Cornell High Energy Synchrotron 
Source (CHESS, beamline G1) at an electron energy of 8 KeV. Protein samples were 
prepared by incubating 100 µM protein with 1 mM nucleotide (or no nucleotide in the 
case of the apo-protein) and 5 mM MgCl2 for 30 min at room temperature, and then 
loaded onto a size exclusion column (Superdex 200 GE 10/300) equilibrated in 
multiangle light scattering (MALS) buffer (25 mM Tris-HCl pH 7.4, 100 mM NaCl, 2 
mM EGTA, 4 mM MgCl2). Peak fractions were collected and concentrated. Protein 
concentrations were determined using UV Abs280 and theoretical extinction 
coefficients. Proteins were centrifuged at 13,200 rpm and 4 °C for 10 min prior to 
loading into a flow cell. Scattering data were collected in triplicate at protein 
concentrations between 1 and 10 mg/mL. Only data showing no sign of radiation 
damage or aggregation based on inspection of Guinier plots were used for further 
analysis. Background scattering was collected from MALS buffer. Scattering data 
were background corrected, averaged, and scaled by using the program BioXtas 
(Soeren Nielson) and were analyzed by using the programs GNOM and CRYSOL (6, 
7, 31-33). Only scattering data with Smax * Rg < 1.3, computed from Guinier plots at 
low-angle regions, were considered for further analysis. Kratky plots were used to 
assess the folded state of the proteins and overall data quality. Distance distribution 
functions P(r), Rg, and Dmax were determined by using the program GNOM (4, 8, 33). 
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Distance distribution function from crystallographic models was calculated by using 
CRYSOL (4, 9, 32). SAXS-based shape reconstructions were carried out with the 
program GASBOR (7, 34) by using the P(r) function as the target. For each sample, 20 
models were calculated, superimposed, averaged, and filtered by using the program 
DAMAVER (10, 11, 35). Similar results were obtained by using the scattering 
intensity as the target. During the modeling of the dimeric states, P2 symmetry was 
applied. Crystal structures were docked in the models using SUPCOMB (12, 36). 
 
Size-exclusion chromatography-coupled multiangle light scattering (SEC-MALS) 
Purified protein (∼1 µg⁄µL or 20 µM, injected concentration) was subjected to 
SEC using a WTC-030S5 column (Wyatt Technology) equilibrated in MALS buffer 
(25 mM Tris-HCl pH 7.5, 100 mM NaCl, 4 mM MgCl2, and 2 mM EGTA). Where 
specified, wild-type or mutant atlastin was incubated with GDP, GppNHp, or 
GDP•AlFx (2 mM) for 30 min at room temperature prior to injection. The SEC was 
coupled to a static 18-angle light scattering detector (DAWN HELEOS-II) and a 
refractive index detector (Optilab T-rEX) (Wyatt Technology). Data were collected 
every second at a flow rate of 1 mL⁄ min. Data analysis was carried out using the 
program ASTRA, yielding the molar mass and mass distribution (polydispersity) of 
the sample. Molecular weight distributions were determined by using the Multipeak 
Fitting Package in Igor Pro (WaveMetrics). For normalization of the light scattering 
detectors and data quality control, monomeric BSA (Sigma) was used. 
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GTPase activity assay 
GTPase activity was measured using the Enzchek Phosphate Assay kit 
(Molecular Probes) following the manufacturer’s instructions. Measurements were 
carried out in a 96-well plate (Nunc) in a total volume of 250 µL. Recombinant wild-
type or mutant atlastin-1 was combined with 1 U/mL Purine Nucleoside 
Phosphorylase, 200 µM 2-amino-6-mercapto-7-methylpurine riboside, and provided 
buffer (20 mM Tris-HCl pH 7.5, 1 mM MgCl2, 0.1 mM sodium azide). The plate was 
incubated at room temperature for 10 min, after which reactions were started by 
addition of 400 µM GTP (or alternatively, 50 mM Tris-HCl pH 7.5 for controls). 
Plates were assayed at 37 °C in a Powerwave XS microplate reader (BioTek). 
Absorbance at 360 nm was monitored in 30 s intervals for 30 min. Data were 
normalized to a phosphate standard curve, and initial velocities were calculated using 
the portion of the curve corresponding to the first 5% of consumed product. Data 
reported in Table 2.2. are means ± SD of three independent experiments. 
 
Thermal melting 
The circular dichroism signal of proteins (0.5 mg/mL) in CD buffer (10 mM 
NaH2PO4 pH 7.4, 100 mM NaCl) was monitored at 222 nm using an Aviv Circular 
Dichroism Spectrometer (Model 62ADS) between 10–90°C (cell pathlength, 1 mm; 
bandwidth, 1.5 nm; signal averaging time, 10 s; temperature step, 1 °C). Curves were 
differentiated and fitted to a Lorentzian distribution to estimate the melting 
temperature and errors of the measurement. 
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Nucleotide binding 
Purified protein (~10 mg/mL) was subjected to size-exclusion chromatography 
(SEC) using a Superdex 200 10/300 GL column (GE Healthcare) equilibrated in 
MALS buffer. Where specified, wild-type or mutant atlastin-1 was incubated with no 
nucleotide, GDP, GppNHp, or GDP•AlFx (2 mM) for 30 min at room temperature 
prior to gel filtration. The entire elution peak was concentrated and subjected to heat 
denaturation. Denatured proteins were precipitated by high-speed centrifugation and 
supernatants were filtered in 10 kDa-cutoff spin filters before injection into a reverse-
phase HPLC column (Phenomenex Gemini C18) equilibrated in HPLC buffer (100 
mM KH2PO4 pH 6.5, 10 mM tetrabutylammonium bromide, 7.5% acetonitrile, and 
0.02% NaN3). 
 
RESULTS AND DISCUSSION 
Crystal Structures of Atlastin-1.  
The purified, cytoplasmic domain of human atlastin-1 (residues 1–446; Figure 
2.1.A) crystallized in two distinct crystal forms (form 1: space group p6522; form 2: 
p212121; Table 2.1.). The form 1 crystals grown from selenomethionine-derivatized 
protein diffracted X-rays to a maximal resolution of 2.7 Å with one molecule in the 
asymmetric unit, and the structure was solved with single anomalous dispersion 
phasing (Figure 2.1.B). The form 2 crystals yielded a native dataset at 3.0 Å (four 
molecules⁄asymmetric unit), and the structure was solved by molecular replacement 
using the separated GTPase and middle domains as the search models (Figure 2.1.C).  
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Figure 2.1. Structure of atlastin-1. (A) Domain organization of atlastin-1. The large G 
domain (orange) is connected to the middle domain (blue) by a short flexible linker (green) 
and is followed by two transmembrane helices (black) that span the membrane and a C-
terminal domain. A topological model is shown (Right). The fragment used in this study 
consists of residues 1–446 of human atlastin-1. (B) Protomer structure of atlastin-1 in crystal 
form 1. (Inset) GDP⁄Mg2+-coordinating residues as sticks. (C) Protomer structure of atlastin-1 
in crystal form 2. The G domain is shown in a similar orientation as shown in B. GDP and 
Mg2+ are shown as sticks and spheres, respectively. 
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Table 2.1. Data collection and refinement statistics.  
 Atlastin-1 (1-446) form 1 Atlastin-1 (1-446) form 2 
Data collection   
X-ray source CHESS A1 CHESS A1 
Wavelength (Å) 0.987 0.987 
Space group P6522 P212121 
Unit cell parameters   
      a, b, c, (Å) 145.4, 145.4, 104.2 104.4, 133.6, 175.8 
      α, β, γ (°) 90, 90, 120 90, 90, 90 
Resolution range (Å) 50-2.70 (2.80-2.70) 50-3.00 (3.11-3.00) 
No. of reflections   
      Total 425,973 406,102 
      Unique 18,381 (1,795) 48,872 (4,788) 
Completeness (%) 100 (100) 99.7 (99.0) 
Redundancy 23.2 (18.3) 8.3 (7.3) 
I/σ (I) 38.1 (3.2) 19.2 (2.8) 
Rmeas (%) 7.7 (84.4) 11.3 (68.3) 
Refinement   
Phasing SAD MR 
Unit cell content 1 GDP!Mg2+-bound 
protomer 
4 GDP!Mg2+-bound 
protomers 
Rwork/Rfree (%) 18.57/24.73 19.04/26.53 
r.m.s. deviations   
      Bond length (Å) 0.008 0.008 
      Bond angles (°) 1.252 1.241 
No. of atoms   
      Protein 3,289 12,732 
      Water 5 - 
      GDP!Mg2+ 29 116 
 
Although crystallization for both forms was carried out in the presence of GTPγS, 
only density for the GDP moiety and a magnesium ion was observed (Figure 2.1.B, 
inset and Figure 2.2.A). In the present structures, the side chain of F76 within the P 
loop is positioned in such a way that the γ-phosphate moiety cannot be accommodated 
(Figure 2.2.A). Conformational changes typically accompanying GTP binding to G 
proteins would allow F76 to flip out to accommodate the terminal phosphate. Both the 
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slow hydrolysis of GTPγS as well as the presence of GDP as a major contaminant in 
the nucleotide solution may have contributed to this result (Figure 2.3.). 
In both crystal forms, the N terminus of atlastin forms a globular GTPase domain fold 
similar to that of GBP1 (rmsd of 4.5 Å) (13-17, 37). The middle domain that connects 
to the transmembrane helices folds into a three-helix bundle (Figure 2.1.B and C). 
Most strikingly, the structures in the two crystal forms differ in their relative 
orientation of the G and middle domains with minimal variance of the individual 
domains (rmsd of 0.7 Å for both the G and middle domains; Figures 2.1. and 2.2.D). A 
rigid body rotation by ∼90° of the middle domain relative to the G domain separates 
the two conformations, with the difference being realized by an alternative 
conformation of the connecting linker segment (residues 337–346). In contrast to the 
extended, random-coil conformation of the linker in form 1, it adopts a U-shaped turn 
in the form 2 crystals. In the latter case, it contributes an additional turn to the first 
helix of the middle domain, consistent with secondary structure predictions, and one 
of the two proline residues (P344) in the linker segment serves as a helix cap (Figure 
2.2.D). Mutation of this residue in the cytoplasmic domain of atlastin-1 (P344G) 
renders the protein insoluble. The second proline (P342) is located at the center of the 
linker. Similarly, proline residues are present at comparable positions in dynamin and 
other G proteins, where they serve as pivot points during nucleotide-dependent 
transitions (4, 18). 
Although atlastin lacks a GED and its sequence conservation to other dynamin-
like proteins predominantly resides in the G domain, there is a remarkable 
conservation with regard to domain arrangements, in particular, when the form 2  
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Figure 2.2. Crystal structures of GDP-bound atlastin-1. (A) Nucleotide binding site. 
Switch and nucleotide binding regions are highlighted as shades of blue. Conserved residues 
and the nucleotide are shown as sticks. A (|Fobs|-|Fcalc|) electron density map contoured at 3.6σ 
is shown as calculated from a model before inclusion of GDP and magnesium. (Right) An 
overview of the G domain dimer observed in crystal form 1. (B) Sequence alignment of 
dynamin superfamily members in the conserved regions involved in nucleotide binding and 
hydrolysis. Conserved residues are highlighted in green and are shown below in the consensus 
sequence. Residues in the form 1 atlastin-1 dimers that form interfacial contacts are marked 
with an asterisk below the alignment. (C) Superposition of G domain dimers observed in 
crystal form 1 (space group P6522) and 2 (space group P212121). Protomer A from each dimer 
(gray and orange domain, respectively) were used as the reference for the superposition. (D) 
Superposition of the cytosolic domain of atlastin-1 in crystal form 1 and form 2 using the 
respective G domains as the reference. (Right) The major conformational differences that 
concern a G domain-internal helix and position of the middle domain accompanied by a 
restructuring of the linker segment. 
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Figure 2.3. Nucleotide-bound state of atlastin wild-type and R217Q. (A) Nucleotide 
standards for GDP (purple), GppNHp (green), and GTPγS (blue). (B) Wild-type atlastin-1. 
Protein was incubated with no nucleotide (red), GDP•AlFx (orange), GDP (purple), or 
GppNHp (green). Excess nucleotide was removed by gel filtration. Nucleotides extracted from 
protein by heat denaturation were subjected to reverse-phase HPLC. Vertical dashed lines 
indicate elution positions for nucleotide standards. (C) Atlastin-1 mutant R217Q. A similar 
analysis was performed for the point mutant R217Q. 
 
crystal structure is considered. In this conformation, atlastin’s middle domain folds 
back onto the G domain and protrudes at a similar position as the BSE (including the 
GED) and middle domain in dynamin and GBP1, respectively (3, 4, 18, 19, 37, 38) 
(Figure 2.4.A and B). Although the contact region in GBP1 and atlastin is preserved, 
containing in part hydrophobic contacts between corresponding secondary structure 
motifs (Figure 2.5.A), the available dynamin structures lack the middle domain 
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impeding a more detailed comparison. Based on low-resolution structural 
reconstructions of near-full-length dynamin, the BSE and middle domain form a 
structural unit (7, 14, 20), and the BSE position in the crystal structure serves as an 
approximate projection of the middle domain (4, 14). The conservation of the overall 
architecture suggests a common molecular mechanism underlying the regulation and 
function of these distantly related proteins. 
GBP1 and dynamin form G domain-mediated homooligomers in the presence 
of GTP and transition state analogs, but not in their apo- and GDP-bound states 
(Figure 2.4.A and B) (4, 21, 22, 37). Considering the symmetry mates in each crystal 
lattice, the atlastin structures provide insights into potential modes for dimerization, 
revealing a common interface observed in both structures formed between adjacent G 
domains (Figure 2.4.C). The two atlastin-1 G domain dimers align with an rmsd of 2 
Å, with the main difference observed in the angle the G domains take with respect to 
each other (Figure 2.2.C). As a result, the interfacial area differs by 470 Å2 
considering only interactions between the G domains (1226 Å2 and 756 Å2 for form 1 
and form 2 G domain dimers, respectively; Figure 2.5.C and D). The dimerization 
involves residues close to the nucleotide-binding pocket, especially within the P loop 
(G1), Walker B (G3) motif, and the guanosine-binding loop (G4) (Figure 2.2.A and 
B). 
The relative position and orientation of the G domains and nucleotide are 
reminiscent of those seen in the crystal structures of GppNHp-bound GBP1 and 
dynamin when bound to GDP• AlF4− (Figures 2.4. and 2.5.B) (4, 23, 37). Specifically, 
there is a remarkable structural conservation with regard to the involvement of  
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Figure 2.4. Crystallographic dimers of atlastin-1. (A) GBP1. A model for GTP-bound, full-
length GBP1 was constructed according to (20, 37). (B) Dynamin. A dynamin G domain-GED 
fusion dimer bound to GDP•AlF4− is shown (PDB ID code 2X2E) (4, 23). (C) Atlastin-1. 
Dimers observed in crystal lattices with P212121 symmetry (form 2, Upper) and with P6522 
symmetry (form 1, Lower) are shown. GDP and Mg2+ positions are indicated and are shown as 
sticks and spheres, respectively. Hypothetical membrane positions based on the location of the 
C terminus of the cytosolic domain are indicated. Positions of missense mutation associated 
with HSP are shown as residues displayed as red spheres in both forms. (D) Nucleotide 
arrangement and G domain dimer interface. The G domain dimer interfaces of atlastin-1 (form 
1; Left) and GBP1 (Right; PDB ID code 2BC9) (3, 20) are shown. The protomers are colored 
in light and dark gray, with the nucleotide-binding regions (G1–G4) shown in shades of blue. 
Nucleotide and Mg2+ are shown as sticks and spheres, respectively. The dashed, red line 
separates the dimer halves, marking the interfacial region. 
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Figure 2.5. Comparison of atlastin-1 and GBP1 dimers. (A) Interdomain interface in GBP1 
and atlastin-1. The G domain of GBP1 (green; PDB ID code 1DG3) was superimposed on the 
G domain of atlastin-1 (orange). The middle domains of GBP1 and atlastin-1 are colored in 
gray and blue, respectively. (B) The G domain dimer of GBP1 bound to GppNHp (PDB ID 
code 2BC9) was superimposed on the form 1 G domain dimer of atlastin-1 bound to GDP. (C) 
Form 1 G domain dimer interface. (D) Form 2 G domain dimer interface. Interfacial residues 
in form 1 dimers (C) or form 2 dimers (D) are shown in color on the surface of one half of the 
dimer. Key residues for dimer formation, R77 and its binding partners F221 and E224 in the 
adjacent G domain, are colored in red. (E) R77E mutant. Based on the crystal structures, we 
introduced a mutation into atlastin-1 at the dimerization interface and determined its 
oligomerization behavior by light scattering as described in Figure 2.6. 
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nucleotide-binding motifs between GBP1 and atlastin-1 (regions G1–G4) in 
dimerization, despite the difference in bound nucleotide species (Figure 2.4.D). 
Dynamin and GBP1 dimers bound to GDP•AlF4− or GppNHp, respectively, involve 
more extensive contributions of the P loop (G1) and the Walker A (G2) motif 
compared to the GDP-bound dimers of atlastin-1 (Figure 2.4.D) (3, 4, 24, 25). Most 
notably, the two crystallographic atlastin-1 dimer forms differ in their relative position 
of the middle domains with respect to the G domain dimers (Figure 2.4.C). Although 
the form 2 dimer resembles GBP1 or dynamin assemblies with the middle domains 
pointing in opposite directions (3, 4, 26, 37), the form 1 dimer of atlastin is distinct 
from those because the middle domains run in parallel (Figure 2.4.). In this 
conformation, the linker segments and middle domains cross over, contributing an 
additional 1571 Å2 to the overall interfacial area (Figures 2.4.C and 2.5.C). Although 
the middle domains in the form 1 structure protrude in the same direction and would 
locate to proximal membrane regions via the successive transmembrane domains 
(Figure 2.4.C), the functional relevance for this conformation remains elusive.  
 
Nucleotide-Dependent Dimerization of Atlastin.  
GTP-dependent dimerization of dynamin and GBP1 establish the catalysis-
competent states of these enzymes (4, 37). Several lines of evidence support the 
presence of a conserved dimerization-based GTPase mechanism for atlastin-1, in 
addition to the crystallographic observation that GDP-bound atlastin dimers are 
reminiscent of dimeric states of dynamin and GBP1. Similar to the latter cases, 
nucleotide-free (apo) and GDP-bound atlastin-1 (residues 1–446) elute in single peaks 
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from a size-exclusion column with molecular weights determined by in-line, 
multiangle light scattering close to that calculated for monomers based on the primary 
sequence (49.2 or 49.3 kDa, respectively; theoretical molecular weight: 51.1 kDa) 
(Figure 2.6. and Table 2.2.). Incubation of the protein with the GTP analog GppNHp 
or the transition state analog GDP• AlFx promotes dimerization, indicated by an earlier 
elution volume and an average molecular weight of 99.2 kDa or 98.2 kDa, 
respectively. 
A nonconservative mutation in residue R77 (R77E), a residue located at the G 
domain dimer interface in the crystal structures of atlastin (Figure 2.5.C), renders the 
protein monomeric in the presence of GDP•AlFx, and only partially dimeric when 
bound to GppNHp, indicating that the crystallographic interface is also involved in the 
nucleotide-dependent dimerization of the protein in solution (Figure 2.5.E and Table 
2.2.). The mutant protein is also devoid of GTPase activity (Table 2.2.), indicating that 
dimerization can have an impact on enzymatic activity. 
 
Figure 2.6. Atlastin-1 oligomerization in solution. SEC-MALS data are shown for wild-type 
atlastin-1 (residues 1–446) in its apo-state (red) or bound to GppNHp (green), GDP (purple), 
or GDP•AlFx (orange). The signal from the 90°-scattering detector and refractive index 
detector are shown as solid, colored lines and black dashed lines, respectively (Left, Y axis). 
Average molecular weight as calculated every second across the protein elution peak is shown 
as black circles (Right, Y axis). Theoretical molecular weights based on primary sequence for 
the monomer and dimer are indicated as horizontal, dashed lines. Proteins (20 µM) were 
incubated with nucleotides (2 mM) prior to SEC-MALS analysis. 
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Table 2.2. Oligomeric state and GTPase activity of wild-type and mutant atlastin-1.a 
Protein Property Apo GppNHp GDP•AlF4- 
wild-type     
 Molecular weightb 49.2kDa 99.2kDa 98.2kDa 
 Polydispersityb 1.001 (±0.004) 1.000 (±0.004) 1.000 (±0.003) 
 Tm (C)c 51.23 (±0.92)   
 GTPase activity (µM 
Pi/min/µM Enz) 
5.33 (±0.09)   
R77E     
 Molecular weightb 50.4kDa 101.2kDa 51.4kDa 
 Polydispersityb 1.000 (±0.010) 1.000 (±0.010) 1.000 (±0.020) 
 Tm (C)c n.d.    
 GTPase activity (µM 
Pi/min/µM Enz) 
0.01 (±0.01)   
T156I     
 Molecular weightb 47.9kDa 96.6kDa 96.9kDa 
 Polydispersityb 1.000 (±0.002) 1.000 (±0.002) 1.000 (±0.003) 
 Tm (C)c 52.77 (±0.1.43)   
 GTPase activity (µM 
Pi/min/µM Enz) 
2.25 (±0.03)   
T157W     
 Molecular weightb 50.9kDa 99.8kDa 102.3kDa 
 Polydispersityb 1.001 (±0.010) 1.000 (±0.020) 1.000 (±0.020) 
 Tm (C)c 51.74 (±1.03)   
 GTPase activity (µM 
Pi/min/µM Enz) 
5.35 (±0.04)   
H189D     
 Molecular weightb 50.5kDa 100.6kDa 103.3kDa 
 Polydispersityb 1.000 (±0.020) 1.000 (±0.010) 1.000 (±0.040) 
 Tm (C)c 52.88 (±1.09)   
 GTPase activity (µM 
Pi/min/µM Enz) 
3.14 (±0.25)   
Q191R     
 Molecular weightb 50.5kDa 52.7kDa 100.8kDa 
 Polydispersityb 1.000 (±0.020) 1.001 (±0.040) 1.000 (±0.020) 
 Tm (C)c 50.49 (±0.93)   
 GTPase activity (µM 
Pi/min/µM Enz) 
4.48 (±0.08)   
Y196C     
 Molecular weightb 52.8kDa 98.1kDa 100.1kDa 
 Polydispersityb 1.000 (±0.050) 1.000 (±0.010) 1.000 (±0.020) 
 Tm (C)c 51.91 (±1.11)   
 GTPase activity (µM 
Pi/min/µM Enz) 
5.38 (±0.06)   
R217Q     
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 Molecular weightb 49.0kDa 49.0kDa 48.9kDa 
 Polydispersityb 1.000 (±0.003) 1.001 (±0.003) 1.001 (±0.003) 
 Tm (C)c 55.82 (±1.76)   
 GTPase activity (µM 
Pi/min/µM Enz) 
0.01 (±0.01)   
R239C     
 Molecular weightb 48.7kDa 98.8kDa 97.3 
 Polydispersityb 1.000 (±0.003) 1.000 (±0.003) 1.000 (±0.003) 
 Tm (C)c 52.60 (±1.01)   
 GTPase activity (µM 
Pi/min/µM Enz) 
2.74 (±0.17)   
H247R     
 Molecular weightb 51.0kDa 99.1kDa 
53.3kDa 
100.1kDa 
 Polydispersityb 1.000 (±0.020) 1.000 (±0.010), 
1.000 (±0.030) 
1.000 (±0.010) 
 Tm (C)c 51.87 (±1.04)   
 GTPase activity (µM 
Pi/min/µM Enz) 
1.48 (±0.04)   
L250P     
 Molecular weightb 53.1kDa 100.4kDa 100.7kDa 
 Polydispersityb 1.004 (±0.060) 1.000 (±0.010) 1.000 (±0.020) 
 Tm (C)c 52.12 (±1.22)   
 GTPase activity (µM 
Pi/min/µM Enz) 
3.31 (±0.21)   
H258R     
 Molecular weightb 48.2kDa 95.9kDa 95.9kDa 
 Polydispersityb 1.000 (±0.002) 1.000 (±0.002) 1.000 (±0.002) 
 Tm (C)c 50.83 (±1.21)   
 GTPase activity (µM 
Pi/min/µM Enz) 
2.50 (±0.09)   
S259F     
 Molecular weightb 50.7kDa 99.2kDa 100.3kDa 
 Polydispersityb 1.000 (±0.020) 1.000 (±0.010) 1.0 (±0.010) 
 Tm (C)c 52.09 (±1.21)   
 GTPase activity (µM 
Pi/min/µM Enz) 
2.34 (±0.04)   
I315S     
 Molecular weightb 47.2kDa 92.0kDa 93.5kDa 
 Polydispersityb 1.001 (±0.005) 1.000 (±0.003) 1.000 (±0.003) 
 Tm (C)c 52.06 (±1.28)   
 GTPase activity (µM 
Pi/min/µM Enz) 
3.42 (±0.04)   
Y336H     
 Molecular weightb 50.4kDa 92.7kDa 
53.1kDa 
99.0kDa 
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 Polydispersityb 1.000 (±0.020) 1.000 (±0.020) 
1.000 (±0.020) 
1.000 (±0.010) 
 Tm (C)c 50.57 (±0.96)   
 GTPase activity (µM 
Pi/min/µM Enz) 
4.24 (±0.11)   
S398Y     
 Molecular weightb 48.8kDa 98.6kDa 98.0kDa 
 Polydispersityb 1.001 (±0.003) 1.000 (±0.003) 1.000 (±0.003) 
 Tm (C)c 44.99 (±2.79)   
 GTPase activity (µM 
Pi/min/µM Enz) 
3.25 (±0.03)   
M408T     
 Molecular weightb 50.4kDa 87.0kDa 
53.4kDa 
99.6kDa 
 Polydispersityb 1.000 (±0.020) 1.000 (±0.050) 
1.002 (±0.020) 
1.000 (±0.010) 
 Tm (C)c 49.22 (±0.93)   
 GTPase activity (µM 
Pi/min/µM Enz) 
5.12 (±0.17)   
M408V     
 Molecular weightb 49.1kDa 91.0kDa 
49.8kDa 
97.0kDa 
 Polydispersityb 1.000 (±0.004) 1.000 (±0.005) 
1.000 (±0.005) 
1.000 (±0.003) 
 Tm (C)c 50.45 (±0.95)   
 GTPase activity (µM 
Pi/min/µM Enz) 
3.11 (±0.14)   
a: The soluble, cytoplasmic domain of atlastin-1 (residues 1-446) was used in these 
experiments.  
b: Molecular weight and polydispersity indices were determined by using SEC-MALS.  
c: protein stability was determined based on measurements of the melting temperature by 
circular dichroism spectroscopy.  
 
Next, we turned to SAXS to gain further insight into the solution structure of 
dimeric atlastin. By using a monodisperse protein sample in diffraction experiments, 
accurate shape information in the form of the radius of gyration (Rg), the maximal 
diameter of the particle (Dmax), and the distance distribution function (P(r)) can be 
obtained (39, 40). The experimental scattering curves and P(r) functions for the 
cytoplasmic domain of atlastin-1 differ in the nucleotide-free, GDP-, GppNHp- and 
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GDP•AlFx-bound states (Figure 2.7.A), indicating that the structures of these 
intermediates feature differences (a detailed analysis of the monomeric, apo-, and 
GDP-bound states is provided as SI Text). The dimeric, GppNHp-, and GDP•AlFx-
bound states have overall similar P(r) profiles but vary slightly in their Dmax and Rg 
with the GDP•AlF -bound specimen being more extended (Dmax ⁄Rg: 120⁄36 Å vs. 
125⁄37 Å for the GppNHp- and GDP•AlFx-bound states, respectively; Figure 2.7.A 
and Table 2.3.). 
We compared the solution scattering data with the crystallographic dimer 
models (Figure 2.8.). Both solution states are more extended than the crystallographic 
form 1 dimer but shorter than the form 2 dimer (Figure 2.8.A and Table 2.3.). The 
position and shape of the main peak in the theoretical P(r) functions calculated from  
 
Figure 2.7. Small-angle X-ray scattering. (A) Solution scattering data for atlastin-1. 
Intensity plots and P(r) functions for apo (red), GDP-bound (purple), GppNHp-bound (green), 
and GDP•AlFx-bound (orange) atlastin-1 (residues 1–446) are shown. (Left, Inset) 
Corresponding Guinier plots. (B) SAXS-based shape reconstructions for nucleotide-bound 
solution states of atlastin-1. The dimeric form 2 crystal structure was docked in the models as 
a reference and is shown as a cartoon presentation. 
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Table 2.3. SAXS data statistics and dimensions of crystallographic models.  
 Rg (Å)a Dmax (Å)a Vp (nm3)b χbestc 
SAXS data 
Apo 30±0.1 97±2.5 90.4 1.694 
GDP 33±0.1 101±2.5 138.7 1.563 
GppNHp 36±0.1 120±2.5 157.7 1.093 
GDP•AlFx 37±0.1 125±2.5 156.7 1.325 
Crystallographic models  
Form 1 monomer 29 104 n. a. n. a. 
Form 2 monomer 24 86 n. a. n. a. 
Form 1 dimerd 31 104 n. a. n. a. 
Form 2 dimere 37 150 n. a. n. a. 
a: Rg and Dmax were determined using the program GNOM (6). Similar values for Rg were 
obtained from analysis of the Guinier equation and data that satisfies Qmax×Rg<1.3. Values for 
the crystallographic models were calculated with Crysol (5).  
b: Vp is the excluded volume (Porod volume). n.a., not applicable 
c: χbest is the lowest χ value obtained for a free atom model from the ab initio shape 
determinations. n.a., not applicable.  
d: χ values for the fit between this model and the SAXS data are 4.89 (GppNHp data) and 6.65 
(GDP•AlFx data).  
e: χ values for the fit between this model and the SAXS data are 2.56 (GppNHp data) and 2.95 
(GDP•AlFx data).  
 
the two crystallographic, GDP-bound dimers are very similar to the corresponding 
region of the experimental curves, consistent with common folds of the domains and 
similar G domain dimerization. Yet, in general the crystalline conformations represent 
inaccurate models for GTP-bound atlastin based on the overall fit (Table 2.3. and 
Figure 2.8.A). Modeling of the SAXS data can yield low-resolution reconstructions 
representing the shape of a protein. A similar approach has been described recently for 
near-full-length dynamin revealing the overall organization of the protein in solution 
(7). Unbiased models for the solution states of GTP-bound and the transition state 
atlastin-1 were obtained by using a free-atom, simulated annealing approach with the 
respective P(r) functions as the target (34). For each state, 20 models were computed, 
averaged, and filtered to yield a consensus envelope. The shape reconstructions for  
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Figure 2.8. SAXS data. (A) P(r) for the form 1 dimer (gray, solid) and the form 2 dimer 
(black, dashed) were calculated by using the respective crystal structures. P(r) based on 
experimental scattering data for GppNHp-bound and GDP•AlFx-bound atlastin-1 (residues 1–
446) are shown in green and orange, respectively. (B) Kratky plots calculated based on 
intensity data from apo (red), GDP added (purple), GppNHp-bound (green), and GDP•AlFx-
bound (orange) atlastin-1. The SAXS data for the nucleotide-free state of atlastin-1 indicated 
an unfolded or flexible component evident in Kratky plots, which was suppressed upon 
binding of GDP. Both flexibility within the G domain and a dislodged middle domain in the 
absence of nucleotide may contribute to these differences. (C) P(r) functions of monomeric 
atlastin-1 species. The apo-state (red) and atlastin-1 incubated in GDP (purple) are shown. 
Theoretical P(r) functions for the form 1 protomer (gray, solid) and form 2 protomer (black, 
dashed) are shown in both plots. The crystallographic conformations of the monomers are 
inaccurate models for the solution state. (D) SAXS-based shape reconstructions for 
monomeric solution states of atlastin-1. Models were calculated by using the P(r) function as 
the target. The monomeric crystal structure protomers (form 1 and 2) were docked in the 
models as a reference and are shown as a cartoon presentation. Modeling the SAXS data from 
apo-atlastin-1 or the GDP-bound protein revealed a large upper lobe that accommodates a G 
domain. A stalk-like extension resembles the middle domain. In the presence of GDP, the 
overall solution conformation of the G domain appears more compressed and globular. Both 
the nucleotide-unbound and GDP-bound solution models could accommodate either crystal 
structure protomer. Relatively high % values for the comparison between the crystalline states 
and the solution scattering data (ranging between 5.51–8.10) suggest that the exact solution 
conformation may be different from the crystallographic states. Given this ambiguity, we 
refrained from modeling the solution states beyond this analysis. 
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atlastin-1 bound to GppNHp or GDP•AlFx are consistent with a central G domain 
dimer carrying lateral middle domains. Despite the inaccurate fits between the SAXS 
data and crystallographic models (Table 2.3.), the overall conformation of the dimeric 
solution states has some resemblance with the extended conformation of the dimeric, 
form 2 crystal structure, in which the middle domains fold back onto their respective 
G domains and point in opposite directions (Figure 2.7.B). The G domain dimer fits 
the mass observed at the center of both models, placing the middle domains roughly 
into the skinnier density at the distal tips. Subtle differences in the SAXS-based 
models for atlastin-1 bound to GppNHp and GDP•AlFx concern these distal regions, 
extending radially from the center of the G domain dimer, but a more exact prediction 
of the structural changes is likely beyond the accuracy of the method. 
In summary, the nucleotide-dependent oligomerization via central G domain 
dimers indicates related mechanisms between atlastin, GBP, dynamin, and other large 
G proteins that are activated by nucleotide-dependent dimerization (2). As described 
in the next section, further corroboration comes from several atlastin-1 mutants 
associated with the neurodegenerative disorder HSP, many of which display defects in 
GTP-dependent dimerization when introduced into the cytosolic domain, suggesting 
that disruption of this mechanism contributes to the pathogenesis in HSP.  
 
Structure-Based Mapping and Characterization of HSP-Associated Mutations of 
Atlastin-1.  
To date, 28 atlastin-1 missense mutants associated with cases of HSP have 
been identified within the construct studied here (24, 25). Within the primary 
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sequence, the mutations are located in the second half of the G domain and the middle 
domain (Figure 2.9.A). By mapping the mutations onto the three-dimensional 
structures determined here, HSP-associated mutants cluster in the regions of the 
protein that vary most between the two crystal forms, including the putative dimer 
interface, the nucleotide-binding pocket, and the region of the intramolecular rigid 
body rotation (Figures 2.4. and 2.9.). 
For a functional characterization, we introduced the HSP-associated, single-
point mutations into the soluble, cytoplasmic domain of atlastin-1 used in this study. 
The majority of the mutants (16 out of 28) expressed and purified indistinguishably 
compared to the wild-type protein and elute from the gel filtration column as a single, 
monodisperse peak (Table 2.2.). Those mutants that did not express in our system 
likely introduce significant folding defects (black spheres, Figure 2.9.). In contrast, the 
soluble mutants exhibit similar thermal melting temperatures that are comparable to 
that of the wild-type protein (Table 2.2. and Figure 2.10.C), indicating that folding 
defects, if any, are local with no apparent effect on protein stability. 
Half of the soluble mutants exhibited dimerization behavior indistinguishable 
from the wild-type protein (Figure 2.10.A and Table 2.2.). In contrast, several mutant 
proteins displayed defects in dimerization (Figures 2.10.A, 2.11., and 2.12.). These 
include L157W, Q191R, Y196C, R217Q, H247R, Y336H, and M408V⁄T (orange and red 
residues, Figure 2.9.). R217Q, the only mutation located in the nucleotide-binding site, 
displays the most drastic effect. R217 is the first residue in the RD motif and interacts 
with the nucleotide’s guanine base (Figure 2.1.B; red residue, Figure 2.9.) (41). The 
protein remains monomeric irrespective of the presence of nucleotide and is defective  
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Figure 2.9. Mapping of hereditary spastic paraplegia (HSP) mutant residues onto the 
primary and tertiary structure of atlastin-1. (A) Overview of the position of HSP 
mutations. The atlastin-1 domain organization is shown as in Fig. 1, with the locations of all 
missense mutations that fall into the crystallized construct being marked. HSP mutations were 
mapped onto the tertiary structure of atlastin-1 (form 1, Right; form 2, Left). The two 
protomers of each dimer are colored in light and dark gray, respectively. Positions of missense 
mutations associated with HSP are shown as spheres and color-coded according to their 
biochemical properties. Position of the dimerization-defective mutants in the form 1 (B) and 
form 2 (C) dimer models for atlastin-1. Detailed views of several HSP mutation sites in 
atlastin-1 that show defects in nucleotide binding and/or oligomerization are shown. Color-
coding is shown as in A. 
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with regard to nucleotide binding and GTPase activity (Figures 2.3., 2.11. and 2.12.), 
consistent with its direct role in nucleotide coordination. The oligomerization 
propensities of the mutants T157W, Q191R, Y196C, H247R, Y336H, and M408V⁄T are 
peculiar in that they exhibit dimer formation similar to wild-type protein upon binding 
of the transition state analog, but show a significant fraction of monomeric species 
upon incubation with GppNHp (Figures 2.11. and 2.12.). Although they show variable 
degrees of GTPase activity and no direct correlation between GppNHp-dependent 
dimer formation and activity, they coalesce at or close to a surface on the G domain 
that is part of the interdomain interfaces in both crystal forms (Figures 2.9. and 2.11.). 
Although the location of the mutations in the crystal structures and type of amino acid 
change do not allow for any obvious predictions regarding their effect on 
oligomerization or enzymatic activity, the defective dimerization upon GppNHp 
incubation and the spatial proximity suggest a common mode of action. 
Taken together, the subset of atlastin-1 mutations with reduced dimerization 
propensity further support a dimer-dependent molecular mechanism for atlastin 
function and reveal a prominent mode of action for genetic alterations that contribute 
to HSP pathogenesis. Despite the measurable reduction in dimer formation upon 
incubation with GppNHp, the transition state dimers appear to be less affected by the 
mutations (with the exception of the nucleotide-binding-deficient mutant R217Q), 
which may explain why changes in GTPase activity are less pronounced. 
Alternatively, nucleotide binding and dimerization may not be necessarily 
interdependent and could potentially constitute distinct mechanisms underlying HSP.  
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Figure 2.10. Solution properties of HSP-associated mutations introduced in the 
cytoplasmic domain of atlastin-1. (A) Nucleotide-dependent dimerization of HSP-associated 
atlastin-1 mutants. Molecular weight distributions for GppNHp- or AlFx-bound atlastin-1 
variants (residues 1–446) were determined by static multiangle light scattering. Errors 
correspond to calculated errors in the fitting function parameters. (B) GTPase activity. GTPase 
activity was determined by measuring the production of inorganic phosphate upon GTP 
hydrolysis (see Material and Methods for details). (C) Protein stability was determined based 
on measurements of the melting temperature by circular dichroism spectroscopy. 
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In addition, other mutants showed only modestly decreased GTPase activity and near 
wild-type dimerization (green spheres, Figures 2.9. and 2.10.; Table 2.2.), indicating 
that they confer defects in some other, yet unknown aspect.  
 
 
 
Figure 2.11. Characterization of HSP-associated mutations in atlastin-1. (A) Mapping of 
HSP mutant residues that affect dimerization (red and orange) onto the crystal structures of 
atlastin-1. Protomers are colored in light and dark gray. R217 (red) is located in the nucleotide-
binding pocket. Dimer interface mutant R77 (blue) is not associated with HSP but was chosen 
based on the crystallographic dimer interface. (B) Nucleotide-dependent dimerization of HSP-
associated atlastin-1 mutants. Molecular weight distributions for GppNHp- or AlFx -bound 
atlastin-1 variants (residues 1–446) were determined by static multiangle light scattering. 
Errors correspond to calculated errors in the fitting function parameters. (C) GTPase activity. 
GTPase activity was determined by measuring the production of inorganic phosphate upon 
GTP hydrolysis. 
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Figure 2.12. SEC-MALS data for selected HSP mutants. SEC-MALS of atlastin-1 Q191R, 
R217Q, H247R, Y336H, and M408T bound to GDP•AlFx (Left) or GppNHp (Right). Plotted on the 
left Y axis, the signal from the 90°-scattering detector and refractive index detector is shown 
in a solid colored line and a black dashed line, respectively. On the right Y axis, average 
molecular weight as calculated every second across the protein elution peak is shown as black 
circles. Theoretical molecular weights based on primary sequence for the monomer and dimer 
are indicated as horizontal, dashed lines. Proteins (20 µM) were incubated with nucleotides (2 
mM) prior to SEC-MALS analysis in a mobile phase lacking nucleotides. 
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CONCLUSIONS 
In summary, the structural and functional analyses revealed a mechanistic 
conservation between atlastin and other dynamin superfamily proteins with regard to 
overall architecture, in particular the position of the respective stalk-like protrusions 
relative to their G domains, and nucleotide-dependent homodimerization. The 
apparent differences in the solution structures in different nucleotide-bound states, the 
distinct conformations observed in the two different crystal forms, and the unique 
behavior of several HSP-associated mutants lead one to speculate that the overall 
structure and function of atlastin is coupled to its GTP hydrolysis cycle. The indication 
that GppNHp and GDP•AlFx induce distinct conformational and functional states is 
analogous to both Gα subunits and small GTPases where these differences are 
attributed to the GTP-bound ground state and transition state for GTP hydrolysis (42, 
43). 
The antiparallel orientation of the middle domains in one of the crystal 
structures (form 2) and the elongated, dimeric solution states suggests that atlastin 
monomers from opposite membranes may engage in this oligomerization. GTP 
hydrolysis and/or the transition state may trigger a conformational change in atlastin, 
facilitating the formation of three-way junctions and membrane fusion (14, 15). The 
association with highly curved membranes and interactions with other proteins will 
further contribute to these processes (14, 20). Such interactions could trigger allosteric 
changes across the middle domain modulating atlastin’s GTPase activity, similar to 
the autoregulatory role of the PH domain in dynamin (7). Although we have not 
observed the second crystalline conformation (form 1) in solution, we speculate it may 
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be relevant in the native environment of the protein and could represent an end state 
(and/or inhibited, GDP-bound state). 
Many mutations occurring in HSP patients impair oligomerization of atlastin, 
nucleotide hydrolysis, or both. Given the minor impact of several mutants on protein 
stability, it is likely that they retain the ability to interact with some (if not all) binding 
partners in the cell. Mixed dimer formation and engagement in dysfunctional 
complexes may affect the wild-type alleles, providing a rationale for the dominant 
phenotype of the mutations. Although many mutations coalesce in the region between 
the nucleotide-binding site and the intramolecular domain interface, their exact 
pathological mechanism remains elusive. One hypothesis awaiting further analysis is 
that these alterations may perturb communication between the G domain and middle 
domain during the nucleotide-dependent, functional cycle. 
Other mutations associated with HSP that occur in regions outside of the 
crystallized fragment would be predicted to affect atlastin’s stability in the membrane 
as well as its interactions with the reticulon and DP1 families (e.g., mutations near or 
in the transmembrane domains; Y459C, G469A, G482V, R495W) (14, 15). Furthermore, 
there are several mutations within the C-terminal domain of atlastin, including 
missense or nonsense mutations, that truncate the C terminus (A492fsX522, 
E502fsX522, I507fsX522, S519N), which would be expected to affect atlastin’s 
interactions with other binding partners, such as spastin, as has been shown previously 
for I507fsX522 (21). 
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CHAPTER 3 
STRUCTURAL BASIS FOR THE CONFORMATIONAL SWITCHING AND 
GTP LOADING OF THE LARGE G PROTEIN ATLASTIN§ 
 
ABSTRACT 
Atlastin, a member of the dynamin superfamily, is known to catalyze 
homotypic membrane fusion in the smooth endoplasmic reticulum (ER). Recent 
studies of atlastin have elucidated key features about its structure and function; 
however, several mechanistic details, including the catalytic mechanism and GTP 
hydrolysis-driven conformational changes, are yet to be determined. Here, we present 
the crystal structures of atlastin-1 bound to GDP!AlF4- and GppNHp, uncovering an 
intramolecular arginine finger that stimulates GTP hydrolysis when correctly oriented 
through rearrangements within the G domain. Utilizing Förster Resonance Energy 
Transfer, we describe nucleotide binding and hydrolysis-driven conformational 
changes in atlastin and their sequence. Furthermore, we discovered a nucleotide 
exchange mechanism that is intrinsic to atlastin’s N-terminal domains. Our results 
indicate that the cytoplasmic domain of atlastin acts as a tether and homotypic 
interactions are timed by GTP binding and hydrolysis. Perturbation of these 
mechanisms may be implicated in a group of atlastin-associated hereditary 
neurodegenerative diseases. 
 
_______________________ 
§ The following sections are reproduced from: Byrnes, L.J., Singh, A., Szeto, K., Benvin, N.M., 
O’Donnell, J.P., Zipfel, W.R., and Sondermann, H. 2013. Structural basis for the conformational 
switching and GTP loading of the large G protein atlastin. EMBO J. 32 pp369-384, doi: 
10.1038/emboj.2012.353, with modifications to conform to the required format. LJB and HS conceived 
the project. LJB, AS, KS, WRZ, and HS designed the experiments. LJB, AS, KS, NMB, and HS 
performed the experiments. LJB, AS, KS, JPO, WRZ, and HS analyzed the data. LJB and HS wrote the 
paper. 
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INTRODUCTION 
Hereditary Spastic Paraplegia (HSP) is a progressive spastic weakness of the 
lower extremities due to the degeneration of axons in corticospinal motor neurons at 
their distal ends (1, 2). While it is a rare disease, affecting 2–7.4 in 100 000 people (1, 
3-5), extensive genetic studies have revealed several hot spots associated with the 
disease, with >50% of cases caused by mutations in just three loci: Spastin-1, REEP-1, 
and atlastin-1 (5, 6). Atlastin-1/SPG3A mutations account for ~10% of autosomal 
dominant HSP cases; however, this locus is the primary site for mutations in children 
affected with the disease (7). Mutations in atlastin-1 have also been detected in 
patients suffering from hereditary sensory neuropathy (HSN), a related 
neurodegenerative disorder affecting lower motor neurons (8). 
Atlastin-1 is found in neurons at the cis-Golgi, endoplasmic reticulum (ER), 
and axon growth cones, where it is part of a complex containing spastin, reticulons, 
and REEP proteins (9-12). Atlastins and reticulons are involved in generating and 
maintaining the tubular ER network (11-15), where atlastin promotes homotypic 
fusion of membranes, generating three-way junctions (11, 15). On a molecular level, 
atlastins are related to large G proteins such as dynamin, MxA, GBP1, and mitofusin, 
many of which are involved in membrane fission or fusion (16). Structural studies on 
near full-length dynamin, MxA, and GBP1 revealed remarkable similarities to atlastin 
regarding the molecular architecture of the G proteins (17-25). All the proteins of this 
family contain a globular G domain followed by an α-helical, stalk-like middle 
domain (Figure 3.1.A). For dynamin, the prototypical member of this family, GTP 
hydrolysis is coupled to conformational changes that alter the position of the stalk-like 
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domain (called the bundle signaling element or BSE) relative to the G domain dimer 
(22-24), yet full activation requires a membrane-dependent, higher order assembly 
(22-24, 26-32). 
A prominent feature of several dynamin superfamily proteins is the 
oligomerization-dependent activation of their GTPase activity, which is in contrast to 
small GTPases that rely on the action of heterologous GTPase activating proteins (15, 
33-35). Recent studies yielded the first crystal structures of atlastin (forms 1 and 2 
with a ‘disengaged’ and ‘engaged’ middle domain, respectively, relative to their G 
domain; Figure 3.1.B), revealing two dimeric conformations that presumably represent 
pre- and post-fusion states and hint at an overall conserved mechanism (20, 21). These 
studies also suggested a model by which GTP binding tethers two opposing 
membranes via G domain dimerization, with GTP hydrolysis being coupled to 
intramolecular conformational changes that drive membrane fusion (36). However, the 
structures depict only GDP-bound states, hence, the exact catalytic mechanism for 
atlastin and the concurrent conformational switching upon GTP hydrolysis remained 
unknown. It has also been established that the middle domain is required for 
dimerization and GTPase activity (37-39), the reason for which is not obvious from 
the initial models. In addition, a recent report demonstrated, using single-particle 
electron microscopy, that atlastin-2 bound to the GTP-mimic GppNHp adopts both the 
presumed pre- and post-fusion conformations, the latter of which depends on an 
intramolecular salt bridge between the middle domain and the adjacent linker (37). 
The authors argued that GTP hydrolysis might not be the direct trigger for 
conformational changes leading to fusion. While this presents an apparent 
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contradiction to earlier studies (20, 21), we now present an alternative model based on 
novel crystal structures and approaches that report on dynamic changes and kinetics 
within the cytoplasmic, N-terminal module of human atlastin-1. Our studies address 
several fundamental questions regarding the intrinsic regulation of atlastin with 
relevance to the mechanism of membrane fusion, in particular: (1) the molecular basis 
for GTP hydrolysis; (2) the conformational changes and their timing along atlastin’s 
GTPase cycle; and (3) the surprising discovery of an intrinsic, middle domain-
mediated mechanism for GTP loading in atlastin. 
 
MATERIALS AND METHODS 
Protein expression and purification 
The cytoplasmic domain (residues 1-446), G domain (1-339), middle domain 
(340-446), truncated middle domain (1-366), and C-terminal ECFP/EYFP fusions 
(atlastin1 1-446 followed by a short linker containing amino acid sequence GSTSTG 
followed by either ECFP or EYFP) of human atlastin-1 were amplified by standard 
PCR and cloned into a modified pET28a expression plasmid (Novagen) yielding N-
terminally hexahistidine-tagged SUMO fusion proteins. The hexahistidine-tagged 
SUMO-moiety was cleavable using the protease Ulp-1 from S. cerevisiae. The 
cytoplasmic domain (1-446) used for crystallization of wild-type atlastin was cloned 
into pET21, yielding C-terminally hexahistidine-tagged protein, which was not 
cleaved during purification. 
Proteins were overexpressed in E. coli BL21 (DE3) (Novagen) or T7 Crystal 
Express (NEB) cells, respectively. For the expression of native proteins, cells were 
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grown in Terrific Broth (TB) media supplemented with 50 µg/ml kanamycin (for 
expression from pET28) or 100 µg/ml ampicillin (for expression from pET21) at 
37°C. At an optical density corresponding to an absorbance of 0.8-1.0 at 600 nm 
(OD600), the temperature was reduced to 18°C, and protein production was induced 
with 0.5 mM IPTG. After 16 hours, cells were harvested by centrifugation, 
resuspended in NiNTA buffer A (25 mM Tris-HCl, pH 8.5, 500 mM NaCl and 20 mM 
imidazole), and flash-frozen in liquid nitrogen. 
After cell lysis by sonication and removal of cell debris by centrifugation, clear 
lysates were loaded onto NiNTA Superflow (Qiagen) equilibrated in NiNTA buffer A. 
The resin was washed with 20 column volumes of NiNTA buffer A, and proteins were 
eluted three times with 2 column volumes of NiNTA buffer A supplemented with 500 
mM imidazole. Proteins were buffer exchanged into desalting buffer (25 mM Tris-
HCl, pH 7.5, 400 mM NaCl, 5mM β-mercaptoethanol), with proteins expressed in 
pET21 constructs immediately subjected to size exclusion chromatography. In the case 
of proteins expressed with a SUMO moiety, affinity tags were removed by incubation 
with the yeast protease Ulp-1 at 4°C overnight. Cleaved proteins were collected in the 
flow-through during NiNTA affinity chromatography, and were subjected to size 
exclusion chromatography on a Superdex 200 column (GE Healthcare) equilibrated in 
gel filtration buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl). Proteins were 
concentrated on a Centricon ultrafiltration device (10 kDa cutoff; Millipore) to a final 
concentration of approximately 0.5-1 mM. Protein aliquots were flash frozen in liquid 
nitrogen and stored at -80°C. 
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Site-directed mutagenesis was carried out using Quikchange (Agilent) 
following the manufacturer’s instructions, followed by validation through DNA 
sequencing. 
 
Crystallization, data collection, and structure solution 
Crystals were obtained by sitting drop vapor diffusion mixing equal volumes 
of protein (10–30mg/ml) and reservoir solution followed by incubation at 20°C. Initial 
crystals were obtained using atlastin-1 protein in gel filtration buffer in the presence of 
2 mM GppNHp (Sigma) and 4 mM MgCl2. In the case of GDP!AlF4-, crystals were 
obtained in the presence of 2 mM GDP (Sigma), 4 mM MgCl2, 2 mM EGTA, 2 mM 
AlCl2, and 20 mM NaF. Rod-shaped crystals belonging to space group P21212 
(atlastin-11–446-N440T) grew in reservoir solution containing 0.2M lithium citrate 
tribasic tetrahydrate and 20% PEG-3350 (for both GppNHp and GDP!AlF4- crystals). 
For cryo-protection, crystals were soaked in reservoir solution supplemented with 25% 
glycerol. For proteins crystallizing in space group P212121 (atlastin-11–446-Chis), the 
reservoir solution contained 0.1 M imidazole, pH 7.0 and 20% v/v Jeffamine ED-
2001, pH 7.0 (GppNHp) or 0.2 M ammonium phosphate dibasic and 20% PEG-3350 
(GDP!AlF4-). Crystals were cryo-protected by soaking in the crystallization solutions 
supplemented with 20% xylitol. Cryo-preserved crystals were flash-frozen and stored 
in liquid nitrogen. Data were collected on frozen crystals at 100 K. 
Data reduction was carried out with the software package HKL2000 (40). 
Phases were obtained either by Single-wavelength Anomalous Dispersion (SAD) or 
Molecular Replacement (MR) methods by using the software package PHENIX (41) 
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with the isolated G and middle domains of atlastin-1 as separate search models for 
MR. Refinement in PHENIX (41) and COOT (42) yielded the final models. Data 
collection and refinement statistics are summarized in Table 3.1. Illustrations were 
made in Pymol (43). 
 
Size-exclusion chromatography-coupled multi-angle light scattering 
Purified protein (<2 mg/ml or 40 mM, injected concentration) was subjected to 
size-exclusion chromatography using a BioSep-SEC-S 3000 column (Phenomenex) 
equilibrated in MALS buffer (25 mM Tris–HCl, pH 7.5, 100 mM NaCl, 4 mM MgCl2, 
and 2 mM EGTA). Where specified, wild-type or mutant atlastin-1 was incubated with 
GDP, GppNHp, or GDP!AlFx (2 mM) for 30 min at room temperature prior to 
injection. The column was coupled to a static 18-angle light scattering detector 
(DAWN HELEOS-II) and a refractive index detector (Optilab T-rEX) (Wyatt 
Technology). Data were collected every second at a flow rate of 1 ml/min. Data 
analysis was carried out using the program ASTRA V, yielding the molar mass and 
mass distribution (polydispersity) of the sample. For normalization of the light 
scattering detectors and data quality control, monomeric BSA (Sigma) was used. 
Molecular weight distributions were determined by using the Multipeak Fitting 
Package in Igor Pro (WaveMetrics). 
 
GTPase assay 
GTPase activity was measured using the Enzchek Phosphate Assay kit 
(Molecular Probes) following the manufacturer’s instructions. Measurements were 
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carried out in a 96-well plate (Nunc) in a total volume of 250 µl. Recombinant wild-
type or mutant atlastin-1 (at concentrations 0, 0.25, 0.5, 1, 2, and 4 µM) was combined 
with 1 U/ml purine nucleoside phosphorylase (PNP), 200 µM 2-amino-6-mercapto-7-
methylpurine riboside (MESG), and provided buffer (20mM Tris–HCl, pH 7.5, 1mM 
MgCl2, 0.1mM sodium azide). The plate was incubated at room temperature for 10 
min, after which reactions were started by addition of 400 µM GTP (or alternatively, 
50 mM Tris–HCl pH 7.5 for controls). Plates were assayed at 37°C in a Powerwave 
XS microplate reader (BioTek). Absorbance at 360 nm was monitored in 30 s intervals 
for 30 min. Data were normalized to a phosphate standard curve, and initial velocities 
were calculated using the portion of the curve corresponding to the first 5% of 
consumed product. Data reported are means ± s.e.m. of three independent 
experiments. 
 
Dye labeling of atlastin-1 
Dye labeling using Alexa dyes 488-C5 maleimide and 647-C2 maleimide 
(Invitrogen) for donor and acceptor, respectively, was performed using the 
manufacturer’s guidelines. In brief, protein at a final concentration of ~80 µM was 
mixed with a 15× molar excess of the dye molecule in a final buffer composition of 25 
mM Tris–HCl, pH 7.4, 100 mM NaCl, and 0.5 mM TCEP. Protein was incubated with 
the reducing agent TCEP for ~15 min prior to mixing with dye. All reactions were 
topped off with nitrogen before sealing off the reaction tubes to reduce reactive 
oxygen species. Reactions were kept at room temperature for 2 h, followed by 
overnight incubation at 4°C, all in the absence of light. Reactions were quenched by 
 80 
the addition of 50 mM β-mercaptoethanol. Excess dye was then removed using 
Millipore concentrators (30kDa cutoff) with several rounds of buffer exchange, 
followed by determination of degree-of-labeling (DOL). All reactions used for FRET 
measurements reached a DOL of 90–110%. 
 
FRET measurements 
FRET measurements were made by mixing 1 µM of donor atlastin-1 (ECFP 
tagged or Alexa 488 labeled) and 20 µM acceptor atlastin-1 (EYFP tagged or Alexa 
647 labeled) in assay buffer (25mM Tris–HCl, pH 7.4, 100 mM NaCl, and 4 mM 
MgCl2), with or without 2 mM GTP, GDP, or GppNHp. Measurements taken for 
GDP!AlF4- were done using 25 mM Tris–HCl, pH 7.4, 100 mM NaCl, 4 mM MgCl2, 
2 mM EGTA, 2 mM AlCl2, and 20 mM NaF with or without 2 mM GDP. 
Measurements were taken on a UV–Vis spectrofluorometer (PTI Quantamaster 40), 
exciting at 445 nm (ECFP) or 493 nm (Alexa 488) and scanning emission spectra 
between 455 and 650 nm (ECFP/EYFP) or 505 and 800nm (Alexa 488/647). All 
measurements were performed in triplicate. FRET efficiencies were calculated by 
using the emission intensity of the apo state (no nucleotide) at 473 nm (emission peak 
of ECFP) or 516 nm (emission peak of Alexa 488) as the no-FRET scenario. The 
following equation was used to calculate the FRET efficiency for equilibrium 
experiments: 
! = 1− !!"!!  
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where E is FRET efficiency, FDA is the fluorescence intensity of the donor with the 
acceptor present, and FD is the fluorescence intensity of the donor without the 
acceptor. Distance estimates were calculated using the equation: 
! = 11+ !!! ! 
where E is the FRET efficiency, calculated above, r is the actual distance (to be 
calculated), and R0 is the Förster distance for a particular FRET pair. For ECFP/EYFP, 
R0 is 47 Å, and for Alexa 488/647 is 56 Å. 
Kinetic FRET data were recorded using a stopped-flow instrument (Kintek SF-
2004) with submillisecond mixing dead times. A mixture of donor and acceptor 
atlastin-1 (both at 1 µM) in assay buffer were mixed with either buffer alone or buffer 
supplemented with nucleotide (2 mM GDP, GTP, GppNHp, or GTPγS) using the 
stopped-flow drive syringes. In the case of GDP!AlFx, the protein donor/acceptor 
mixture was in a buffer containing 25 mM Tris–HCl, pH 7.4, 100 mM NaCl, and 4 
mM MgCl2, 2 mM EGTA, 2 mM AlCl2, and 20 mM NaF. This was then mixed with 
this buffer supplemented with 2 mM GDP. The two solutions were mixed at a ratio of 
1:1, at a flow rate of 8 ml/s in a total cell volume of 30 µl. The cell was illuminated by 
light from a xenon arc lamp, with a monochromator used to select a narrow band 
around 445 nm (the excitation of ECFP) or 493 nm (the excitation of Alexa 488). 
Fluorescence signals from ECFP/EYFP or Alexa 488/647 were recorded using two 
independent photomultiplier tubes with appropriate filters (Chroma) in place (B460-
490, D535/25 for ECFP/EYFP; D525/50, HQ645/75 for 488/647). 
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Kinetic modeling of fast-mixing FRET 
FRET simulations were programmed and performed using MATLAB R2010b 
(Mathworks). First, time-dependent binding was modeled by simple second-order 
kinetics for dimerization constrained by the mass conservation law. Discrete time 
steps of 10 ms were used to match instrumentation resolution. The bound-state model 
for the dimer consisted of two quasi-stable configuration states: the initial dimerization 
state D1 and a relaxed dimer state D2. Transitions between these states were governed 
by a relaxation rate constant k12, the transition time t12, and a set of transition states 
D12. Finally, by assuming the proximity of conjugate labels within dimers at each 
configuration and transition state, the Förster equation was used to determine FRET 
efficiencies, and to calculate the total simulated FRET signal at each time step. A full 
description of equations used and assumptions made are described in Appendix A. 
 
N-Methylanthraniloyl (Mant)-nucleotide binding 
On and off rates of mant nucleotides (mant-GppNHp, mant-GDP, or mant-
GTP) were determined by measuring the change in fluorescence of the mant 
nucleotide over time upon mixing with atlastin-1 constructs. Using a Kintek stopped-
flow apparatus (Kintek SF-2004), a final concentration of 2.5 µM mant-GDP, mant-
GTP, or mant-GppNHp (Invitrogen) was mixed with increasing concentrations of 
atlastin-1 (10–50 µM). Mant fluorescence (λexc = 366 nm, emission filter HQ460/40M; 
Chroma) was measured and the first 500ms of data was fit to a single-exponential 
decay curve. Observed rate constants from exponential fits were plotted versus protein 
concentration, with the resulting slope of the linear fit corresponding to kon, and the y 
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intercept to koff. In parallel experiments, the off rate (koff diss.) was also directly 
measured by preloading atlastin-1 proteins with mant nucleotide and chasing with a 
high concentration (2.5 mM) of unlabeled nucleotide (GDP). The first 500ms of the 
resulting fluorescence decay curve was fit to a single-exponential decay, whose 
observed rate constant corresponds directly to the off rate (koff). All fits were 
performed using Prism 5 (GraphPad Software Inc.). Rates obtained from both 
techniques are listed in Table 3.2. 
 
RESULTS AND DISCUSSION 
Crystallization of atlastin-1 bound to GppNHp and GDP-AlF4- 
We determined two sets of crystal structures for the N-terminal, cytoplasmic 
module of human atlastin-1 comprising the G and middle domains (residues 1–446), 
bound to a transition state analogue GDP!AlF4- or non-hydrolysable GTP-mimic 
GppNHp (Table 3.1.). For the first set, we used the HSP disease mutant variant N440T 
(space group P21212; 4 molecules/asymmetric unit), while the second set made use of 
the wild-type protein containing a C-terminal hexahistidine tag (space group P212121; 
2 molecules/asymmetric unit). Crystallization conditions differed between the mutant 
and wild-type proteins, but for each variant the conditions were nearly identical for 
both nucleotide-bound states. The different conditions and constructs resulted in 
unique crystal packing interactions for N440T and wild-type atlastin-1 variants, 
respectively (Figures 3.2. and 3.3.). Nevertheless, the conformation of the protomers 
and dimeric assemblies within the crystals were virtually identical in all four crystal 
structures (Table 3.3.), with the exception of the identity of the bound nucleotide and  
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Figure 3.1. Structures of atlastin-1. (A) Topology of atlastin-1. The globular G domain 
(orange) is connected to the middle domain (blue) by a short linker (green). This N-terminal, 
cytoplasmic unit is followed by two transmembrane a helices (black) and a C-terminal 
amphipathic helix (grey), which has been shown to interact with the lipid membrane. (B) 
Protomer structures of crystal forms 1 and 2. The GDP-bound structures of atlastin-11–446 were 
aligned relative to their G domains (Byrnes and Sondermann, 2011). Nucleotide and Mg2+ are 
shown as sticks and spheres, respectively. (C) Protomer structures of crystal form 3. The 
GDP!AlF4--bound form 3 structure of atlastin-11–446-N440T was superimposed on the GDP-
bound form 1 structure with the G domain as the reference. The form 1 structure is shown in 
grey and the form 3 structure is colored according to (A). Position of missense mutation in 
form 3 structure is indicated and its Cα is shown as a black sphere. An Fo − Fc omit map for 
the nucleotide (inset) is contoured at 4.0 sigma. 
 
the extreme C-termini that contain either the N440T mutation or the hexahistidine tag 
(and are involved in specific crystal lattice contacts) (Figures 3.2. and 3.3.). The 
crystallographic data suggest nucleotide-bound dimers as the biologically relevant 
unit, which is supported by size-exclusion chromatography-coupled static multi-angle 
light scattering (SEC-MALS), a method for determining the absolute molecular weight 
of particles in solution. In these experiments, there is no evidence of higher order 
oligomerization beyond dimers for the soluble, wild-type protein or the N440T mutant  
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Figure 3.2. Crystal structure of atlastin-11-446-N440T form 3 crystal structure bound to 
GppNHp or GDP•AlF4-. (A) Overview of asymmetric unit. Atlastin-11-446-N440T crystallizes 
as a tetramer in the asymmetric unit. An interaction of the C-terminal tail of one protomer with 
the G domain of an adjacent molecule is shown in the inset. (B) Detailed view of interactions 
of the C-terminal tail with an adjacent G domain. Residues 440-446 (grey) from molecule B 
and residues from the G domain of molecule C (yellow) that interact with them are shown as 
sticks and labeled. An Fo − Fc omit map for the tail motif is contoured at 3.5 sigma. (C) 
Superposition of crystal form 1 and 3. The respective G domains of crystal form 1 and 3 were 
superimposed to assess whether tail packing interactions coincide with conformational 
changes in the G domain. No significant changes were observed. (D) Nucleotide binding 
pocket of form 3 crystal structures. The protein is shown in cartoon presentation, GDP!AlF4- 
(upper panel) or GppNHp (lower panel) are shown as sticks, and Mg2+ and waters are shown 
as green and red spheres, respectively. Nucleotide Fo− Fc omit map is contoured at 4.0 sigma. 
(E) Catalytic residues in the nucleotide binding pocket of form 3 crystal structures. The 
protein is shown in cartoon presentation except for residues that interact with the phosphates 
of the nucleotide, which are shown as sticks. GDP!AlF4- (upper panel) or GppNHp (lower) are 
shown as sticks, and Mg2+ is shown as spheres. 
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Figure 3.3. Crystal packing interactions. (A) Asymmetric unit and crystal packing of 
atlastin11-446-N440T bound to GppNHp or GDP!AlF4-. The asymmetric unit contains 4 
protomers, forming an anti-parallel dimer of dimers. (B) Asymmetric unit and crystal packing 
of atlastin11-446-C-His6 bound to GppNHp or GDP!AlF4-. The asymmetric unit contains 2 
protomers that form a very similar dimer as observed in atlastin11-446-N440T structures bound to 
the same nucleotides. 
 
variant when bound to GppNHp or GDP!AlF4- (Figure 3.4.). We chose the atlastin 
N440T mutant bound to GDP!AlF4- for our illustration of this particular state, yet the 
crystallographic results apply to all four structures considering the striking similarities 
between them. We refer to this state as crystal form 3. 
The structures reveal several previously unseen features that provide novel 
insights into the catalytic mechanism of atlastin-mediated membrane fusion, which  
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Figure 3.4. Atlastin-11-446-N440T oligomerization in solution. (A) SEC-MALS data for wild-
type Atlastin-11-446. The signal from the 90°-light scattering detector and refractive index 
detector are shown as colored, solid lines (apo, red; GppNHp-bound, green; GDP-bound, 
purple; GDP!AlFx-bound, orange) and black, dashed lines respectively (left Y axis). Average 
molecular weight calculations across the protein peak are shown as black circles (right Y 
axis). The theoretical molecular weight (based on primary sequence) for the monomer and 
dimer are shown as horizontal dashed lines. Proteins (30-40 µM) were incubated with 
nucleotides (2 mM) at least 30 min prior to SEC-MALS analysis. (B) SEC-MALS data for the 
N440T mutant introduced into atlastin-11-446.  
 
will be discussed in detail below. Notably, we observe clear density for the γ-
phosphate or AlF4- moiety, in the GppNHp- and GDP!AlF4--bound structures, 
respectively (Figure 3.1.C). Dimerization in solution is only observed in the presence 
of GppNHp or GDP!AlF4-, but not in the apo state or when bound to GDP (21), 
indicating that we crystallized a physiologically relevant conformation. In addition, we 
observe conformational changes of the G domain’s switch regions and G domain 
dimer interface associated with GTP analogue binding. Overall, the form 3 crystal 
structure is most similar in conformation to the previously determined, GDP-bound 
form 1 structure, characterized by the middle domain being dislodged from the G 
domain, with one difference being an 18°-rigid-body rotation of the middle domain 
relative to the G domain (Figure 3.1.C). 
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Table 3.1. X-ray data collection and refinement statistics.  
 atlastin-1 
1-446, N440T 
GDP!AlF4- 
atlastin-1 
1-446, N440T 
GppNHp 
atlastin-1 
wildtype, CHis6 
GDP!AlF4- 
atlastin-1 
wildtype, CHis6 
GppNHp 
Data collection     
X-ray source CHESS A1 CHESS A1 CHESS A1 CHESS A1 
Wavelength (Å) 0.9771 0.9771 0.9771 0.9771 
Space group P21212 P21212 P212121 P212121 
Unit cell parameters     
     a, b, c, (Å) 129.0, 267.1, 
62.1 
132.0, 268.1, 
62.4 
49.6, 116.4, 
185.4 
49.7, 115.8, 
181.1 
     α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution range 
(Å)a 
50-2.3 (2.38-
2.30) 
50-2.6 (2.69-
2.60) 
50-2.1 (2.18-
2.09) 
50-2.2 (2.28-
2.20) 
No. of reflections     
     Total 743,898 
(45,513) 
540,312 (44,595) 512,721 (43,745) 334,053 (9,968) 
     Unique 92,313 (7,714) 69,639 (6,656) 63,782 (6,730) 47,929 (2,167) 
Completeness (%) 95.3 (81.1) 99.7 (97.4) 98.9 (96.8) 90.3 (41.7) 
Redundancy 14.6 (3.0) 7.8 (6.7) 8.0 (6.5) 7.0 (4.6) 
I/σ (I) 35.6 (10.5) 12.3 (3.1) 23.3 (4.1) 16.1 (1.9) 
Rmeas (%) 12.0 (50.4) 16.0 (61.1) 8.1 (47.4) 10.1 (59.3) 
Refinement     
Rwork/Rfree (%) 20.6/25.6 20.1/23.6 19.9/24.9 17.3/21.8 
r.m.s. deviations     
     Bond length (Å) 0.008 0.014 0.008 0.006 
     Bond angles (°) 1.19 1.68 1.23 0.98 
No. of atoms 14,506 14,015 7,459 7,192 
     Protein 13,486 13,480 6,730 6,762 
     Ligands 212 132 68 66 
     Water 704 403 661 364 
Ave. B-factors (Å2)     
     Protein 27.8 28.2 30.7 41.5 
     Water 32.8 24.5 34.0 40.6 
Ramachandran (%)     
      Favored 99 98 98 98 
      Outliers 0 0 0 0.1 
aValues in brackets are for the highest resolution bin.   
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Table 3.2. Nucleotide binding to human atlastin-1. !
Protein Nucleotide kon (1/µM s) koff (1/s) koffdiss. (1/s) Kd (µM)!
Atlastin-11-446 wt GDP 0.40±0.015 4.80 ±0.384 2.31 ±0.171 5.77 ±0.479!
 GTP 0.32±0.021 4.05±0.594 3.72±0.287 11.63±1.18!
 GppNHp 0.51±0.079 19.36±2.23 20.63±3.285 40.45±8.99!
     !
Atlastin-11-446 R77A GDP 0.34±0.013 5.92±0.302 2.77±0.170 8.14±0.589!
 GTP 0.64±0.030 4.38±0.828 8.02±0.166 12.53±0.642!
 GppNHp 0.70±0.093 5.08±2.73 4.25±1.465 6.07±2.243!
     !
Atlastin-11-339 wt GDP 0.20±0.009 7.21±0.214 4.53±0.592 22.65±3.13!
 GTP ND ND ND ND!
 GppNHp ND ND ND ND!
     !
Atlastin-11-446 wt GDP 0.108±0.010 8.30±0.245 6.55±0.673 60.65±8.39!
+ GTP 0.055±0.040 9.34±1.24 7.30±4.47 132.7±126.2!
Atlastin-1340-446 wt GppNHp ND ND ND ND!
     !
Atlastin-11-446 wt GDP 0.086±0.010 9.07±0.252 8.12±0.674 94.42±13.49!
+ GTP ND ND ND ND!
Atlastin-1340-446 M347E GppNHp ND ND ND ND!
     !
Atlastin-11-366 wt GDP 0.128±0.020 8.65±0.520 6.36±0.551 49.69±8.88!
 GTP 0.153±0.041 7.93±1.11 7.12±2.865 46.54±22.50!
 GppNHp ND ND ND ND!
     !
Atlastin-11-446 M347E GDP 0.186±0.010 5.63±0.165 4.13±0.108 22.2±1.33!
 GTP 0.128±0.027 4.29±0.661 4.21±1.00 32.9±10.45!
 GppNHp ND ND ND ND!
Abbreviations: ND, not detected; wt, wild type. amant derivatives were used to determine on and 
off rates using stopped-flow fluorescence spectroscopy. !
 
Table 3.3. Comparison of G and middle domains in atlastin-1 crystal structure. !
Protomer RMSD:     
 C-His GppNHp C-His GDP!AlF4- N440T GppNHp N440T GDP!AlF4- 
C-His GppNHp ✕ 0.209 0.268 0.271 
C-His GDP!AlF4- 0.209 ✕ 0.276 0.265 
N440T GppNHp 0.268 0.276 ✕ 0.157 
N440T GDP!AlF4- 0.271 0.265 0.157 ✕ 
     
Dimer RMSD:     
 C-His GppNHp C-His GDP!AlF4- N440T GppNHp N440T GDP!AlF4- 
C-His GppNHp ✕ 0.220 0.301 0.320 
C-His GDP!AlF4- 0.220 ✕ 0.335 0.310 
N440T GppNHp 0.301 0.335 ✕ 0.163 
N440T GDP!AlF4- 0.320 0.310 0.163 ✕ 
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Extensive dimerization in the GppNHp and transition state-bound structure 
Distinct crystallographic dimers of GDP-bound atlastin-1 were apparent in the 
previously determined structures (form 1, ‘relaxed-parallel’; form 2, ‘extended’; 
Figure 3.5.A) (20, 21). Both had dimerized G domains, but they differed in the spatial 
arrangement of their middle domains. In the form 2 dimer, the middle domains fold 
back onto and are engaged with their respective G domains, with the C-termini 
pointing in opposite directions. In contrast, the protomers in the form 1 dimer are 
crisscrossed with the middle domains running in parallel without interacting with each 
other. Despite the new form 3 dimer having similar topology to the original GDP-
bound form 1, the interfaces are quite different. In general, the interfacial area is larger 
in the structures of atlastin bound to GppNHp and GDP!AlF4- than in the GDP-bound 
models (3852 versus 2797 Å2), both considering the G domain dimerization as well as 
the interactions between the middle domains (G domain dimer: 1886 versus 1226 Å2; 
linker/ middle domain dimer: 1257 versus 406 Å2). The middle domains in the parallel 
dimers interact at the crossover point, which involves the linker between the G and 
middle domains (Figure 3.5.). In addition, the interfacial surface extends to the first 
and third helix of the middle domains in the form 3 dimer (Figure 3.5.B), forming a 
tight-parallel state with respect to middle domain packing and orientation, 
respectively. The more extensive buried surface area in the tight-parallel form 3 dimer 
is consistent with atlastin’s ability to dimerize in solution in the presence of GppNHp 
and GDP!AlF4- (Figure 3.4.A; (21)). 
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Figure 3.5. Crystallographic dimers of atlastin-11–446. (A) Atlastin-1 dimers. 
Crystallographic dimers observed in crystal form 2 (extended, P212121 symmetry, left), form 1 
(relaxed-parallel, P6522 symmetry, middle), and form 3 (tight-parallel, P21212 symmetry, 
right) are shown. Bound nucleotides and metal ions are shown as sticks and spheres, 
respectively. (B) Crystal form 3 dimer interface. Interface residues are shown in color on the 
surface of one half of the dimer. 
 
The catalytic mechanism of atlastin-1 
 As with other G proteins, binding of GTP and transition state analogues, 
GppNHp or GDP!AlF4-, respectively, has profound effects on the conformation of the 
switch regions within the G domain of atlastin (Figure 3.6.). While the GDP-bound G 
domains adopt a somewhat open conformation with regard to the nucleotide-binding 
pocket, switch motifs G2 (switch 1) and G3 (switch 2) in the newly determined 
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structures undergo major conformational changes, folding over the phosphate and 
AlF4- moieties (Figure 3.6.A). The conformational change positions R77 of the G1 
motif (P-loop) above the phosphate moiety, with the guanidinium group interacting 
with the α- and γ-phosphate (or AlF4-) of the nucleotide (Figure 3.6.B), establishing its 
role as a catalytic arginine finger. R77 is conserved in the atlastin and GBP families of 
dynamin-related proteins, but not in dynamins, mitofusins, MxA, or Sey1p, a 
functional atlastin paralogue in yeast (Figure 3.6.A; (11)). This observation suggests 
that GBP and atlastin are more closely related and use an intramolecular arginine 
finger, whereas Sey1p employs a catalytic mechanism potentially involving an 
accessory metal ion and residues of an adjacent G domain within a dimeric assembly, 
as has been described for dynamin (19). 
It is worth noting that in the GDP-bound structures, the side chain of R77 is 
surface exposed and forms a salt bridge with a glutamate residue of an adjacent G 
domain, and hence is central to the G domain dimer interface in these structures (20, 
21). In our previous study, we introduced a charge-reversal mutation at position R77 
(R77E) to probe its involvement in dimerization of the N-terminal, cytoplasmic module 
used for crystallization. We noticed a markedly destabilized GppNHp-bound dimer 
and no dimerization in the presence of GDP!AlFx (21). The mutant protein is also 
devoid of enzymatic activity and binds nucleotide poorly (20, 21). Here, we 
introduced a more subtle mutation by replacing R77 with alanine. In contrast to the 
R77E mutant, simple removal of the side chain (R77A) has little effect on nucleotide-
dependent dimerization in light scattering-based assays (Figure 3.6.C). Both wild-type 
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Figure 3.6. Catalytic mechanism of atlastin-1. (A) Conformational changes upon GTP 
analogue binding. The conformational changes in the nucleotide binding site between GDP-
bound form 1 (grey) versus GDP!AlF4--bound form 3 (colored) are shown after 
superpositioning of the respective G domains. Nucleotide binding and switch motifs (motifs 
G1–G4) of the form 3 crystal structure are colored in shades of blue. On the right, a sequence 
alignment of several dynamin superfamily members shows conserved regions involved in 
nucleotide binding and hydrolysis. Strictly conserved residues are highlighted in green. 
Residues shown in (B) are marked with an asterisk. (B) Residues involved in nucleotide 
hydrolysis. The nucleotide binding pocket of crystal form 3 (upper) is shown, with residues 
making direct or indirect contacts with the phosphate groups of the nucleotide analogue are 
shown as sticks. Mg2+ is shown as a green sphere. The attacking water molecule (labeled ‘aw’) 
and Mg2+-coordinating water molecules are shown as red spheres. Mutation of R77 to alanine 
abolishes GTPase activity (lower panel). The GTPase activity was determined by measuring 
the production of inorganic phosphate over time at various protein concentrations. (C) 
Nucleotide-dependent oligomerization of atlastin-11–446-R77A SEC-MALS data for wild-type 
(left panels) and mutant (R77A, right panels) atlastin-11–446 is shown. The signal from the 90°-
light scattering detector and refractive index detector is shown as colored, solid lines (apo, red; 
GppNHp bound, green; GDP bound, purple; GDP!AlFx bound, orange) and black, dashed 
lines, respectively (left Y axis). Average molecular weight calculations across the protein peak 
are shown as black circles (right Y axis). The theoretical molecular weight (based on primary 
sequence) for the monomer and dimer is shown as horizontal dashed lines. Proteins (30–40 
µM) were incubated with nucleotides (2 mM) at least 30 min prior to SEC-MALS analysis. 
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atlastin and the R77A mutant variant form dimers in the presence of GppNHp and 
GDP!AlFx, but are monomeric in GDP or in the absence of any nucleotide. Yet, R77A 
mutant protein has negligible GTPase activity of 0.1M µM Pi/min/µM when compared 
to 4.1mM µM Pi/min/µM for wild type (Figure 3.6.B), corroborating the role of R77 as 
atlastin’s arginine finger. Based on the structural and mutagenesis data, one cannot 
rule out the possibility that R77 may have a dual function as an interfacial residue as 
well as a catalytic residue. 
Thus far, we established that crystal form 3 depicts a catalytically competent, 
dimeric state of atlastin. Together with the observation of form 1-like, relaxed-parallel 
atlastin-2 dimers bound to GppNHp in electron micrographs (37), these new structures 
deviate from our modeling of small-angle X-ray scattering (SAXS) data that indicated 
GppNHp- and transition state analogue-bound atlastin adopting an extended 
conformation in solution, more similar to the crystal form 2 dimer (21). Yet, the fits 
between the crystallographic models and the solution scattering data were imperfect, 
suggesting either the presence of an alternative conformation or an ensemble of 
conformations in solution. Indeed, modeling of the SAXS data with multiple 
conformations (e.g., form 1, 2, and 3 dimers) improves the fits significantly, and 
points to a conformational heterogeneity of GppNHp- and GDP!AlF4--bound atlastin-
1 (data not shown). 
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Measuring middle domain dimerization in atlastin via Förster Resonance Energy 
Transfer 
While we revealed the catalytic core of atlastin, it is less clear what functional 
state the new crystal form 3 structure depicts and what role GTP hydrolysis plays 
during membrane fusion. The aforementioned studies focused on states that were 
bound to non-hydrolysable nucleotide analogues, limiting the insight into the 
molecular consequences of catalysis. To further investigate the solution conformation 
of atlastin and to later measure the kinetics of conformational changes within the 
dimer, we developed a Förster Resonance Energy Transfer (FRET)-based assay. 
Based on the crystal structures, we would predict that the extended form 2 dimer 
would not support FRET between fluorescent probes fused to the distal tips of the 
middle domains, while in the parallel dimers (forms 1 and 3) the fluorophores would 
come into close proximity allowing FRET to occur. We fused ECFP or EYFP to the 
C-terminus of the middle domain using a short linker segment to increase the 
rotational freedom of the fluorescent proteins (human atlastin-1, residues 1–446; 
linker: GTSTSG). Fusion proteins showed dimerization propensity similar to the 
parent proteins without the fluorescent moiety when analyzed by SEC-MALS, with 
dimerization occurring in the presence of GppNHp and GDP!AlFx, but not in GDP or 
in the absence of any nucleotide (Figure 3.7.B). In addition, GTPase rates were almost 
identical (Figure 3.7.C) indicating proper functionality of the proteins used in the 
FRET assays. 
First, we measured FRET at equilibrium in the presence of different 
nucleotides (Figure 3.7.D and E). Based on previous data, we predicted that no FRET  
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Figure 3.7. Atlastin-1 middle domain FRET using C-terminal ECFP/EYFP fusions. (A) 
Experimental design of measuring middle domain dimerization. Cartoon depiction of 
fluorescent protein-labeled atlastin-11–446 in various crystallographic dimer conformations. 
Estimated length measurements are based on the crystal structures shown in Figure 3.5.A. (B) 
Nucleotide-dependent dimerization of atlastin-11–446-ECFP/ EYFP-fusion proteins. Molecular 
weight fractions for GppNHp- or GDP!AlF4--bound atlastin-1 were determined by SEC-
MALS and fitted using the Multipeak Fitting Package in Igor Pro. Error bars correspond to 
calculated errors in the fitting function parameters. (C) GTPase activity atlastin-11–446-
ECFP/EYFP-fusion proteins. GTPase activity was determined by measuring the production of 
inorganic phosphate over time upon GTP hydrolysis at various protein concentrations. (D) 
Emission spectra of atlastin-11–446-ECFP/atlastin-11–446-EYFP mixtures at equilibrium. Protein 
(20µM total, 1:20 ratio of donor to acceptor) was mixed with either buffer or nucleotide for at 
least 20min prior to measurement, and was excited at 445 nm (apo, red dashed line; GDP, 
purple; GppNHp, green). (E) FRET efficiencies. FRET efficiencies of wild-type (black) and 
R77A mutant (white) atlastin-11–446-ECFP/EYFP in the presence of various nucleotides were 
calculated as stated in Materials and methods. (F) FRET efficiency versus time of wild type 
and mutant R77A in the presence of GTP. Either wild-type (dark blue) or mutant R77A (light 
blue) atlastin-11–446-ECFP/EYFP were mixed with an excess of GTP. Emission spectra were 
measured immediately after mixing, every 2 min up to 10 min, at 15 min, and at 30 min. The 
sample was then spiked with additional GTP, mixed, and measured again. Lamp shutters were 
closed in between measurements. A black dashed line represents the FRET efficiency of wild-
type FRET pair in the presence of GppNHp at equilibrium. 
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would occur in the presence of GDP or absence of any nucleotide and there would be 
an increase in FRET efficiency in the presence of GTP or GTP analogues, although it 
was not clear to what extent or time-scale. Indeed, no change in either donor (ECFP) 
or acceptor (EYFP) fluorescence was detected between the apo state and the GDP-
bound state (FRET efficiency of <0.02%). For incubations in the presence of GppNHp 
or GDP!AlFx, we observed a decrease in donor fluorescence intensity and 
concomitant increase in acceptor fluorescence intensity, indicating robust FRET, with 
the FRET efficiency being comparable in both samples (30% in GppNHp and 22% in 
GDP!AlFx). Using the FRET efficiencies obtained from the measurements in the 
presence of GppNHp and GDP!AlFx, average distances of 54 and 57 Å were 
determined, respectively. In general, the FRET efficiency depends on the distance 
between the donor and acceptor fluorophores but also on the fraction of proteins in an 
FRET-competent state, and we cannot distinguish between the relative contributions 
with the current assay. Nevertheless, the apparent distances establish that the middle 
domains come into close proximity, at least for a fraction of the population, within 
atlastin dimers in solution. 
Middle domain-mediated FRET was higher in GDP!AlFx and GppNHp, or for 
the catalytically inactive R77A mutant in GTP than that observed for wild-type 
atlastin-1 in the presence of GTP (Figure 3.7.F). Since GTP will be hydrolyzed 
efficiently by atlastin-1 over the course of the assay, a lower FRET efficiency can be 
explained by sample heterogeneity and by exhaustion of the available GTP pool and a 
build-up of GDP, which does not support dimerization and therefore FRET. This 
argument was corroborated by the observation that FRET decreased over time in 
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solution containing GTP and reached a minimum after about 10 min under the chosen 
conditions (Figure 3.7.F). Addition of GTP at a later time point brought the signal up 
again to the initial value. The aforementioned differences in apparent FRET maxima 
may be due to fast rates of hydrolysis and the fact that GTP-bound wild-type atlastin 
likely populates different conformations than the catalytically inactive mutant. It may 
also indicate that the FRET-competent state is rather short-lived for a nucleotide 
hydrolyzing system. 
 
Kinetics of middle domain dimerization 
The equilibrium FRET data suggest that at least a fraction of atlastin resides in 
the more compact conformation, characterized by parallel middle domains (crystal 
form 1 or 3), when bound to GppNHp or GDP!AlF4- (Figure 3.7.). In addition, it 
appears that the states interconvert over time, suggesting that the protein may populate 
several conformations. To determine the kinetics of this conformational switch, we 
turned to rapid-mixing fluorescence measurements. An equimolar mixture of ECFP- 
and EYFP-fusion proteins (0.5µM each, final concentration) was mixed with buffer or 
buffer containing an excess concentration of nucleotide (1mM final concentration) 
using the syringe drive from a submillisecond-dead time stopped-flow instrument, and 
the subsequent changes in donor and acceptor fluorescence were monitored 
simultaneously over time. 
Both donor and acceptor fluorescence traces showed little to no change when 
the FRET pair was mixed with either buffer alone or GDP-containing buffer. 
However, after mixing with GTP, GppNHp, GTPγS, or the transition state analogue 
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GDP!AlFx, the proteins exhibited concurrent, inverse changes of donor and acceptor 
fluorescence intensity, indicating FRET (Figures 3.8.A and 3.9.A). When incubated 
with GppNHp, GTPγS, or GDP!AlFx, fluorescence intensities change gradually over 
about a 10-min period. In contrast, when the FRET pair is mixed with GTP, there is a 
rapid decrease in donor fluorescence and simultaneous increase in acceptor 
fluorescence, with maximal FRET being reached after only ~2s. Subsequently, the 
system relaxes to an intermediate FRET level before it drops off after several minutes 
when the GTP pool is consumed (Figures 3.7.F and 3.8.A). Since the on-rates of 
nucleotide binding for both GTP and GppNHp are approximately the same (Table 
3.2.), this sharp difference in timescale can be explained by a driving force incurred by 
GTP hydrolysis. In addition, the unique appearance of the minimum/maximum 
observed in the donor/acceptor time trace with GTP can possibly be rationalized by an 
initial synchronization of the GTP hydrolysis reaction, where the dimer takes on a 
very close conformation (i.e., the tight-parallel form 3 conformation; Figure 3.5.A) 
followed by a more relaxed FRET state (i.e., the relaxed-parallel form 1 conformation; 
Figure 3.5.A), possibly coupled with post-hydrolysis events such as phosphate release. 
Although dimerization of the catalytically inactive mutant R77A has been 
observed in light scattering and steady-state FRET experiments, the kinetics appear to 
be rather slow (Figure 3.8.A, right panel), indicating a crucial role of the arginine 
finger in the catalytic mechanism and conformational switching. Interestingly, binding 
on-rates of fluorescently labeled nucleotides are comparable for wild-type and R77A  
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Figure 3.8. Kinetics of atlastin-1 middle domain FRET. (A) Stopped-flow FRET 
measurements. A mixture of atlastin-11–446-ECFP/EYFP fusion proteins (1 µM each) was 
prepared in the absence of nucleotide, and mixed 1:1 with either buffer (apo) or nucleotide-
containing buffer (GDP, GTP, GppNHp, or GDP!AlFx; concentration: 2 mM) using a 
stopped-flow apparatus. A xenon arc lamp was set to 445 nm excitation, and two 
photomultiplier tubes with appropriate filters in place were used to measure emission output 
over time. (B) Simulations of FRET data. A three-state system was used for a hydrolysis 
competent reaction (left, green), whereas a two-state system (right, orange) was applied to 
model nucleotide-dependent processes in the absence of GTP hydrolysis. Both simulations 
start with a monomeric assembly, which is then allowed to interconvert to a tight-parallel 
(form 3-like) dimer. In the hydrolysis competent case, this dimer is then allowed to 
interconvert to a relaxed-parallel (form 1-like) dimer. 
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Figure 3.9. FRET in an alternative GTP analog and middle domain interaction 
characterization. (A) Middle and G domain time-resolved FRET following mixing with the 
GTP analog GTPγS. A mixture (1µM final) of atlastin-11-446-ECFP/EYFP fusion proteins (left 
panel) or Alexa 488 and 647-labeled atlastin-11-446 (right panel) was prepared in the absence of 
nucleotide, and mixed 1:1 with nucleotide-containing buffer (GTPγS; 2 mM) using a stopped-
flow apparatus. Experimental details are as stated in Figures 3.8A and 3.11. Time scale of 
FRET change was monitored over 10 min, and proceeds with similar kinetics to the GTP 
analog GppNHp (see Figures 3.8.A and 3.11. for comparison). (B) Middle domain titration 
increases G domain activity. With a G domain concentration of 2 µM, middle domain 
concentrations (either wild-type [squares] or point mutant M347E [triangles]) were varied from 
0.5 µM to 500 µM and the resulting change in activity compared to G domain alone was 
plotted versus the concentration of middle domain added on a log10 scale. The data were fit to 
a one-site saturated binding equation with a variable hill coefficient (fit shown in grey for 
wild-type; no fit could be determined for M347E data). The fit resulted in an apparent Kd of 
62.2±6.6 µM and a hill coefficient of 0.931±0.048. Experiments were conducted in triplicate. 
We report the means with the error bars representing SEM. (C) Middle domain point mutation 
M347E reduces the GTPase activity of the N-terminal cytoplasmic domains of atlastin-1 
(residues 1-446). The M347E mutation was introduced into the soluble atlastin-11-446 construct, 
and its GTPase activity was determined by measuring the production of inorganic phosphate 
over time upon GTP hydrolysis at various protein concentrations. 
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atlastin-11–446 (Table 3.2.), and occur at a faster timescale than dimerization for 
reactions that do not undergo catalysis. 
Using simple kinetic equations and our structural information (see Materials 
and methods and Appendix A), the time-resolved FRET data could be modeled using 
a molecular simulation, replicating the main features of the time-resolved FRET 
experiments (Figure 3.8.B). A two-state model describes well the data observed in the 
absence of hydrolysis. Addition of a third state representing a relaxed FRET 
constellation reproduces the appearance of a peak in the FRET data followed by a 
drop-off of the signal. These simulations corroborate our experimental observations, 
indicating that our interpretations provide a feasible framework. 
 
Correlation between G and middle domain dimerization kinetics 
Thus far, we defined the catalytic core of atlastin-1 and showed that nucleotide 
hydrolysis drives middle domain dimerization. Yet, considering the structural and 
FRET data, the question arises as to whether G domain dimerization precedes middle 
domain dimerization or occurs at a similar timescale. The two different scenarios have 
distinct implications for the molecular mechanism of atlastin-mediated membrane 
fusion and the role of GTP hydrolysis in the functional cycle. In the former model, 
GTP binding to atlastin would tether two opposing membranes via G domain 
dimerization, with the middle domains contributing to the interaction only 
subsequently following GTP hydrolysis, bringing the opposing membranes into closer 
proximity. In the alternative model, GTP hydrolysis would act as the timer for the 
formation of a tight tethering dimer, involving G and middle domains simultaneously. 
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Determining the sequence of G and middle domain dimerization will allow us to 
distinguish between these models. 
To measure G domain dimerization, we mutated the sole cysteine in the middle 
domain (C375A) and introduced a cysteine in the G domain at a non-conserved and 
solvent-exposed position (K295C), which, based on all three dimeric crystal structures, 
would support FRET when labeled with appropriate fluorophores (Figure 3.10.A and 
B). These atlastin-1 mutants showed similar dimerization and GTPase characteristics 
as the wild-type proteins (Figure 3.10.C and D). Alexa dyes 488-C5 maleimide (FRET 
donor) and 647-C2 maleimide (FRET acceptor) were reacted with this mutant protein. 
FRET efficiency was measured based on changes in the donor fluorescence. Although 
we report a minor FRET signal in the case of GDP (efficiency of <10%), the drop in 
donor fluorescence was not accompanied by a rise in acceptor fluorescence (Figure 
3.10.E). We interpret this result as a no-FRET state, consistent with the lack of 
dimerization in independent assays (e.g., Figure 3.4.). Importantly, in the presence of 
GppNHp and GDP!AlFx, we observed a significant drop in donor fluorescence, with a 
concomitant rise in acceptor emission, indicating robust FRET. The extent of FRET 
was comparable in both samples (51% in GppNHp and 56% in GDP!AlFx; Figure 
3.10.F), corresponding to apparent distances of 55 and 54 Å, respectively. The 
discrepancy to the measured distance of ~32 Å (between Cβ positions of K295) based 
on the crystal structures may be rationalized considering the linker length of the 
fluorophore (a C5 linker for Alexa 488 and a C2 linker for Alexa 647, which 
correspond to an additional ~8 and ~3 Å, respectively) and/or a minor fraction of 
monomeric protein. 
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Figure 3.10. Atlastin-1 G domain FRET using Alexa 488/647 dye-labeled proteins. (A) 
Experimental design of measuring G domain dimerization. Cartoon depiction of fluorescently 
labeled atlastin-11–446 in various crystallographic dimer conformations. Estimated distances 
between Cβ atoms of K295, which is mutated to a cysteine for site-specific labeling, are based 
on the crystal structures shown in Figure 3.5.A. (B) SDS–PAGE of dye-labeled atlastin-11–446. 
Atlastin-1 mutants were first labeled with Alexa 488-C5 Maleimide as described in Materials 
and methods. Two gels run side-by-side were loaded with 2.5 µg of indicated atlastin-1 
proteins. One gel was stained with Coomassie brilliant blue (protein dye). The second, 
unstained gel was imaged upon excitation of the fluorophore. (C) Nucleotide-dependent 
dimerization of dye-labeled atlastin-11–446 proteins. SEC-MALS experiments were carried out 
and analyzed as in Figure 3.7.B. (D) GTPase activity of atlastin-11–446 mutant proteins used for 
dye labeling. GTPase activity was determined as shown in Figure 3.7.C. (E) Emission spectra 
of dye-labeled atlastin-11–446 mixtures at equilibrium. Alexa Protein (20 µM total, 1:20 ratio of 
donor to acceptor) was mixed with either buffer or nucleotide for at least 20 min prior to 
fluorescence measurement (apo, red dashed line; GDP, purple; GppNHp, green). (F) FRET 
efficiencies. FRET efficiencies of wild-type (black) and R77A mutant (white) calculated for 
dye-labeled atlastin-11–446 donor/acceptor mixtures in the presence of various nucleotides were 
carried out as stated in Materials and methods. (G) G domain-mediated FRET efficiency 
versus time of wild type and mutant R77A in the presence of GTP. Either wild-type (dark 
green) or mutant R77A (light green), dye-labeled atlastin-11–446 was mixed with an excess of 
GTP essentially as in (E). Emission spectra were measured right after mixing, every 2 min up 
to 10 min, at 15 min, and at 30 min. The sample was then spiked with additional GTP, mixed, 
and measured immediately. Lamp shutters were closed in between measurements. A black 
dashed line represents the FRET efficiency of wild-type FRET pair in the presence of 
GppNHp at equilibrium. 
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In contrast to middle domain-mediated FRET that never achieved the same 
efficiencies in the presence of GTP as it did when mixed with GppNHp or the 
transition-state analogue (Figure 3.7.E and F), GTP binding to G domain-labeled 
atlastin-1 peaked at a comparable maximum value as all other dimerization-supporting 
conditions before FRET decreased again due to GTP hydrolysis (Figures 3.10.F and 
G). As before, the drop-off could be reversed by the addition of GTP (Figure 3.10.G). 
On the other hand, GTP-induced FRET via G domain dimerization of a catalytically 
inactive atlastin-1 variant (R77A) rose to a maximum value over the course of 5 min 
and remained unchanged, approaching the steady-state FRET efficiency of 
catalytically competent atlastin-1 in the presence of GppNHp (Figure 3.10.G). Taken 
together, these observations suggest that G domains adopt an invariable, stable dimer, 
unlike the middle domains that appear to exist in equilibrium between different 
dimeric arrangements or populations. 
Next, we assessed the kinetics of G domain dimerization, and compared it to 
those of middle domain-supported FRET. Interestingly, fluorescence changes in both 
the G domain and middle domain FRET pairs followed similar kinetics, with fast rises 
in FRET when mixed with GTP (second timescale), and slower kinetics when the 
catalytically dead mutant was used and/or in the presence of GDP!AlFx, GppNHp, and 
GTPγS (minute timescale) (Figure 3.9. and 3.11.). Similarly to the middle domain 
dimerization kinetics, G domain dimerization is overall slower for the inactive R77A 
mutant compared to the catalytically active parent protein. Since nucleotide binding 
kinetics and affinities are similar for active and inactive proteins (Table 3.2.), it is 
likely that the arginine finger is involved in dimerization and/or allosteric switching of  
 108 
atlastin-1. 
These results indicate that the GTPase activity of atlastin is required to drive a 
conformational change allowing concomitant G and middle domain dimerization. 
Rather than bringing opposing membranes into close proximity via sequential steps, 
the entire N-terminal, cytoplasmic module acts as the tethering unit. Consequently, the 
tight-parallel dimer structures bound to GTP analogues (crystal form 3; Figure 3.5.) 
are likely depicting a post-hydrolysis state.  
 
Figure 3.11. Rapid-mixing, stopped-flow kinetics of G domain-mediated FRET. Alexa 
488 and 647-labeled atlastin-11–446 mixtures were prepared in a 1:1 ratio of donor to acceptor 
in a nucleotide-free buffer. Samples were mixed 1:1 with either buffer (apo) or buffer 
containing the indicated nucleotides (2 mM) using a stopped-flow apparatus. A xenon arc 
lamp was set to 493 nm excitation, and two photomultiplier tubes with appropriate filters in 
place were used to measure emission output over time. 
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The middle domain promotes GTP loading at the G domain and supports dimerization 
If indeed the middle domain is released from the G domain prior to or 
concomitant with dimerization upon GTP hydrolysis, what is the relevance of the form 
2 crystal structure, in which the middle domain folds back onto the G domain? Other 
observations not explained by the current model include the impaired GTPase activity 
of the isolated G domain, its inability to dimerize in the presence of any nucleotide, 
and its failure to act as a competitive inhibitor in membrane fusion (38, 39). Likewise, 
mutations that are predicted to impact the fold of the middle domain generate a non-
functional protein, yet the exact mechanism remained elusive (37, 39). 
A comparison of form 2 and 3 crystal structures highlights differences in the 
linker region and immediate docking site of the middle domain on the G domain, 
foremost the conformation of a central helix (residues 184–204; Figure 3.12.A). This 
helix is bent in form 2, providing a cradle for the middle domain, but is straight in 
form 3 occluding the middle domain-docking site. Spatially, it is adjacent to the 
nucleotide binding regions, which may indicate an overall regulatory role. We 
speculated that it might impact nucleotide binding, which could explain the 
aforementioned gaps in our mechanistic understanding. To test this hypothesis, we 
conducted nucleotide-binding assays using mant-labeled derivatives that change 
fluorescence upon interacting with protein (mant-GDP, mant-GTP, and mant-
GppNHp). We noted that the isolated G domain binds mant-GDP readily with  
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Figure 3.12. Middle domain-mediated control of atlastin’s GTPase activity. (A) 
Comparison of the G-middle domain interface in form 2 and form 3 crystal structures. The G 
domain of atlastin-1 is shown in orange except for switch regions (shades of blue) and 
residues 184–204 (dark red), which form a helix that changes its conformation between the 
form 2 and form 3 (or form 1) structures. In the GDP-bound form 2, the helix is bent to 
accommodate the first helix of the middle domain (blue with linker in green), while in the 
GDP!AlF4--bound form 3 (and GDP-bound form 1) structure, the helix straightens out, 
preventing this interaction. Nucleotide positions are indicated and shown as fuzzy spheres. (B) 
The G-middle domain interface in the form 2 crystal structure. The area of the structure boxed 
in red is shown, with the same coloring introduced in (A). Positions of point mutants used in 
(C) and (E) and the last residue of the truncated atlastin-1 construct (atlastin-11–366) are shown 
as sticks. (C) GTPase activity. The catalytic activity of atlastin-1 constructs 1–446, 1–339 (G), 
and 1–366 were measured. In addition, the effect of the isolated middle domain (M; residues 
340–446) on the activity of the G domain was determined. Structure-guided mutants of the 
middle domain were included as well. (D) Effect of the middle domain on the nucleotide-
dependent oligomerization of the G domain. SEC-MALS data for the isolated G domain 
(atlastin-11–339; left panel) alone or with addition of a 10× molar excess of the isolated middle 
domain (atlastin-1340–446; right panel) in the presence of GppNHp are shown. The signal from 
the 90°-light scattering detector and refractive index detector is shown as colored, solid lines 
(G domain alone, green; G and M domains mixed, blue) and black, dashed lines, respectively 
(left Y axis). Average molecular weight calculations across the protein peak are shown as 
black circles (right Y axis). The theoretical molecular weight (based on primary sequence) for 
the monomer and dimer of the G domain, as well as the middle domain in the right panel, is 
shown as horizontal dashed lines. Proteins (30–40 µM) were incubated with nucleotides 
(2mM) at least 30min prior to SEC-MALS analysis. (E) Quantification of nucleotide-
dependent dimerization of atlastin-1’s G domain. SEC-MALS data for the indicated atlastin-1 
constructs in the absence or presence of isolated middle domain variants are shown. Data for 
samples incubated with GppNHp or GDP!AlFx are shown. The experimental approach and 
presentation was as in Figure 3.7.B. 
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comparable kinetics as the construct also containing the middle domain (Table 3.2.). 
Yet, only the latter binds mant-GTP and the GTP-analogue mant-GppNHp, suggesting 
an influence of the middle domain on GTP loading. 
As further corroboration, we used the separate G and middle domains (atlastin-
11–339 and atlastin-1340–446, respectively). In addition, we made a construct comprising 
the G domain and a short stretch of the first middle domain helix, which is buttressed 
by the G domain in our form 2 crystal structure (atlastin-11–366; Figure 3.12.B). First, 
we asked whether the middle domain has an effect on nucleotide binding of the 
isolated G domain, when it is added in trans. While the isolated G domain failed to 
bind mant-GTP (and mant-GppNHp) under the conditions used here, we observed a 
rescue of mant-GTP binding when the isolated middle domain was present, albeit with 
weaker affinity than the intact cytoplasmic unit (atlastin-11–446). A similar result was 
obtained with the protein that contained the truncated middle domain (atlastin-11–366), 
confirming the middle domain’s role in GTP loading (Table 3.2.). 
We predicted that efficient GTP loading is a prerequisite for GTPase activity, 
and hence we would expect an effect of the middle domain on catalysis. While the 
isolated G domain has close to background activity, similar to its Drosophila 
counterpart (38), co-incubation with the middle domain (10× molar excess over the G 
domain) yielded an activity of about five times the initial value (Figure 3.12.C). The 
middle domain truncation mutant leaving the G domain interaction region intact 
(atlastin-11–366) was also able to similarly rescue GTPase activity. No stimulation 
effect was seen when the middle domain was added to the entire N-terminal 
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cytoplasmic domain of atlastin, which includes the middle domain in the same 
polypeptide chain and has robust activity (data not shown). 
Next, we asked whether the G-middle domain interface, which is unique to the 
form 2 crystal structure, is involved in the activation of the G domain, possibly as an 
allosteric site for nucleotide loading control (Figure 3.12.B). We introduced several 
single-point mutations into the isolated middle domain along this interface. 
Remarkably, mutant middle domains with changes across this largely hydrophobic 
surface were significantly impaired in the activation of the GTPase that was observed 
with addition of wild-type middle domain, and interestingly this effect was lessened 
the further from the top of the middle domain the mutant was located (Figure 3.12.B 
and C). Using middle domain titration experiments and the GTPase activity of the 
isolated G domain as the readout, we estimated that the wild-type middle domain 
associates with the G domain with an apparent affinity of 62.2 µM, whereas no 
stimulation was observed with a middle domain mutant (M347E) across the entire 
concentration gradient (Figure 3.9.B). Likewise, the same mutation introduced into the 
construct comprising both G and middle domains affected nucleotide binding (Table 
3.2.) and GTPase activity (Figure 3.9.C), corroborating the findings with the isolated 
domains. 
Since GTP binding (and hydrolysis) facilitates G domain dimerization (see 
above), we assessed the dimerization propensity of the isolated domain in the absence 
and presence of the middle domain or its point mutants. When subjected to SEC-
MALS-based analysis, the G domain alone elutes predominantly in a monomeric state 
in the presence of GppNHp (~8% dimer fraction) or GDP!AlFx (no detectable dimer) 
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(Figures 3.12.D and E). In samples with 10× molar excess of wild-type middle 
domain, a large fraction of the G domain formed dimers in GppNHp (~49%), but not 
in GDP!AlFx. Similar to their decreased effect on GTPase stimulation, middle 
domains with mutations in the G domain interface failed to induce G domain 
dimerization (Figure 3.12.E). Again, mutants further along the middle domain affected 
dimerization slightly less than those at the top of the middle domain. Notably, the 
dimer seen on the SEC-MALS trace corresponds to a G domain dimer alone, 
suggesting that the middle domain interaction with the G domain is rather transient 
and, based on our structural analysis, possibly incompatible with the GTP-bound 
conformation of the G domain (Figure 3.12.A). 
In summary, we demonstrated a dual role for the middle domain in the reaction 
cycle of human atlastin-1 (Figure 3.13.). Initially, it is required for the efficient 
binding of GTP to the G domain via an intramolecular interaction, presumably by 
allosterically altering the conformation or dynamics of the switch regions, which could 
render the G domain more promiscuous for nucleotide binding (Table 3.2.). This role 
is important for atlastin’s GTPase activity and dimerization of the G domains. Upon 
GTP binding, the middle domain dislodges from the G domain, likely involving a 
conformational change within the G domain imposing a steric clash with the middle 
domain. The middle domain then contributes to homotypic dimerization of atlastin. 
This transition is faster upon GTP hydrolysis, suggesting that hydrolysis could 
potentially occur in the context of a monomeric G domain. This notion is supported 
not only by the different timescales at which nucleotide binding and dimerization 
occur in the absence of hydrolysis, but also by the absence of apparent cooperativity in  
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Figure 3.13. Model for atlastin-mediated membrane fusion. Atlastin begins in a form 2-
like, GTP-loading-competent state with the middle domain engaging the G domain. GTP 
binding and hydrolysis drive rapid disengagement of the middle domain from the G domain, 
immediately followed by G and middle domain dimerization. Once in this tethering complex, 
membrane curvature and stress caused by atlastin’s transmembrane domains and C-terminal 
amphipathic helix would allow fusion to occur spontaneously. Phosphate release follows, with 
relaxation and subsequent disassembly of the dimer. Other proteins that may interact with 
atlastin and contribute to membrane curvature, such as reticulons, are not shown. 
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the GTPase kinetics. GTPase rates appear slower than GTP binding and atlastin 
dimerization in GTP. Rather than indicating a requirement of G domain dimerization 
for enzymatic activity, the somewhat slower GTPase rate compared to both nucleotide 
binding and protein dimerization can be explained by the fact that we measure 
phosphate release in the activity assay, which may be rate limiting. We predict that the 
actual rate of hydrolysis is faster than the apparent rate we measured (Figure 3.6.B). 
As a side note, non-hydrolysable nucleotides or transition state analogues and likewise 
the catalytically inactive R77A mutant may only capture parts of the reaction cycle, 
while experiments under GTP-hydrolyzing conditions provide insight into the entire 
functional cycle and its timing. 
 
CONCLUSIONS 
 While they have some common features, membranes of different cellular 
organelles are specialized environments that support particular biological functions. 
The ER is a prime example of this specialization, as lipids form an interconnected 
system of cisternae, vesicles, and tubules, which provides a highly compartmentalized 
structure for a multitude of biochemical processes. Its unique reticular structure has 
functional relevance, as mutations in atlastin-1, a protein involved in maintaining the 
ER’s morphology by mediating homotypic membrane fusion (11, 15), are associated 
with hereditary, neurodegenerative disorders (6, 8). Interestingly, the majority of 
mutations cluster around the nucleotide binding site, and extend towards the site of 
intra-molecular interaction between the G and middle domains in the crystal form 2 
dimer (20, 21). This observation in conjunction with our current data could indicate a 
 117 
compromised allosteric network, which we would predict to couple middle domain 
interaction, GTP binding, and hydrolysis. 
Our results suggest that membrane fusion follows a tethering step, involving 
the N-terminal cytoplasmic G and middle domains, which dimerize upon GTP binding 
and hydrolysis. This tight pairwise interaction would bring opposing membranes or 
membrane tubules into close proximity, the distance of which is critical since an 
increase in the length of the linker between the N-terminal module and the 
transmembrane segments impairs fusion (39). Once membranes are in close proximity, 
increased membrane curvature and stress mediated by the transmembrane helices and 
the amphipathic C-terminus of atlastin facilitate membrane fusion (38, 44, 45). By 
analogy to molecular mechanisms described for dynamin-mediated membrane fission 
(22, 29), membrane fusion may proceed spontaneously, probably upon release or 
relaxation of the tether. In that sense, the underlying principles of dynamin-mediated 
vesicle scission and atlastin-mediated membrane fusion appear to follow a conserved 
mechanism via G domain-regulated processes and implementation of protein domains 
or complexes that increase membrane curvature. While there are many parallels to be 
drawn between members of the dynamin superfamily, their differences pertain to their 
intrinsic control (e.g., self-assembly and catalytic mechanism), fine-tuning of the 
reaction (e.g., cooperativity and nucleotide exchange), and basic requirements that 
differ between fusion and fission. For example, unlike in atlastin, the isolated G 
domain of human GBP1 dimerizes readily in the presence of GTP and its analogues 
(18). Interestingly, GBP1 also shows cooperativity with regard to nucleotide 
hydrolysis, which relies on G domain dimerization, while atlastin apparently lacks this 
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mode of higher order regulation. Also, while membrane fission can originate from one 
membrane, fusion relies on bringing two opposing membranes into close proximity. 
While we cannot formally rule out a mechanism by which the N-terminal domains of 
atlastin dimerize on the same membrane (e.g., to further increase membrane curvature 
leading to the formation of three-way junctions in the ER), the observation that full-
length, Drosophila atlastin is sufficient to facilitate proteoliposome fusion indicates a 
canonical fusion reaction (15). It remains to be seen whether other G proteins employ 
similar mechanism as we described here for atlastin, or if they are subject to unique 
modes of control. 
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CHAPTER 4 
STRUCTUAL SUPPORT OF AN INTRINSIC GTP LOADING MECHANISM 
IN HUMAN ATLASTIN-1 
 
ABSTRACT 
 Atlastin related proteins belong to the superfamily of large, dynamin-related G 
proteins, which are involved in membrane fusion and fission events. Recent data 
identified atlastin as a fusion protein in the endoplasmic reticulum (ER), where it 
facilitates the formation of three-way junctions. Subsequent crystallographic studies 
yielded several high-resolution structures of human atlastin-1 in different nucleotide-
bound states, revealing numerous conformations that the protein may sample during 
its nucleotide hydrolysis cycle. These, along with biochemical and biophysical 
evidence have begun to elucidate the molecular mechanisms of how atlastin proteins 
mediate homotypic membrane fusion. However, several aspects of atlastin regulation 
remain poorly understood. Here, we focus on the requirements for nucleotide binding 
and hydrolysis by using both reported and new structures as a guide. The crystal 
structure of wild-type atlastin-1’s GTPase domain confirms the reliance of GTP 
binding on a previously discovered interaction between the GTPase and middle 
domains. A second structure of a mutated catalytic core fragment comprising the 
GTPase and middle domains of atlastin-1 bound to GDP shows atlastin in a 
monomeric form, revealing a more biologically relevant structural model for this state. 
Lastly, a mutational analysis gives insight into nucleotide loading and hydrolysis, as 
well as the importance of dimerization in the molecular mechanism of atlastin-1.  
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INTRODUCTION 
 In just over a decade, the family of atlastin GTPases has gone from a simple 
genetic locus identified in patients with a hereditary axonopathy, to having numerous 
high-resolution structures solved and cellular functions described (1-6). The human 
atlastin-1 gene was first found in patients suffering from a subtype of autosomal 
dominant Hereditary Spastic Paraplegia (HSP, subtype SPG3A) and was classified as 
a member of the dynamin superfamily of large GTPases (7). Subsequently, in vivo 
studies of atlastin-1 found that it was expressed predominantly in neurons of the 
central nervous system, where it localizes to the cis-Golgi, growth cones, and the 
endoplasmic reticulum (ER) (8-11). Two other mammalian isoforms (atlastin-2 and 3) 
were also identified, with more ubiquitous expression patterns (11). Like other 
dynamin family members, the atlastins exhibited GTPase activity and were found to 
self-associate (8, 9). Recent studies revealed atlastin’s function as a membrane 
fusogen similar to mitofusins (also in the dynamin superfamily) as opposed to a 
membrane scission molecule, a reaction catalyzed by several other dynamin-related 
proteins (11-14). As major evidence, a knockdown of atlastin in Drosophila 
melanogaster caused ER fragmentation, while atlastin reconstitution into liposomes 
catalyzed fusion of proteoliposomes in the presence of GTP and magnesium (12). A 
loss of atlastin isoforms or expression of dominant-negative alleles in mammalian 
cells results in the loss of three-way junction in the reticular ER (11, 12, 14). A 
functional ortholog in Saccharomyces cerevisiae, Sey1p, is thought to have a similar 
role in yeast, a conjecture that was recently verified with both in vivo and in vitro 
experiments (14-18). 
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 Structures of atlastin have since emerged, and provided a more detailed picture 
of its internal molecular mechanism (19-21). All structures solved to-date have been 
comprised of the N-terminal catalytic core fragment of atlastin, which consists of the 
GTPase and middle (helical) domains, ending just before the two transmembrane 
domains of the protein. The first structures revealed two intriguing conformations (19, 
21), which we call form 1 and form 2. Both structures were bound to the nucleotide 
GDP, and their respective GTPase and middle domains have nearly identical 
conformations. Strikingly though, the position of the middle domain, which forms a 
three-helix bundle, differs by nearly a ninety-degree rigid-body rotation relative to the 
GTPase domain. In the case of the form 1 structure the middle domain does not 
interact with the GTPase domain, but in the form 2 structure it bends back onto the 
GTPase domain in a docked conformation. The crystal lattice symmetry also revealed 
a weak dimerization interface between two atlastin GTPase domains. This hinted at 
pre- and post-fusion conformations when the position of the middle domains was 
considered as membrane proximal points. Subsequently determined structures 
(collectively called form 3) bound to GTP or transition state analogs uncovered the 
molecular mechanism of GTP hydrolysis in atlastin’s catalytic core fragment and 
revealed a much tighter, biologically relevant dimer interface that is also observed in 
solution (20). Furthermore, this study indicated an unanticipated dependence for 
nucleotide loading on an interaction between the GTPase and middle domains. 
Additionally, the dynamics of domain interactions during nucleotide binding and 
hydrolysis were monitored using Förster Resonance Energy Transfer (FRET). 
Together, a working model emerged where GTP binding to the G domain occurs 
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within an atlastin monomer, facilitated by the middle domain. GTP hydrolysis would 
introduce a coordinated conformational change allowing the G and middle domain to 
dimerize. 
 Despite these significant advances in the understanding of atlastin proteins, 
many of the details have yet to be uncovered and many questions remain. In particular, 
the available crystal structures rely on G domain dimers, even when the protein is 
bound to GDP, a nucleotide which does not support dimerization in solution (22, 23). 
To shed light on the conformation(s) of atlastin prior to dimerization, we obtained a 
crystal form in which the switch regions are not involved in crystal packing contacts, 
as is the case in all other structures determined to date. The resulting structural model 
and the biochemical characterization of structure-guided mutants provide additional 
insight into the nucleotide loading mechanism and the role of oligomerization in 
atlastin’s GTPase activity, an essential part of its function as a membrane fusogen. 
 
MATERIALS AND METHODS 
Protein expression and purification 
The catalytic core fragment (residues 1-446) and G domain (1-339) of human 
atlastin-1 were amplified by standard PCR and cloned into a modified pET28a 
expression plasmid (Novagen) yielding N-terminally hexahistidine-tagged SUMO 
fusion proteins. The hexahistidine-tagged SUMO-moiety was cleavable using the 
protease Ulp-1 from S. cerevisiae. Proteins were overexpressed in E. coli BL21 (DE3) 
cells (Novagen), which were grown in Terrific Broth (TB) media supplemented with 
50 µg/ml kanamycin at 37°C. At an optical density corresponding to an absorbance of 
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0.8-1.0 at 600 nm (OD600), the temperature was reduced to 18°C, and protein 
production was induced with 0.5 mM IPTG. After 16 hours, cells were harvested by 
centrifugation, resuspended in NiNTA buffer A (25 mM Tris-HCl, pH 8.5, 500 mM 
NaCl and 20 mM imidazole), and flash-frozen in liquid nitrogen. 
After cell lysis by sonication and removal of cell debris by centrifugation, clear 
lysates were loaded onto NiNTA Superflow (Qiagen) equilibrated in NiNTA buffer A. 
The resin was washed with 20 column volumes of NiNTA buffer A, and proteins were 
eluted three times with 2 column volumes of NiNTA buffer A supplemented with 500 
mM imidazole. Proteins were buffer exchanged into desalting buffer (25 mM Tris-
HCl, pH 7.5, 400 mM NaCl, 5mM β-mercaptoethanol). Affinity tags were removed by 
incubation with the yeast protease Ulp-1 at 4°C overnight. Cleaved proteins were 
collected in the flow-through during NiNTA affinity chromatography, and were 
subjected to size exclusion chromatography on a Superdex 200 column (GE 
Healthcare) equilibrated in gel filtration buffer (25 mM Tris-HCl, pH 7.5, 100 mM 
NaCl). Proteins were concentrated on a Centricon ultrafiltration device (10 kDa cutoff; 
Millipore) to a final concentration of approximately 0.5-1 mM. Protein aliquots were 
flash frozen in liquid nitrogen and stored at -80°C. 
Site-directed mutagenesis was carried out using Quikchange (Agilent) 
following the manufacturer’s instructions, followed by validation through DNA 
sequencing. 
 
 
 
 128 
Crystallization, data collection, and structure solution 
Crystals were obtained by sitting drop vapor diffusion mixing equal volumes 
of protein (10–30mg/ml) and reservoir solution followed by incubation at 20°C. Initial 
crystals were obtained using atlastin-1 protein in gel filtration buffer in the presence of 
2 mM GDP (Sigma) and 4 mM MgCl2. Rectangular-shaped crystals belonging to 
space group F23 (atlastin-11–339) grew in reservoir solution containing 0.1M 
ammonium citrate tribasic pH7.0 and 12% PEG-3350. For cryo-protection, crystals 
were soaked in reservoir solution supplemented with 25% glycerol. For proteins 
crystallizing in space group P1 (atlastin-11–446-R77A), the reservoir solution contained 
0.2 M sodium malonate pH6.0, 20% PEG-3350. Crystals were cryo-protected by 
soaking in the crystallization solutions supplemented with 25% glycerol. Cryo-
preserved crystals were flash-frozen and stored in liquid nitrogen. Data were collected 
on frozen crystals at 100 K. 
Data reduction was carried out with the software package HKL2000 (24). 
Phases were obtained by Molecular Replacement (MR) methods by using the software 
package PHENIX (25) with the isolated G and middle domains of atlastin-1 as 
separate search models for MR. Refinement in PHENIX (25) and COOT (26) yielded 
the final models. Data collection and refinement statistics are summarized in Table 
4.1. Illustrations were made in Pymol (27). 
 
Size-exclusion chromatography-coupled multi-angle light scattering (SEC-MALS) 
Purified protein (<2 mg/ml or 40 mM, injected concentration) was subjected to 
size-exclusion chromatography using a BioSep-SEC-S3000 column (Phenomenex) 
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equilibrated in SEC-MALS buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 4 mM 
MgCl2, and 2 mM EGTA). Where specified, wild-type or mutant atlastin-1 was 
incubated with GDP, GppNHp, or GDP!AlFx (2 mM) for 30 min at room temperature 
prior to injection. The column was coupled to a static 18-angle light scattering detector 
(DAWN HELEOS-II) and a refractive index detector (Optilab T-rEX) (Wyatt 
Technology). Data were collected every second at a flow rate of 1 ml/min. Data 
analysis was carried out using the program ASTRA V, yielding the molar mass and 
mass distribution (polydispersity) of the sample. For normalization of the light 
scattering detectors and data quality control, monomeric BSA (Sigma) was used. 
Molecular weight distributions were determined by using the Multipeak Fitting 
Package in Igor Pro (WaveMetrics). 
 
GTPase assay 
GTPase activity was measured using the Enzchek Phosphate Assay kit 
(Molecular Probes) following the manufacturer’s instructions. Measurements were 
carried out in a 96-well plate (Nunc) in a total volume of 250 µl. Recombinant wild-
type or mutant atlastin-1 (at concentrations 0, 0.25, 0.5, 1, 2, and 4 µM) was combined 
with 1 U/ml purine nucleoside phosphorylase (PNP), 200 µM 2-amino-6- mercapto-7-
methylpurine riboside (MESG), and provided buffer (20mM Tris–HCl, pH 7.5, 1mM 
MgCl2, 0.1mM sodium azide). The plate was incubated at room temperature for 10 
min, after which reactions were started by addition of 400 µM GTP (or alternatively, 
50 mM Tris–HCl pH 7.5 for controls). Plates were assayed at 37°C in a Powerwave 
XS microplate reader (BioTek). Absorbance at 360 nm was monitored in 30 s intervals 
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for 30 min. Data were normalized to a phosphate standard curve, and initial velocities 
were calculated using the portion of the curve corresponding to the first 5% of 
consumed product. Data reported are means ± s.e.m. of three independent 
experiments. 
 
N-Methylanthraniloyl (Mant)-nucleotide binding 
On and off rates of mant nucleotides (mant-GppNHp, mant-GDP, or mant-
GTP) were determined by measuring the change in fluorescence of the mant 
nucleotide over time upon mixing with atlastin-1 constructs. Using a Kintek stopped-
flow apparatus (Kintek SF-2004), a final concentration of 2.5 µM mant-GDP, mant- 
GTP, or mant-GppNHp (Invitrogen) was mixed with increasing concentrations of 
atlastin-1 (10–50 µM). Mant fluorescence (λexc = 366 nm, emission filter HQ460/40M; 
Chroma) was measured and the first 500 ms of data were fit to a single-exponential 
decay curve. Observed rate constants from exponential fits were plotted versus protein 
concentration, with the resulting slope of the linear fit corresponding to kon, and the y 
intercept to koff. In parallel experiments, the off rate (koff diss.) was also directly 
measured by preloading atlastin-1 proteins with mant nucleotide and chasing with a 
high concentration (2.5 mM) of unlabeled nucleotide (GDP). The first 500 ms of the 
resulting fluorescence decay curve was fit to a single-exponential decay, whose 
observed rate constant corresponds directly to the off rate (koff diss.). All fits were 
performed using Prism 5 (GraphPad Software Inc.).  
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RESULTS AND DISCUSSION 
Crystallization of the isolated GTPase domain bound to GDP 
 The purified GTPase domain of atlastin-1 (residues 1-339, Figure 4.1.) 
crystallized in a single crystal form bound to GDP (spacegroup F23). The structure, 
solved by molecular replacement, diffracted X-rays to a maximal resolution of 3.15Å 
with four protomers in the asymmetric unit (Table 4.1.). Crystals were grown in the 
presence of GDP and magnesium, and electron density for both of these moieties are 
present in each of the four protomers, though density was weaker for magnesium 
(Figure 4.1.A). The structure is generally well ordered, except for the surface exposed 
loop containing residues 114 through 117 for which electron density was not apparent, 
most likely due to disorder or multiple conformations. This loop comprises the switch 
1 GTP-binding motif. Overall, the structure takes on a conformation most similar to 
that seen in the form 1, undocked middle domain crystal structure of the catalytic core 
fragment of atlastin (19), with significant overlaps in secondary structure (Figure 
4.1.B, RMSD of 0.435Å).  
The isolated GTPase domains of Drosophila atlastin and human atlastin-1 
were shown in previous studies to have lost the ability to bind and therefore hydrolyze 
GTP (20, 23). The GTPase domain of human atlastin-1 is able to bind to GDP 
independently, but depends on the middle domain interaction observed in crystal form 
2 to allow it to bind to GTP, and can catalyze its hydrolysis once bound (20). The 
crystal structure presented here of the GTPase domain of atlastin-1 in isolation 
presents some evidence as to why this occurs. Without the middle domain present and 
docked onto the GTPase domain, all helices involved in the interaction remain in the 
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positions observed in the form 1 structure suggesting this may be the “default” 
conformation of the GTPase domain when the middle domain is undocked. Similar to 
the form 1 structure, the nucleotide binding motifs take on a more closed 
conformation, in which F76 is positioned towards and above the nucleotide, effectively 
blocking the position that would be occupied by the gamma phosphate of GTP. In the 
form 2 structure (in which the middle domain is docked onto the GTPase domain) this 
residue swings into a more open conformation, though it still needs to move further to 
fully accommodate the gamma phosphate, as observed in the form 3 catalytically 
competent structure (Figure 4.1.C). The function of F76 will be further discussed in a 
later section, where we analyze the effect of mutating this residue. 
Within the crystal, a dimer interface is apparent and resembles that of the form 
1 structure. Towards the bottom of the dimer (where the middle domains would cross 
over in form 1) the dimer interface is looser (Figure 4.1.D) most likely due to the fact 
that the interactions between adjacent middle domains and linker regions are absent. 
Within the interface, a number of specific contacts between the molecules are 
preserved as in the form 1 structure, including that between R77 and E224. However, 
like the first structures of atlastin-1 this dimer interface is most likely the result of a 
relatively high protein concentration within the crystal as well as preferred crystal 
packing interactions, since dimers are not observed in solution when the protein is 
bound to GDP.  
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Table 4.1. X-ray data collection and refinement statistics.  
 Human atlastin-1 
1-339, GDP 
Human atlastin-1 
1-446, R77A, GDP 
Data collection   
X-ray source CHESS A1 CHESS A1 
Wavelength (Å) 0.9771 0.9771 
Space group F23 P1 
Unit cell parameters   
     a, b, c, (Å) 307.95, 307.95, 307.95 51.1, 68.5, 75.7 
     α, β, γ (°) 90, 90, 90 63.3, 82.0, 80.9 
Resolution range (Å)a 50-3.15 (3.26-3.15) 50-1.95 (2.02-1.95) 
No. of reflections   
     Total 1,037,464 149,932 
     Unique 41,762 (4,116) 62,895 (6,137) 
Completeness (%) 99.95 (100) 95.93 (88.35) 
Redundancy 24.8 (23.7) 2.4 (2.3) 
I/σ (I) 27.13 (4.97) 7.12 (2.19) 
Rmeas (%) 14.1 (74.2) 8.1 (36.1) 
Refinement   
Rwork/Rfree (%) 15.7/19.7 21.0/27.4 
r.m.s. deviations   
     Bond length (Å) 0.009 0.009 
     Bond angles (°) 1.21 1.27 
No. of atoms 9,925 6,485 
     Protein 9,809 5,899 
     Ligands 116 58 
     Water 0 528 
Ave. B-factors (Å2)   
     Protein 50.1 34.4 
     Water 31.1 38.3 
Ramachandran (%)   
      Favored 96 97 
      Outliers 0.5 0.41 
aValues in brackets are for the highest resolution bin.  
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Figure 4.1. GTPase domain structure. (A) Domain organization of atlastin-1. The large G 
domain (orange) is connected to the middle domain by a short flexible linker and is followed 
by two transmembrane helices that span the membrane and a C-terminal domain. A 
topological model is shown (right panel). The fragment crystallized consists of residues 1–339 
of human atlastin-1 (orange, lower panel). An inset displays a larger view of the binding 
pocket with GDP and magnesium, with an Fo–Fc omit map contoured at 4.0σ (B) Protomer 
overlay of the GTPase domain structure (orange) with crystal form 1 (grey) from (19). (C) 
Differing orientations of F76 (sticks, various colors) from atlastin-1 structures solved to-date. 
(D) Overlay of atlastin-1 GTPase dimer onto form 1 dimer structure (shown as cartoon 
cylinders). Black arrows indicate a region of secondary structure that shifts in the new 
structure due to lack of linker and middle domain interactions found in the form 1 structure.  
 
Crystal structure of the arginine finger mutant bound to GDP 
 The catalytic core fragment containing the mutation R77A was purified and 
crystallized, resulting in a single crystal form bound to GDP and magnesium 
(spacegroup P1, two molecules/asymmetric unit; Table 4.1. and Figure 4.2.). Mutant 
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crystals diffracted X-rays to 1.95Å and the structure was solved using molecular 
replacement with the GTPase domain and middle domains from the form 2 structure 
(PDB ID code 3Q5E) as separate search models (19). Despite the high resolution of 
the acquired data, many surface exposed loops of the structure are disordered and 
remain absent from the model. These include residues 102-106, 112-117 (switch 1), 
149-156 (switch 2), 338-339 (flexible, inter-domain linker), and 376-379 (loop 
connecting the first and second helices of the middle domain). The loop containing the 
R77A mutation is well ordered, and appears to take on the same conformation as it 
does in the form 2 crystal structure (Figure 4.2.B).  
 
 
 
Figure 4.2. R77A structure. (A) Asymetric unit cell contents. (B) Protomer overlay of the 
R77A structure (orange and blue) with crystal form 2 (grey) from (19). Two views are shown 
(top and bottom). Inset shows an expanded view of binding pocket of the two aligned with the 
mutation and nucleotide displayed as sticks. (C) Middle domain interactions between unit 
cells. A protomer from one unit cell (colored orange and blue) and that of its neighboring unit 
cell (grey), with an inset to show the details of the interactions between residues in their 
middle domains. (D) Detailed view of F76. Residue (shown as sticks) is modeled as an alanine 
with GDP and magnesium; an Fo–Fc omit map around the residue is contoured at 3.0σ.  
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 One of the most noteworthy features of the structure is that it shows atlastin-1 
in a monomeric state. There are no molecules in the asymmetric unit that form 
biologically relevant interfaces (28), and adjacent unit cells do not present any 
additional interactions with the protein’s GTPase domain. In particular, the switch 
regions of the G domain, which are the elements that presumably change conformation 
in a nucleotide-dependent manner, are not involved in any interactions. Despite this, 
the overall conformation is very similar to that of the form 2 atlastin-1 structure 
(RMSD 0.819Å, Figure 4.2.). Like the form 2 structure, the middle domain docks 
against the GTPase domain, interacting with the same surfaces and residues. 
Interestingly, the middle domain three-helix bundle packs together in a slightly 
different way, with the third helix of the middle domain kinking at residue 415, which 
presumably causes the remaining two helices to adjust their positions. This minor 
change in angle is most likely a result of crystal packing interactions, as there are 
several significant points of contact between molecules in adjacent unit cells along the 
middle domain’s third helix (Figure 4.2.) but could have some biological relevance. 
Other areas of the structure that vary between the R77A mutant and the form 2 
structure include loops close to the dimer interface, several of which are disordered in 
the new structure. Considering the relatively large number of disordered regions 
(many of which are conserved and crucial parts of the protein) this structure would 
suggest that most of these loops are flexible in solution where the protein is 
monomeric and with the middle domain docked at the G domain. This would allow the 
protein to sample many conformations in solution. Notably, the F76 residue in the P-
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loop has little electron density associated with it (difference density is limited to a 
small area around Cβ) suggesting multiple conformations (Figure 4.2.D).  
 
Mutations in the P-loop and dimer interface perturb nucleotide binding, hydrolysis, 
and dimerization 
 Both the structures discussed above and those that have already been published 
have allowed us to design mutations in atlastin-1 that shed light onto the more detailed 
mechanisms of nucleotide binding as well as the role of dimerization in hydrolysis. 
Specifically, we targeted two residues in the GTPase domain of human atlastin-1 
within the construct of the catalytic core fragment (amino acids 1-446). Mutants 
included F76 (located in the P-loop) mutated to either alanine or glycine, and E224 
(located at the G domain dimer interface) mutated to either alanine or histadine 
(Figure 4.3.A). The first, F76 of the P-loop, is in close proximity to the nucleotide beta 
and gamma phosphate groups in the binding pocket. In the GDP bound structures it is 
positioned such that the gamma phosphate cannot be accommodated, suggesting it 
could play a role in gating this area of the binding pocket. Residue E224 forms cross- 
dimer interactions in all dimeric atlastin structures, including a salt bridge with R77 in 
those bound to GDP and hydrogen bonds in those bound to GTP and transition state 
analogs. All mutants expressed and purified with similar purity and stability as the 
wild-type. These four mutants were all tested for GTPase activity, oligomerization, 
and nucleotide binding.  
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Figure 4.3. GTPase activity and nucleotide binding properties of atlastin mutants. (A) 
Position of mutants probing for nucleotide binding and dimerization properties of atlastin-1. 
The form 1 atlastin-1 dimer is shown. Mutant residues are shown as spheres, with those on the 
left protomer in red and the right protomer in orange (B) GTPase activity. GTPase activity 
was determined by measuring the production of inorganic phosphate upon GTP hydrolysis at 
various protein concentrations. (C) Nucleotide on rates (left), off rates (middle), and Kd (right) 
of mant-GDP, mant-GTP, and mant-GppNHp.  
 
All four mutants exhibited a decrease in activity as tested in a velocity vs. 
enzyme concentration assay (Figure 4.3.B). The most severely affected mutant was 
F76G, retaining less than a quarter of the wild-type activity. The remaining three 
mutants retained approximately one third of wild-type activity. Interestingly, the 
mutants located at residue E224 showed some non-linearity in the plot of activity vs. 
enzyme concentration, suggesting some degree of cooperativity may be present 
(Figure 4.3.B). 
Next, oligomerization propensity in the presence of various nucleotides was 
tested using multi-angle light scattering coupled to a size exclusion column (SEC-
MALS). All mutants tested were monomeric in their apo and GDP-bound forms 
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(Figure 4.4., red and purple traces, respectively). In the presence of the GTP analog 
GppNHp (green traces), all of the mutants exhibited a dominant, shifted peak that 
corresponded to the molecular weight of a dimer. The wild-type atlastin-1 catalytic 
core in the presence of GppNHp was also predominantly a dimer, with a very small 
(<5%) portion of the population running as a monomer. In both E224A/H mutants, this 
monomeric species was slightly more populated. Lastly, in the transition state analog 
GDP!AlFx, all mutants showed a single, monodisperse peak at the molecular weight 
corresponding to a dimer (Figure 4.4., orange traces). These results suggest that while 
the F76A/G mutants do not perturb the dimer interface, both E224A/H mutants seem to 
have some (if only a weak) effect on dimerization over a longer, near equilibrium 
timescale after nucleotide binding.  
Finally, we assessed the binding kinetics of the different mutants for several 
nucleotides, in particular mant-GDP, mant-GTP, and mant-GppNHp. All four mutants 
were able to bind the three nucleotides tested, with both kon and koff measured directly 
and Kd calculated from these experimental values. Both F76A/G mutants showed a 
higher affinity for all three nucleotides, especially GTP and GDP as a result of faster 
on-rates for these nucleotides and slower off-rates. Interestingly, differences in GTP 
on-rates correlated with the side chain length of residue 76, with phenylalanine 
showing the slowest on-rates, alanine showing an intermediated level and glycine 
showing the fasted on-rates of the three. The E224A/H mutants in contrast, showed 
very little difference from wild-type values except for in mant-GppNHp, where the Kd 
was lower than wild-type due to a lower average koff (Figure 4.3.C). 
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Figure 4.4. SEC-MALS for function-probing mutants. SEC-MALS of atlastin-1 WT, F76A, 
F76G, E224A, or E224H nucleotide free (Left, red) or bound to GppNHp (Left, green), GDP 
(Right, purple), or GDP•AlFx (Right, orange). Plotted on the left Y axis, the signal from the 
90°-scattering detector and refractive index detector is shown in a solid colored line and a 
black dashed line, respectively. On the right Y axis, average molecular weight as calculated 
every second across the protein elution peak is shown as black circles for the major peak and 
grey circles for the second, minor peak (if present). Theoretical molecular weights based on 
primary sequence for the monomer and dimer are indicated as horizontal, dashed lines. 
Proteins (40 µM) were incubated with nucleotides (2 mM) prior to SEC-MALS analysis in a 
mobile phase lacking nucleotides.  
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All four mutants showed at least a two-fold decrease in GTPase activity, 
indicating they have some significant effect on hydrolysis. The first mutants, located 
at F76, do not have any effect on the protein’s ability to dimerize but both mutations of 
this residue drastically increased the binding affinity of mant-GDP and mant-GTP, 
with a more muted effect on the affinity for mant-GppNHp. In previously solved 
structures as well as the GTPase domain structure presented here, this phenylalanine 
takes on an important position within the enzyme. Along with F151 and two conserved 
glycines G74 (in the P-loop) and G149 (in the switch 2 motif), these two aromatic side 
chains form a “glycine brace”, like those described for Ras-like GTPases (29), when 
the protein is in its form 2 conformation (Figure 4.5.). This interaction involves C–H-π 
interactions between F76-G149 and F151-G74, which are both 4-4.5Å apart in the form 2 
structure (consistent with this type of interaction (30)), but they are ~7-8Å apart in 
both the form 1 and new isolated GTPase domain structures. This form of structural 
stabilization would be lost upon mutation of F76 to alanine or glycine, and would allow 
the P-loop a greater degree of flexibility that could result in a faster nucleotide-binding 
on-rate, but also slow down hydrolysis by altering the kinetics of how the nucleotide 
binding motifs rearrange around GTP to form a tight and efficient binding pocket.  
While it also shows a significant decrease in activity, the E224 mutant displays 
little change in nucleotide affinity and a minor defect in dimerization. More interesting 
is the potential cooperativity exhibited by these mutants, which would suggest they 
affect the Kd of dimerization in atlastin-1, and that dimerization is indeed important 
for its catalytic activity like other dynamin superfamily members. In the past, we have  
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Figure 4.5. Intra- and intermolecular contacts of mutations. Structure-guided mutant 
positions and environments are shown for all three published crystal forms, including form 1 
(top panels), form 2 (middle panels), and form 3 (bottom panels). Nucleotide, residues 
selected for mutation, and important residues in their vicinity are shown as sticks, with F76 
illustrated on the left and E224 on the right. Displayed residues that are located on the main 
protomer (dark grey) are colored orange, and those on the opposing protomer (light grey) are 
colored in cyan. Residue names are labeled proximally, and residue distances (black, dashed 
lines) are displayed.  
 
never observed cooperativity in the wild-type atlastin-1 catalytic core fragment, 
although it is possible that the Kd for dimerization is much lower than the 
concentrations that can be measured in our current assay (the lowest being 250 nM) 
making cooperativity difficult to detect. This residue (conserved in atlastins) makes 
cross-dimer contacts in both GDP-bound and GTP-bound structures. In form 1 and 2 
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structures, as well as our newest GTPase domain structure, E224 makes a salt bridge 
with R77 in the opposing dimer. Alternatively, in the form 3 structures (bound to either 
GppNHp or GDP!AlF4-) this residue instead contacts S116 in the opposing dimer with 
a hydrogen bond, pulling switch 1 into a position that covers the nucleotide-binding 
pocket. Disruption of this interaction and subsequent destabilization of nucleotide 
binding motif arrangement could lead to the reduction in hydrolysis efficiency 
observed for this mutant, although we did not see evidence for dimerization prior to 
hydrolysis in our previous FRET and GTPase activity results (20). Altogether, we 
have reported two novel atlastin-1 structures as well as mutagenesis data that enhance 
the working model of how the G domain may be activated by the middle domain and a 
potential role for cooperativity in hydrolysis.  
 
CONCLUSIONS 
 The superfamily of dynamin-related GTPases has become an area of intense 
study, not only because of their involvement in diverse and important cellular 
functions, but also because many are implicated in human disease. Although they do 
share some commonalities in domain architecture and sequence, new evidence 
continues to show that they each have many unique characteristics as well. Atlastins 
are relatively new to this group and most of their molecular details only started being 
worked out in the last five years. As the furthest related member of the dynamin 
family, atlastins have proved themselves to be unique and interesting in their own 
right.  
The two structures and mutagenesis experiments presented here provide more 
insight into these differences and add to our understanding of atlastin’s function as a 
GTPase, which will help uncover the mechanism of its fusogenic activity in future 
studies. The GTPase domain takes on a form 1-like conformation, which could 
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represent the conformation found in solution of this domain alone. We have shown in 
the past that the interaction between the GTPase and middle domain observed in the 
form 2 crystal structure is indispensible for GTP loading and subsequent hydrolysis 
(20). This mode of regulation is unique in the atlastin subfamily. The second structure, 
that of the R77A mutant in the catalytic core of atlastin-1, presents a monomeric 
atlastin bound to GDP. This oligomeric state coincides with experiments done in 
solution, and could represent a better picture of how atlastin behaves in its monomeric, 
middle domain docked state. The numerous exposed, disordered loops in this structure 
are common in other structures of small GTPases, as well as some dynamin family 
protein structures especially in the absence of a gamma phosphate (31-33). This 
flexibility and dynamic movement of critical binding motifs is important for these 
proteins’ overall function as nucleotide binding and hydrolysis machines. 
In addition to these structures, our mutant data provide interesting clues for the 
role of two residues, F76 in the P-loop and E224 at the dimer interface. All four residues 
involved in the “glycine brace” discussed above (G74, F76, G149, and F151) are 
completely conserved in atlastins. Moreover, F151 is a known disease locus in patients 
with the neurodegenerative disorder Hereditary Spastic Paraplegia (HSP), highlighting 
the importance of this structural motif. E224 serves as a contact in all dimeric structures 
of atlastin-1 solved to-date. In GDP bound structures it pairs with R77 from the P-loop, 
while in GTP analog and transition state analog structures it forms a hydrogen bond 
with S116 from the opposite monomer’s switch 1 (G2) motif that caps the nucleotide 
binding pocket after GTP is bound. The disruption of this contact results in the 
destabilization of the dimer itself, and lowered efficiency for hydrolysis possibly due 
to improper positioning of this important loop. While it still may be possible that 
atlastin-1 can hydrolyze GTP in its monomeric state, the efficiency of this event could 
be lowered dramatically without this and other cross-dimer contacts forcing the 
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binding pocket into the optimal position. Our current model shows atlastin first 
binding to GTP in a form 2-like state, and proceeding with hydrolysis just before 
dimerization of both GTPase and middle domains simultaneously. Minor alterations to 
accommodate these results, perhaps by bringing dimerization and hydrolysis into the 
same, simultaneous step could help reconcile our data with the current model. In data 
published recently by our lab, FRET based analysis showed that simultaneous 
dimerization by the GTPase and middle domains happens on a fast timescale only in 
conditions where GTP hydrolysis can occur. When a catalytically dead mutant or GTP 
analogs are used, dimerization does take place but on a much slower timescale (over 
the course of 10 minutes vs. 5 seconds). It’s important to note that all other dynamin 
superfamily members rely on oligomerization to accelerate hydrolysis (34-40), though 
the possibility that atlastin could possess this and other unique molecular features 
should not be discounted. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
STRUCTURAL AND BIOCHEMICAL STUDIES OF ATLASTIN-1 
Summary of findings 
 Membrane fusion is a complex but necessary function in every eukaryotic cell for 
tasks ranging from mitochondrial and ER fusion to exocytosis and endosomal trafficking. 
This biophysical phenomenon serves many vital purposes for maintaining cellular health 
with its importance epitomized in the diseases that result when these processes go wrong. 
SNAREs and viral fusion proteins were some of the first fusogens discovered and 
intensively studied, resulting in huge leaps in our understanding of how membrane fusion 
and dynamics work in general (1, 2). The atlastin proteins are relative newcomers to this 
field, with work on their molecular details beginning only about five years ago.  
 Studying the catalytic core of atlastin has resulted in numerous high-resolution 
crystal structures, revealing novel modes of regulation and intriguing conformational 
changes. Eight crystal structures in total have resulted in models for states bound to 
different forms of guanine nucleotide including GDP, GppNHp (a GTP analog), and 
GDP!AlF4- (a transition state analog). The first two structures were the first solved for 
atlastin, and were both bound to GDP (3, 4). However, there was a striking difference 
between the two structures that suggested they could represent pre- and post-fusion 
conformations. While this finding is still somewhat puzzling, the current hypothesis 
remains that the first structure (called form 1) is the post-hydrolysis, GDP-bound state, 
while the second (form 2) structure is an inhibited GDP-bound form. In the same study, we 
showed for the first time in vitro that the catalytic core of atlastin could dimerize upon 
binding to GTP and transition state analogs. This is somewhat at odds with previous 
findings of cellular extracts that suggested atlastin is a tetramer in the membrane (5-7), 
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however since our studies only use the N-terminal soluble portion of the protein, there is a 
possibility that oligomerization of atlastin could be different in the context of the full-
length protein in the membrane. Additionally, GTPase activity was confirmed for the 
human isoform 1 of atlastin, having only been observed once before (8). Along with these 
biochemical characterizations of wild-type atlastin-1, we tested numerous HSP mutant 
forms of the protein and found several with deficiencies in their ability to dimerize or 
hydrolyze GTP, sheading some light onto disease pathogenesis.  
 These two initial structures, while informative, contained only a few clues about 
the catalytic mechanism of these proteins. We subsequently solved four nearly identical 
structures, two bound to the GTP analog GppNHp and two bound to the transition state 
analog GDP!AlF4-, that demonstrated how the conserved nucleotide binding motifs 
position themselves for GTP hydrolysis (9). The dimeric structures observed in all four 
crystals also proved to be biologically relevant, showing that an interaction between the 
GTPase and the middle domains contributes to a robust dimer interface. These structures 
added a new conformation (which we call form 3) to the two previously mentioned GDP-
bound structures. From these, we designed a FRET-based assay system to detect the 
movements of the GTPase and the middle domains when they came into close proximity to 
another protomer. The results of these experiments forced us to reconsider the current 
model of atlastin-mediated fusion, which was originally based on the two crystal structures 
bound to GDP. In the original model, atlastin GTPase domains would bind GTP and 
dimerize, followed by GTP hydrolysis and a subsequent “power stroke” of the middle 
domain, bringing them and opposing membranes together. However, FRET data have 
revealed that both the GTPase and middle domains come together on approximately the 
same timescale. In addition, other groups working on atlastin found that the GTPase 
domain in isolation could not hydrolyze GTP efficiently and could not interact with itself 
(i.e. dimerize), which was also inconsistent with the model at the time. When we looked 
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carefully at all of the structures, the form 2 structure stood out because of an interaction 
region between the GTPase and middle domain. Separated GTPase and middle domain 
constructs mixed together rescued the ability of the GTPase domain to bind to GTP, 
hydrolyze it, and dimerize with itself. Moreover, mutations to the region where the GTPase 
and middle domain interact in the form 2 structure abolish this ability. From the 
compilation of this and all available data, we proposed a new model (9). This model 
(Figure 5.1.) starts with a monomeric atlastin GTPase domain, with the middle domain 
docked against it, as is observed in the form 2 structure. This conformation allows GTP to 
bind, and once this occurs the middle domain disengages the GTPase domain and both 
domains come together to dimerize in a form 3-like conformation. This tight dimer 
conformation would also bring together opposing membranes and with the help of the 
transmembrane domains and C-terminal amphipathic helix these membranes would fuse, 
followed by phosphate release and subsequent relaxation of the dimer (into a more form 1-
like conformation, bound to GDP).  
 
 
 
Figure 5.1. Working Model (9). 1.) Atlastin begins in a form 2-like, GTP-loading-competent state 
with the middle domain engaging the G domain. 2.) GTP binding and hydrolysis drive rapid 
disengagement of the middle domain from the G domain, immediately followed by G and middle 
domain dimerization. Once in this tethering complex, membrane curvature and stress caused by 
atlastin’s transmembrane domains and C-terminal amphipathic helix would allow fusion to occur 
spontaneously. 3.) Phosphate release follows, with relaxation and subsequent disassembly of the 
dimer.  
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The aforementioned crystal structures, three unique conformations in total, were 
novel contributions to the current understanding of atlastin proteins. In the midst of these 
discoveries, smaller pieces of the puzzle came together including the structures of the 
isolated GTPase domain and an arginine finger mutant, both bound to GDP. While these 
two structures did not present new conformations, they have added some details to the 
atlastin story. The GTPase domain structure resembles the conformation this domain takes 
on in the form 1 structure, suggesting that the form 2 conformation of the GTPase domain 
most likely arises only when in contact with the middle domain. The arginine finger 
mutant (R77A) structure of the catalytic core fragment bound to GDP was the first structure 
not to crystallize in the typical dimerized GTPase domain conformation, a more 
biologically relevant state since no oligomerization is ever observed with atlastin bound to 
GDP. This mutation to the catalytic arginine finger is devoid of GTPase activity but retains 
its ability to dimerize when bound to GTP and transition state analogs, but it requires long 
incubation times since hydrolysis-driven conformational changes are impaired. Other 
functional mutants were also designed based on all of the structures solved to-date, 
including F76A/G (a mutation to the switch 1 GTP binding motif) and E224A/H (a dimer-
interface mutant). All mutations reduced the activity of atlastin-1 by at least half, with the 
strongest mutation (F76G) retaining less than 20% of wild-type activity. Despite this, both 
F76 mutants displayed an increase in nucleotide binding affinity, suggesting a type of “gate 
keeper” role for this bulky residue. The mutations to the dimer interface located at E224, 
while they decrease the activity of the enzyme did not affect nucleotide binding rates or 
affinities. However, they did have a subtle effect on dimerization in the GTP analog 
GppNHp, and showed a small degree of cooperativity in the GTPase activity experiment, 
suggesting they could affect the affinity for dimerization of the enzyme and that 
dimerization is indeed important for catalysis. 
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Future directions 
 The atlastins represent a new and interesting family of proteins that catalyze 
membrane fusion in a way that has not yet been studied extensively. While the studies 
presented here contribute to the overall understanding of atlastin’s molecular mechanism 
and internal regulation, many unanswered questions remain with regard to disease 
mutations, conformational changes, and full-length atlastin’s behavior in the membrane.  
The majority of HSP mutations occur on the soluble portion of atlastin-1, 
suggesting that they may impact the protein’s fundamental enzymatic properties. However, 
many of the mutations tested in Chapter 2 had no effect on either GTPase activity or 
atlastin’s ability to dimerize in response to nucleotide binding. To further investigate the 
effects of these mutations we can implement our newest experimental approaches such as 
the FRET assay presented in Chapter 3. The result of this assay will indicate whether or 
not the mutants allow the protein to perform the same type of conformational switching as 
the wild type, and whether or not the kinetics of this process are affected. In addition, a 
new version of the FRET assay that can monitor intramolecular interactions and 
conformational changes is currently being developed using non-natural amino acid 
incorporation (10) to introduce two distinct dyes onto the same protein (donor and 
acceptor) (Figure 5.2.). This assay will reveal which mutations affect the interaction 
between the GTPase and middle domains, an interaction necessary for GTP binding. In 
addition to FRET, mant-nucleotide binding experiments and analytical ultracentrifugation 
could uncover other defects previously undetected by our original methods. Once their 
effects on the soluble domain are clearer, addressing the outcome on atlastin in the context 
of the full-length protein will also be important to understanding disease pathogenesis.  
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Figure 5.2. Protein labeling. (A) Labeling will proceed through thiol-modification on engineered 
cysteines (top; (9)) or click chemistry on incorporated azido-phenyl-alanine (bottom). (B) Click 
chemistry-based labeling of atlastin-1’s catalytic core fragment. The wild-type protein without 
azido-phenylalanine did not label. (C) Strategy for measuring intra-molecular conformational 
changes. 
 
The major lingering question in the study of atlastin proteins concerns whether or 
not molecular mechanisms established for the soluble domain apply to the full-length 
protein. For instance, does atlastin change its oligomeric state when going from a 
nucleotide-free or GDP-bound to a GTP-bound form? Do conformations observed in our 
crystal structures and confirmed in solution also take place during fusion? Early studies 
suggest that atlastin forms constitutive oligomers (tetramers) in the membrane, 
confounding our data on the soluble domain (5-7). Indeed, our initial purification and 
characterization efforts for full-length Drosophila atlastin revealed constitutive dimers in 
solution (Figure 5.3.B), and partial tetramerization upon addition of the GTP analog 
GppNHp. This additional degree of oligomerization has been suggested to occur through 
the transmembrane domains of atlastin, which would explain the apparent discrepancy 
with studies of the soluble domain. Regardless, these observations do not negate the 
possibility that the oligomerization interfaces observed in our structures are valid. 
Verification of these interactions and determination of participating domains are both 
necessary to compose a better picture of atlastin in the membrane. In the same way, 
conformational changes observed in the soluble domains must be confirmed or redefined 
in the full-length context. To accomplish this, FRET probes can still be used in  
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Figure 5.3. Purified, full-length atlastin. (A) SDS-PAGE of Drosophila and human atlastin 
(expressed in E.coli) prior to gel filtration. (B) SEC-MALS analysis of Drosophila atlastin in 
detergent micelles with (green) and without (red) GppNHp. A shift in the dimer peak may indicate 
a conformational change. Grey and black symbols across the protein peaks indicate absolute 
molecular weights determined by MALS. (C) Reconstituted membrane fusion (assay established by 
the McNew group (11)). 
 
reconstituted lipid systems to monitor domain motions as was done for the soluble domain. 
Another approach would be to use electron microscopy (EM) to reconstruct full-length 
atlastin as has been done for the G-protein coupled receptor, β2-adrenergic receptor in 
complex with its heterotrimeric G-protein complex (12). This approach has been shown to 
work for the soluble domain of atlastin by ours (Figure 5.4.) as well as another group (13), 
and will uncover important details on the overall structure while efforts for crystallizing 
the full-length protein continue.  
During the time of this thesis, new details have emerged regarding the requirements 
for fusion activity of full-length atlastin from Drosophila melanogaster. Perhaps most 
obviously, early experiments confirmed a requirement for GTP hydrolysis (11). More 
interestingly, fusion of membranes in vitro was nearly abolished without atlastin’s C-
terminus, but could be rescued by adding it in trans (5, 14). This part of atlastin was 
thought to be unstructured, but a more detailed analysis suggests that it most likely forms 
an amphipathic helix that dips into the membrane and causes local membrane curvature 
and disruption to lipid order. The same study revealed that the specific sequence of 
atlastin’s transmembrane domains was also important for fusion activity. Other studies 
have also demonstrated a necessity for dimerization through the middle domain to achieve  
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Figure 5.4. Atlastin-1 TEM class averages. (A) Sample class averages (showing various 
orientations) of atlastin-1 soluble domain bound to GppNHp. Two lobes are visible in most images, 
consistent with crystal structures of this nucleotide-bound state. Images were compiled from 
approximately 500 particles, using negative stain TEM on the FEI Tecnai F20 in Cornell’s NBTC. 
(B) Raw particle image showing the scale of the particles is similar to those found in the crystal 
structures.  
 
fusion (14, 15). To better understand how this family of proteins catalyzes membrane 
fusion, additional studies to work out the timing of domain interactions and conformational 
changes during this process must move forward. Several labs (including our own) have 
successfully purified full-length, recombinant Drosophila atlastin protein and have 
confirmed that it is competent for GTP-dependent membrane fusion when reconstituted 
into liposomes in an assay established by the McNew lab (11) (Figure 5.3.C). Full-length 
human atlastin-1 can be purified similarly, but attempts to demonstrate fusion activity have 
been unsuccessful so far. While the other two isoforms have yet to be tested, the fact that 
atlastin-1 cannot fuse membranes in vitro is puzzling. Though we simply may not have 
determined the correct environmental requirements for human atlastin-1 to catalyze fusion, 
another possibility is that it has lost this ability over the course of evolution. Perhaps only 
one or two of the three human isoforms has retained its ability to fuse membranes, leaving 
the remaining redundant copy(ies) to perform other, more specific functions. Human 
atlastin-1 is not expressed ubiquitously like the other two isoforms and is mainly found in 
neurons, leaving this explanation as a distinct possibility (6, 7). Drosophila only have a 
single atlastin isoform, therefore the essential function of fusing ER tubules must be 
 158 
retained considering the lack of redundancy in the system. For these reasons it is necessary 
to expand the techniques used here to other isoforms and homologs to gain a better 
understanding of what qualities are necessary for fusion-competent atlastins. At the same 
time, determining atlastin-1’s role in the cell via other cell biological and biochemical 
methods should be pursued. Two hereditary neuropathies caused by atlastin-1 mutations 
give a not-so-subtle hint of its necessity to these highly specialized and essential cells. 
Future research combined with the knowledge outlined here may ultimately lead to new 
treatments and a better understanding of axonopathies in general, carving a path to prevent 
these devastating diseases.  
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APPENDIX A 
 
MODELING OF THE TIME-RESOLVED FRET DATA. 
Dimerization kinetics 
For time-dependent FRET simulations, we propose a simple three-state model 
based on the available structural information: a monomeric non-FRET state M, an 
initial dimerization state D1, and a possible “relaxed” dimer state D2. We assume that 
the dynamics of nucleotide binding is sufficiently fast as to not significantly contribute 
to apparent dimerization and FRET behavior and is therefore ignored. Dimerization is 
modeled by the 2nd order kinetic equation: ! !!" = !!" ! ! − !!"" !  
Where [D] is the dimer concentration, [M] is concentration of free monomers, kon is 
the rate constant for dimerization, and koff is the rate constant for dissociation. The two 
populations are related by the mass conservation equation: !! = ! + 2 !  
Where [M0] is the initial monomer concentration at time equals 0 and the initial dimer 
concentration ([D0]) equals 0. The monomer concentration as a function of time 
([M(t)]) can be modeled numerically by discretizing the kinetic equation above: ∆ ! ∆!! = !!" ! ∆!! ! − !!"" ! ∆!! ∆! ! ∆!!!! = ! ∆!! − 2∆ ! ∆!!  
Where ∆! is the discretized time interval, and the subscript n indicates the nth interval 
such that ! = !∆!. The dimer concentration [D] is modeled similarly.  
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However, with the incorporation of a second possible “relaxed” dimer state, 
the populations are determined by: !! ∆!!!! = !! ∆!! 1− !!""∆! − !!"∆! + [! ∆!! ]!!!"∆! !! ∆!!!! = !! ∆!! 1− !!""∆! + !! ∆!! !!"∆! 
Where D1 is the initial dimerization state and hence receives all new dimerization 
events at each time interval. D2 is the relaxed dimer state and is acquired through D1 at 
the relaxation rate k12. A second, backward rate constant k21 could have also been 
incorporated, but was found to be an unnecessary parameter for simulating the 
observed FRET signal. 
The above equations are sufficient for instantaneous transitions between D1 
and D2. However, for a finite relaxation time, an additional set of transition states D12 
is acquired with a total transition time of !!" = !∆!. Here, m is an integer 
representing the number of concentration elements of the vector [D12]. The final time-
dependent equations can be written: !! ∆!!!! = !! ∆!! 1− !!""∆! − !!"∆! + [! ∆!! ]!!!"∆! 
!!" !,∆!!!! = !! ∆!! !!"∆!, ! = 1[!!"(! − 1,∆!!)](1− !!""∆!), 2 ≤ ! ≤ ! 
 !! ∆!!!! = !! ∆!! 1− !!""∆! + !!" !,∆!! !!"∆! 
Where i indicates the ith element of the set of states D12 and the total time a 
subpopulation of dimers has spent in transition is ! = !∆!. 
 
FRET calculations 
FRET can be determined by applying the Förster equation: 
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! = 11+ !!!! ! 
Where E is the FRET efficiency, r is the distance between the donor and the acceptor, 
and R0 is the Förster distance at which ! = !!!. If the fraction of donor molecules is F, 
and acceptor molecules is (1-F), then the distribution of dimer pairs is given by the 
binomial distribution:   2! !! 1− ! !!! !!!!!!"#!! = 0,1,2 
For any sub-population of dimers, the donor fluorescence (SDONOR) and the FRET 
signal (SFRET) are proportional to the probability of getting a FRET pair: !!" = 2!(1− !) !!"#$ ∝ !!"!(!) ! !  !!"#"$ ∝ !!" 1− ! ! ! !  
By assigning a value for r for each state D1, D2, and a set of r-values for the vector of 
states D12, we can determine the FRET efficiency at each state (E1, E2, E12). The total 
signal is given by: 
!!"#$ ∆!! = 2! 1− ! !![!! ∆!! ]+ !![!! ∆!! ]+ !!" ! !!" !,∆!!!!!!  !!"#"$ ∆!! = ! ! ∆!! + 2!! ! ∆!!
+ 2! 1− ! (1− !!)[!! ∆!! ]+ (1− !!)[!! ∆!! ]
+ 1− !!" ! !!" !,∆!!!!!!  
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Simulation parameters 
For the GTP-binding dimer simulations, the Förster distance R0 we used was 
the calculated value of 47 Å. The value of r for D1 and D2 were 30 Å and 50 Å as 
determined from structural data. We estimate that the equilibrium dissociation 
constant for dimerization to be better than 1µM, therefore we assumed a dissociation 
constant !! = !!""!!"  of 500 nM. Assuming a kon of about 0.32 µM-1s-1 koff was 
calculated to be 0.16 s-1. The relaxation rate k12 was taken to be 0.50 s-1 with a 
transition time τ12 of 0.10 s. The time interval ∆! was 0.01 s, which matches the time 
resolution of the relevant instrumentation. Finally the transition states D12 were 
calculated by assuming a uniform transition speed: ∆!∆! = !! − !!!!"  !!" !! = !! − !!!!!" !∆!!!!!!"#!! = 1…! 
For the GppNHp-binding dimer simulations, only the kinetic parameters are 
assumed to change. Since this system cannot undergo hydrolysis, it is assumed that the 
relaxation rate constant k12 is zero and hence does not undergo any transition (i.e. D12 
and D2 are always zero). We also observed a significantly longer time scale for 
equilibration of over an order of magnitude. Assuming the equilibrium dissociation 
constant for dimerization is unchanged, we chose to use a lower kon of 0.006  µM-1s-1 
and thus a calculated koff of 0.003 s-1. 
